US20060229708A1 - Methods, systems and devices for cardiac valve repair - Google Patents
Methods, systems and devices for cardiac valve repair Download PDFInfo
- Publication number
- US20060229708A1 US20060229708A1 US11/349,742 US34974206A US2006229708A1 US 20060229708 A1 US20060229708 A1 US 20060229708A1 US 34974206 A US34974206 A US 34974206A US 2006229708 A1 US2006229708 A1 US 2006229708A1
- Authority
- US
- United States
- Prior art keywords
- heart
- valve
- mitral valve
- left ventricle
- leaflet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
- A61F2/2457—Chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2454—Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2463—Implants forming part of the valve leaflets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2478—Passive devices for improving the function of the heart muscle, i.e. devices for reshaping the external surface of the heart, e.g. bags, strips or bands
- A61F2/2487—Devices within the heart chamber, e.g. splints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0487—Suture clamps, clips or locks, e.g. for replacing suture knots; Instruments for applying or removing suture clamps, clips or locks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
- A61B2017/00783—Valvuloplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00876—Material properties magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0412—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from suture anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0414—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having a suture-receiving opening, e.g. lateral opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0417—T-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
- A61B2017/0435—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body the barbs being separate elements mechanically linked to the anchor, e.g. by pivots
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0445—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors cannulated, e.g. with a longitudinal through-hole for passage of an instrument
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0446—Means for attaching and blocking the suture in the suture anchor
- A61B2017/0454—Means for attaching and blocking the suture in the suture anchor the anchor being crimped or clamped on the suture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0464—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors for soft tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B2017/0496—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials for tensioning sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2445—Annuloplasty rings in direct contact with the valve annulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/009—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof magnetic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
- A61F2220/0016—Fixation appliances for connecting prostheses to the body with sharp anchoring protrusions, e.g. barbs, pins, spikes
Definitions
- the present invention relates generally to medical methods, devices, and systems.
- the present invention relates to methods, devices, and systems for the endovascular or minimally invasive surgical repair of the atrioventricular valves of the heart, particularly the mitral valve.
- Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium.
- the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve.
- Regurgitation of the valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.
- Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve.
- the valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may be damaged or otherwise dysfunctional.
- the valve annulus may be damaged, dilated, or weakened limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle.
- the mitral valve leaflets detach from the chordae tendinae, the structure that tethers them to the ventricular wall so that they are positioned to coapt or close against the other valve leaflet during systole.
- mitral valve disease can include functional mitral valve disease which is usually characterized by the failure of the mitral valve leaflets to coapt due to an enlarged ventricle, or other impediment to the leaflets rising up far enough toward each other to close the gap or seal against each other during systole.
- valve annuloplasty A recent technique for mitral valve repair which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge-to-edge” technique. While all these techniques can be very effective, they usually rely on open heart surgery where the patient's chest is opened, typically via a sternotomy, and the patient placed on cardiopulmonary bypass. The need to both open the chest and place the patient on bypass is traumatic and has associated morbidity.
- methods and devices may be deployed directly into the heart chambers via a trans-thoracic approach, utilizing a small incision in the chest wall, or the placement of a cannula or a port.
- methods, devices, and systems may not require open chest access and be capable of being performed endovascularly, i.e., using devices which are advanced to the heart from a point in the patient's vasculature remote from the heart.
- the methods, devices, and systems should not require that the heart be bypassed, although the methods, devices, and systems should be useful with patients who are bypassed and/or whose heart may be temporarily stopped by drugs or other techniques. At least some of these objectives will be met by the inventions described hereinbelow.
- a method of treating a heart comprising attaching a first device to a first location of a wall of a left ventricle of the heart; attaching a second device to a second location of the heart, wherein the second location is located opposite the first location; and moving the first device and the second device toward one another to cause the first location and second location to move toward one another so as to re-shape at least one of the mitral valve annulus or the left ventricle in a manner that reduces backflow through the mitral valve.
- a method of treating a heart comprising coupling at least one valve to a steerable delivery device; percutaneously introducing the valve into the heart using the steerable delivery device; and placing the valve in a pulmonary vein of the heart, wherein the valve regulates blood flow into the left ventricle of the heart.
- a method of treating a heart comprising coupling a first wedge-shaped device to a steerable delivery device, wherein the first device has a contact surface adapted to be positioned adjacent a first mitral valve leaflet of the heart; percutaneously introducing the first device into the heart using the steerable delivery device; and securing the first device to the heart such that the first mitral valve leaflet is positioned adjacent the contact surface of the device.
- a device for treating heart disease comprising a prosthetic comprising a wedge having a length that is about equal to a length of a line of coaptation of a mitral valve and a depth sufficient to prevent prolapse of a mitral valve when the wedge is placed atop an annulus of the mitral valve along the line of coaptation; and one or more anchors protruding from the wedge for coupling the wedge to the annulus of the mitral valve.
- FIG. 1A is a schematic illustration of the left ventricle of a heart showing blood flow during systole with arrows.
- FIG. 1B shows a cross-sectional view of the heart wherein a flexible stent is positioned at or near the mitral valve.
- FIG. 2A shows a cross-sectional view of the heart showing one or more magnets positioned around the annulus of the mitral valve.
- FIG. 2B shows an annular band with magnets that can be positioned on the mitral valve annulus.
- FIG. 3 shows a cross-sectional view of the heart identifying locations for placement of valves.
- FIG. 4 show a cross-sectional view of the heart with a pair of flaps mounted at or near the mitral valve.
- FIG. 5A shows a schematic side view of the mitral valve leaflets with a flap positioned immediately below each leaflet.
- FIG. 5B shows a downward view of the mitral valve with a pair of exemplary flaps superimposed over the leaflets.
- FIG. 5C shows a pair of mitral valve leaflet flaps having complementary shapes.
- FIG. 6A shows a cross-sectional view of the heart with a membrane ring positioned at the mitral valve annulus.
- FIG. 6B shows a schematic view of the membrane ring, which includes an annular ring on which is mounted a membrane.
- FIG. 7A shows a cross-sectional view of a heart with a bladder device positioned partially within the left ventricle and partially within the left atrium.
- FIG. 7B shows a schematic side view of the mitral valve leaflets failing to coapt.
- FIG. 7C shows a schematic side view of a the mitral valve leaflets with a bladder positioned between the leaflets.
- FIG. 7D shows a plan view of the mitral valve with the leaflets in an abnormal closure state such that a gap is present between the leaflets.
- FIG. 8 shows a cross-sectional view of the heart wherein a one-way valve device is located in the left atrium.
- FIG. 9A shows a prosthetic ring that is sized to fit within a mitral valve.
- FIG. 9B shows another embodiment of a prosthetic ring wherein a one-way valve is positioned inside the ring.
- FIG. 10 shows a prosthetic with one or more tongues or flaps that are configured to be positioned adjacent the flaps of the mitral valve
- FIG. 11A shows an exemplary embodiment of one or more clips that are positioned on free edges of the leaflets.
- FIG. 11B shows pair of leaflets with a magnetic clip attached to the underside of each leaflet.
- FIG. 11C shows the leaflets coapted as a result of the magnetic attraction between the magnetic clips.
- FIG. 11D shows a pair of leaflets with a single clip attached to one of the leaflets.
- FIG. 12 shows a schematic, cross-sectional view of the heart with a wedge positioned below at least one of the leaflets of the mitral valve.
- FIG. 13A shows an artificial chordae tendon.
- FIGS. 13B and 13C show attachment devices for attaching the artificial chordae tendon to a heart wall.
- FIG. 14 shows a cross-sectional view of the heart with a first and second anchor attached to a wall of the heart.
- FIG. 15 shows a catheter that has been introduced into the heart.
- FIG. 16 shows a schematic view of a papillary muscle with a ring positioned over the muscle.
- FIG. 17 shows a cross-sectional view of the heart with one or more magnets attached to a wall of the left ventricle.
- FIG. 18A shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle.
- FIG. 18B shows the heart wherein tethered magnets are implanted in various locations to geometrically reshape the annulus or the left ventricle.
- FIG. 18C shows the heart wherein magnets are implanted in various locations to geometrically reshape the annulus or the left ventricle.
- FIG. 19 shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle.
- FIG. 20 shows a cross-sectional view of the left ventricle with a tether positioned therein.
- FIG. 21 shows a cross-sectional view of the left ventricle with a delivery catheter positioned therein.
- FIG. 22 shows a cross-sectional view of the left ventricle with the delivery catheter penetrating a wall of the left ventricle.
- FIG. 23 shows a cross-sectional view of the left ventricle with the delivery catheter delivering a patch to the wall of the left ventricle.
- FIG. 24 shows a cross-sectional view of the left ventricle with the delivery penetrating delivering a second patch.
- FIG. 25 shows a cross-sectional view of the left ventricle with two tethers attached together at opposite ends from the patches mounted in the heart.
- FIG. 26 shows a cross-sectional view of the left ventricle with a needle or delivery catheter passed transthoracicaly into the left ventricle LV to deliver a patch to the exterior of the ventricular wall.
- FIG. 27 shows a schematic, cross-sectional view of the left ventricle in a healthy state with the mitral valve closed.
- FIG. 28 shows the left ventricle in a dysfunctional state.
- FIG. 29 shows the left ventricle with a biasing member mounted between the papillary muscles.
- FIG. 30 shows the left ventricle with a suture mounted between the papillary muscles.
- FIG. 31 shows the left ventricle with a snare positioned around the chordae at or near the location where the chordae attach with the papillary muscles.
- FIG. 32 shows a leaflet grasping device that is configured to grasp and secure the leaflets of the mitral valve.
- FIGS. 33A-33C show the leaflet grasping device grasping leaflets of the mitral valve.
- FIG. 34 shows the left ventricle with a needle being advanced from the left atrium into the left ventricle via the leaflet grasping device.
- FIG. 35 shows the left ventricle with sutures holding the papillary muscles in a desired position.
- FIG. 36 shows a cross-sectional view of the heart with one or more clips clipped to each of the papillary muscles.
- FIG. 37 shows a cross-sectional view of the heart with tethered clips attached to opposed walls of the left ventricle.
- the present invention provides methods, systems, and devices for the endovascular repair of cardiac valves, particularly the atrioventricular valves which inhibit back flow of blood from a heart ventricle during contraction (systole), most particularly the mitral valve between the left atrium and the left ventricle.
- endovascular it is meant that the procedure(s) of the present invention are performed with interventional tools, guides and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart.
- the interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach the heart.
- the procedures of the present invention will generally not require penetrations made directly through the exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route.
- the procedures of the present invention will usually be percutaneous and intravascular, many of the tools will find use in minimally invasive and open surgical procedures as well that includes a surgical incision or port access through the heart wall.
- the tools for capturing the valve leaflets prior to attachment can find use in virtually any type of procedure for modifying cardiac valve function.
- the atrioventricular valves are located at the junctions of the atria and their respective ventricles.
- the atrioventricular valve between the right atrium and the right ventricle has three valve leaflets (cusps) and is referred to as the tricuspid or right atrioventricular valve.
- the atrioventricular valve between the left atrium and the left ventricle is a bicuspid valve having only two leaflets (cusps) and is generally referred to as the mitral valve.
- the valve leaflets are connected to the base of the atrial chamber in a region referred to as the valve annulus, and the valve leaflets extend generally downwardly from the annulus into the associated ventricle. In this way, the valve leaflets open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle.
- valve leaflets are pushed together and closed to prevent back flow of blood into the atria.
- the lower ends of the valve leaflets are connected through tendon-like tissue structures called the chordae, which in turn are connected at their lower ends to the papillary muscles.
- Interventions according to the present invention may be directed at any one of the leaflets, chordae, annulus, or papillary muscles, or combinations thereof. It will be the general purpose of such interventions to modify the manner in which the valve leaflets coapt or close during systole so that back flow or regurgitation is minimized or prevented.
- the left ventricle LV of a normal heart H in systole is illustrated in FIG. 1A .
- the left ventricle LV is contracting and blood flows outwardly through the tricuspid (aortic) valve AV in the direction of the arrows.
- Back flow of blood or “regurgitation” through the mitral valve MV is prevented since the mitral valve is configured as a “check valve” which prevents back flow when pressure in the left ventricle is higher than that in the left atrium LA.
- the mitral valve MV comprises a pair of leaflets having free edges FE which meet evenly to close, as illustrated in FIG. 1A .
- the opposite ends of the leaflets LF are attached to the surrounding heart structure along an annular region referred to as the annulus AN.
- chordae tendineae CT (referred to hereinafter as the chordae) which include plurality of branching tendons secured over the lower surfaces of each of the valve leaflets LF.
- the chordae CT in turn, are attached to the papillary muscles PM which extend upwardly from the lower portions of the left ventricle and interventricular septum IVS.
- atrioventricular valves While the procedures of the present invention will be most useful with the atrioventricular valves, at least some of the tools described hereinafter may be useful in the repair of other cardiac valves, such as peripheral valves or valves on the venous side of the cardiac circulation, or the aortic valve.
- the methods of the present invention can comprise accessing a patient's vasculature at a location remote from the heart, advancing an interventional tool through the vasculature to a ventricle and/or atrium, and engaging the tool against a tissue structure which forms or supports the atrioventricular valve.
- tissue structure By engaging the tool against the tissue structure, the tissue structure is modified in a manner that reduces valve leakage or regurgitation during ventricular systole.
- the tissue structure may be any of one or more of the group consisting of the valve leaflets, chordae, the valve annulus, and the papillary muscles, atrial wall, ventricular wall or adjacent structures.
- the interventional tool will be oriented relative to the atrioventricular valve and/or tissue structure prior to engaging the tool against the tissue structure.
- the interventional tool may be self-orienting (e.g., pre-shaped) or may include active mechanisms to steer, adjust, or otherwise position the tool.
- orientation of the interventional tool may be accomplished in whole or in part using a separate guide catheter, where the guide catheter may be pre-shaped and/or include active steering or other positioning means such as those devices set forth in U.S. patent application Ser. Nos. 10/441,753 filed May 19, 2003, Ser. No. 10/441,508 filed May 19, 2003 and Ser. No. 10/441,687 filed May 19, 2003, all of which are expressly incorporated by reference herein. In all cases, it will usually be desirable to confirm the position prior to engaging the valve leaflets or other tissue structures.
- Such orienting step may comprise positioning the tool relative to a line of coaptation in the atrioventricular valve, e.g., engaging positioning elements in the valve commissures and confirming the desired location using a variety of imaging means such as magnetic resonant imaging (MRI), intracardiac echocardiography (ICE), transesophageal echo (TEE), fluoroscopy, endoscopy, intravascular ultrasound (IVUS) and the like.
- imaging means such as magnetic resonant imaging (MRI), intracardiac echocardiography (ICE), transesophageal echo (TEE), fluoroscopy, endoscopy, intravascular ultrasound (IVUS) and the like.
- heart disease in general, and valve repair in particular are treated by targeting the pacing of the heartbeat.
- heart disease is treated by introducing one or more pacing leads into a heart chamber.
- the pacing leads are placed in contact with a heart muscle and are in electrical communication with a power source.
- the power source provides paced electrical stimuli to the heart muscle.
- the electrical stimuli are provided during or immediately after systole to extend systolic contraction of the heart, thereby extending the range of systole during each heartbeat. This extension of systole extends the amount of time in which the heart muscle tightens when it would otherwise be relaxing, when there is most mitral regurgitation in diseased mitral valves.
- FIG. 1B shows a cross-sectional view of the heart wherein a flexible stent 100 is positioned at or near the mitral valve MV.
- the stent 100 is annular and is sized and shaped to be positioned on the annulus of the mitral valve.
- the stent 100 can transition between a collapsed state of reduced size and an expanded state of enlarged size relative to the collapsed state.
- the flexible stent 100 can be percutaneously introduced into an individual's heart while being biased toward the collapsed state.
- the stent is advanced partially through the annulus of the mitral valve so that it is coaxially positioned within the annulus, as shown in FIG. 1B .
- the stent 100 is then secured to the annulus such that the stent exerts an inward force on the annulus thereby causing the annulus to resist dilation during diastole of the heart.
- a device for treating the mitral valve.
- the device can be a stent, such as the stent 100 , that is sized to fit coaxially within an annulus of a mitral valve.
- the stent includes a hollow frame.
- the frame can be annular such that it has a cross-sectional diameter that is sized such that an outer surface of the frame is in continuous coaxial contact with the annulus.
- the frame also includes one or more anchors protruding from it for securing the stent to the annulus.
- the anchors can be prongs, barbs, protrusions, or any structure adapted to secure the stent to the annulus.
- the stent is flexible between an expanded configuration and a contracted configuration and is biased toward the contracted configuration so that it exerts an inward force on the annulus.
- the stent 100 is delivered using a delivery catheter 10 that is advanced from the inferior vena cava IVC into the right atrium RA. Once the catheter 10 reaches the anterior side of the interatrial septum IAS, a needle 12 may be advanced so that it penetrates through the septum at the fossa ovalis FO or the foramen ovale into the left atrium LA. At this point, a delivery device can be exchanged for the needle and the delivery device used to deliver the stent 100 . The catheter 10 can also approach the heart in other manners.
- FIG. 2A shows a cross-sectional view of the heart showing one or more magnets 210 positioned around the annulus of the mitral valve MV.
- a corresponding method of treating heart disease involves the use of magnets. The method includes percutaneously introducing at least a first magnet 205 into an individual's heart and securing it to the mitral valve MV annulus. At least a second magnet 210 is percutaneously introduced into the heart and advanced so that it is within a magnetic field of the first magnet. The second magnet is secured to the heart. The polarity of one of the two magnets is then cyclically changed in synchronization with the heart beat so that the magnets attract and repel each other in synchronization with the heart beat.
- the first magnet therefore moves in relation to the second magnet and exerts an inward closing force on the mitral valve during systole.
- the magnets 210 can be positioned on an annular band 215 (shown in FIG. 2B ) that is sized and shaped to be implanted on the annulus of the mitral valve.
- the band 215 can be, for example, a stent.
- the magnets 210 or the annular band 215 are delivered using a delivery catheter 10 that is advanced from the inferior vena cava IVC into the right atrium RA, as described above with reference to FIG. 1 .
- a delivery catheter 10 that is advanced from the inferior vena cava IVC into the right atrium RA, as described above with reference to FIG. 1 .
- Any of the devices described herein can be percutaneously delivered into the heart by coupling the device to a delivery device, such as a steerable delivery catheter.
- two or more magnets are percutaneously introduced into an individual's coronary sinus such that they attract or repel each other to reshape the coronary sinus and an underlying mitral valve annulus.
- a method of treatment includes placing one or more one-way valves in one or more pulmonary veins of an individual either near the ostium of the vein or at some point along the length of the PV.
- Valves that may be used may be stentless valves such as designs similar to the TORONTO SPV® (Stentless Porcine Valve) valve, mechanical or tissue heart valves or percutaneous heart valves as are known in the art provided they are sized appropriately to fit within the lumen of the pulmonary vein, as shown in FIG. 3 .
- FIG. 3 In FIG.
- valves can be positioned in pulmonary vein orifices are represented by an “X”.
- X the locations in the left atrium LA where valves can be positioned in pulmonary vein orifices are represented by an “X”.
- certain venous valve devices and techniques may be employed such as those described in U.S. Pat. Nos. 6,299,637 and 6,585,761, and United States Patent Applications 20040215339 and 20050273160, the entire contents of which are incorporated herein by reference.
- a valve prosthesis for placement in the ostia of the pulmonary vein from the left atrium may be in the range of 6-20 mm in diameter.
- Placement of individual valves in the pulmonary vein ostia may be achieved by obtaining trans septal access to the left atrium with a steerable catheter, positioning a guidewire through the catheter and into the targeted pulmonary vein, and deploying a valve delivery catheter over the guidewire and deploying the valve out of the delivery catheter.
- the valve may be formed of a deformable material, such as stainless steel, or of a self-expanding material such as NiTi, and include tissue leaflets or leaflets formed of a synthetic material, such as is known in the art.
- a line of +++++ symbols in FIG. 3 represents a mid-atrial location above the mitral valve where a single valve can be positioned as disclosed later in this specification.
- FIG. 4 show a cross-sectional view of the heart with a pair of flaps mounted at or near the mitral valve.
- FIG. 5A shows a schematic side view of the mitral valve leaflets LF with a flap 300 positioned immediately below each leaflet.
- the flap 300 can be contoured so as to conform at least approximately to the shape of a leaflet, or the flap 300 can be straight as shown in FIG. 4 .
- FIG. 5B shows a downward view of the mitral valve with a pair of exemplary flaps superimposed over the leaflets LF.
- the flaps can have complementary shapes with a first flap having a protrusion that mates with a corresponding recess in a second flap.
- a first flap 300 with an attachment end 305 and a free end 310 is provided.
- the attachment end 305 of the first flap 300 is secured to the inside wall of the ventricle below the mitral valve.
- a second flap 315 with an attachment end 320 and a free end 330 is provided and is also secured to the inside wall of the ventricle below the mitral valve.
- the first and second flaps 300 , 315 are oriented so that they face each other and the free ends 310 , 330 are biased toward each other and approximate against each other during systole. This system provides a redundant valving system to assist the function of the native mitral valve.
- FIG. 6A shows a cross-sectional view of the heart with a membrane ring 610 positioned at the mitral valve annulus.
- FIG. 6B shows a schematic view of the membrane ring 610 , which includes an annular ring on which is mounted a membrane.
- the membrane includes a series of perforations 615 extending through the membrane surface.
- One or more anchor devices, such as prongs, can be located on the ring for securing the ring to the mitral valve.
- a device for treating heart disease in general and defective or diseased mitral valves in particular includes a disc having a ring, a membrane stretched across an opening of the ring, and one or more anchors for securing the disc to an annulus of a mitral valve.
- the disc is sized to cover the annulus of the mitral valve, and the membrane includes one or more perforations that permit one way fluid flow through the disc.
- FIG. 7A shows a cross-sectional view of a heart with a bladder device positioned partially within the left ventricle and partially within the left atrium.
- a device for treating heart disease in general and defective or diseased mitral valves in particular includes a fluid-filled bladder 600 .
- the bladder 600 is placed across the mitral valve between the left atrium and the left ventricle. Upon compression of the left ventricle, the volume of the bladder is expanded on the left atrial side of the heart, providing a baffle or sealing volume to which the leaflets of the mitral valve coapt.
- the bladder may also act as a blocking device in the case of flail of a leaflet, blocking said flailing leaflet from billowing into the left atrium causing regurgitation.
- the bladder also includes one or more anchors for securing the bladder to an annulus of a mitral valve, or may be formed on a cage or other infrastructure to position it within the line of coaptation of the mitral valve.
- a bladder can also be used to treat functional mitral valve disease.
- functional mitral valve disease is usually characterized by the failure of the mitral valve leaflets to coapt due to an enlarged ventricle, or other impediment to the leaflets rising up far enough toward each other to close the gap or seal against each other during systole.
- FIG. 7B shows a schematic side view of the mitral valve leaflets LF failing to coapt such that regurgitation can occur (as represented by the arrow RF.)
- a baffle or bladder 630 is positioned between the leaflets LF along the line of coaptation of the leaflets.
- the bladder 630 provides a surface against which at least a portion of the leaflets LF can seal against.
- the bladder 630 thus serves as a coaptation device for the leaflets.
- the bladder can be attached to various locations adjacent to or on the mitral valve.
- FIG. 7D shows a plan view of the mitral valve with the leaflets LF in an abnormal closure state such that a gap G is present between the leaflets.
- the bladder is attached or anchored to the mitral valve at opposite edges E of the gap G.
- Methods of treatment using the bladder include providing the bladder and inserting it through an annulus of a mitral valve such that the bladder is coaxially positioned through the mitral valve.
- An atrial portion of the bladder extends into the left atrium, and a ventricular portion of the bladder extends into the left ventricle.
- a mid portion of the bladder may be secured to the annulus of the mitral valve such that the mid portion remains stationery while the atrial and ventricular portions expand and contract passively between the atrium and ventricle based on pressure differentials during systole and diastole.
- FIG. 8 shows a cross-sectional view of the heart wherein a one-way valve device 700 is located in the left atrium.
- the valve device is represented schematically in FIG. 8 .
- a corresponding method of treating heart disease includes introducing a one-way valve device 700 into the left atrium of an individual's heart proximal the mitral valve.
- the valve device 700 is configured to permit fluid flow in one direction while preventing fluid flow in an opposite direction.
- the valve device can have various structures.
- the device can comprise a valve that is mounted on a stent that is sized to be positioned in the left atrium.
- Valves that may be used, for example may be stentless valves such as the TORONTO SPV® (Stentless Porcine Valve) valve, mechanical or tissue heart valves or percutaneous heart valves as are known in the art.
- the outer wall of the one-way valve device is sealed to the inner wall of the atrium so that a fluid-tight seal is formed between the outer wall of the one-way valve device and the inner wall of the left atrium.
- the valve device can include a seal member that is configured to seal to the inner wall of the atrium.
- FIG. 9A shows a prosthetic ring 800 that is sized to fit within a mitral valve annulus
- the ring includes one or more anchors 805 that extend around the periphery of the ring 800 .
- one or more struts 810 struts extend across the diameter of the ring, and can be made of a material that includes nitinol or magnetic wires for selectively adjusting the shape of the ring.
- the struts can also be instrumental in baffling mitral valve leaflet “flail”.
- FIG. 9B shows another embodiment of a prosthetic ring 807 wherein a one-way valve 815 is positioned inside the ring such that blood flow BF can flow through the valve in only one direction.
- the valve can be manufactured of various materials, such as silicone.
- FIG. 10 shows a prosthetic with one or more tongues or flaps that are configured to be positioned adjacent the flaps of the mitral valve.
- the prosthetic includes a ring 900 sized to fit within a mitral valve annulus.
- At least two tongues 910 project from the ring 900 in a caudal direction when the ring is implanted into a heart of an individual.
- the ring is flexible between an expanded configuration and a contracted configuration and is biased toward the contracted configuration.
- One or more anchors 920 protrude from the flexible ring for coupling the ring coaxially to the annulus such that the contracted configuration of the ring exerts an inward force to the annulus.
- the two tongues can each have a length sufficient to prevent prolapse of a mitral valve when the ring is placed atop the leaflets of the mitral valve.
- the tongue elements may be attached at a central point.
- a prosthetic for treating heart disease in general and a defective or diseased mitral valve in particular includes a wedge.
- the wedge has a length that is about equal to a length of the line of coaptation of a mitral valve.
- the wedge has a depth sufficient to prevent prolapse of a mitral valve when the wedge is placed atop an annulus of the mitral valve along the line of coaptation, and may provide a point of coaptation for each leaflet.
- One or more anchors protrude from the wedge for coupling the wedge to the annulus of the mitral valve.
- Methods of treatment using the wedge are also disclosed. The methods include inserting the wedge into an individual's heart, placing the wedge lengthwise along the line of coaptation of the mitral valve. The wedge is then secured to an annulus of the mitral valve along the line of coaptation.
- the wedge may be positioned also just under one segment of the leaflet (likely P2 in the case of functional MR).
- a device for treating heart disease includes a clip for attachment to a free end of a heart valve leaflet.
- FIG. 11A shows an exemplary embodiment of one or more clips 1101 that are positioned on free edges of the leaflets LF.
- Each of the clips 1101 has a shape that prevents flail of the leaflet by catching against an underside of an opposing leaflet.
- Methods of treatment using the clip are also disclosed. The methods include introducing the clip into an individual's heart and attaching the clip to a free end of a heart valve leaflet opposite the free end of an opposing leaflet of the heart valve so that the clip catches to the underside of the opposing leaflet during systole.
- a clip may be placed on both leaflets such that the clips meet or catch when the leaflets are in proximity.
- the clips may attach momentarily during systole, and then detach during diastole, or may clip permanently resulting in a double orifice mitral valve anatomy.
- the clips of this embodiment may include a magnetic element, or one may be magnetic and the other of a metal material attracted to said electromagnetic field of the magnetic clip.
- the clip elements may be placed on the underside of the leaflets (e.g. not necessarily on the free edge of the leaflet), provided that the magnetic field of the clip is sufficient to attract the opposing magnetic or metal clip element.
- FIG. 11B shows pair of leaflets LF with a clip 1101 attached to the underside of each leaflet.
- At least one of the clips is magnetic, while the other clip is of an opposite magnetic polarity than the first clip or of a metal attracted to the magnetic field of the first clip.
- the magnetic field is sufficiently strong such that the clips 1101 can attach to one another either momentarily or permanently to coapt the leaflets, as shown in FIG. 11C .
- a single clip 1101 is attached to one of the leaflets.
- the clip 1101 is sufficiently long to increase the likelihood that the clip 1101 will coapt with the opposite leaflet.
- a device for treating heart disease includes a wedge for placement under a heart valve leaflet.
- FIG. 12 shows a schematic, cross-sectional view of the heart with a wedge 1205 positioned below at least one of the leaflets of the mitral valve.
- the wedge 1205 can be positioned below one or both of the leaflets.
- the wedge 1205 is sized to fit under the valve leaflet and caudal the annulus of the heart valve.
- the wedge 1205 can have a shape that is contoured so as to provide support to a lower surface of the leaflet.
- LA left atrium
- the left ventricle is labeled LV.
- An anchor is attached to the wedge for coupling the wedge to a wall of the heart chamber adjacent the heart valve.
- the wedge forms a fixed backstop against the bottom side of the heart valve leaflet, thereby providing a location for the leaflet to coapt against, and/or providing support or “pushing up” a restricted leaflet.
- a method of treating heart disease includes obtaining access to a heart valve leaflet and injecting a stiffening agent into the leaflet to stiffen the leaflet and minimize flail.
- a method of treating heart disease includes obtaining access to a heart valve chord and cutting it mechanically or with energy such as a laser, or by heating the chordae to elongate them, thereby allowing the previously restricted leaflet to be less restricted so that it can coapt with the opposing leaflet.
- a cam-shaped ring is disclosed.
- the cam-shaped ring is sized to fit within a left ventricle of a heart.
- the ring forms a hole that is sized to receive two or more chordae tendineae.
- the ring is formed by connecting two detachable ends of the ring.
- One method in particular includes introducing the ring into a left ventricle of a heart.
- One or more chordae tendineae are then surrounded by the ring, and the two ends of the ring are then attached to form a closed ring around the chordae tendineae.
- the ring is then rotated such that one or more of the chordae tendineae are shifted away from their initial orientation by the rotation of the cam-shaped ring.
- the ring may then be fixed in the rotated or tightened position.
- FIG. 13A shows a device that can be used to alter a chordae.
- a method includes obtaining access to a chordae tendinea (chord) within an individual's heart chamber. The chordae is then cut at a point along its length so that a length of the chorda tendinea is freed from the heart chamber leaving behind a length of chorda tendinea having a free end and an end attached to an edge of a heart valve.
- a synthetic chord 1005 of greater length than the free length of chordae is introduced into the heart chamber.
- One end of the synthetic chordae 1005 is connected to a wall 1305 of the heart chamber or to a muscle attached to the wall of the heart chamber.
- Another end of the synthetic chord is attached to the free end of the chorda tendinea or to the leaflet.
- FIGS. 13B and 13C show enlarged views of attachment devices contained within box 13 of FIG. 13A .
- the attachment devices can be used to attach the chord 1005 to the wall 1305 .
- the attachment device 1310 is an enlarged ball having a distal trocar for penetrating the wall 1305 .
- the attachment device 1310 is a hook that is configured to penetrate through the wall 1305 .
- the attachment device 1310 can have other structures and it not limited to the structures shown in FIGS. 13B and 13C . In variations of these embodiments, it may be advantageous to adjust the length of the chordae (synthetic, or modified), determine the therapeutic effect of the shortening or lengthening, and then fix the chordae at the most efficacious location.
- FIG. 14 shows a cross-sectional view of the heart with a first and second anchor attached to a wall of the heart.
- the system includes a first anchor 1410 a having a screw portion 1415 for screwing into a wall of the heart and a connector portion.
- the connector portion is rotatable around an axis of rotation.
- the first anchor includes a power source to power rotation of the connector portion and a receiver for receiving telemetric signals from an external controller for controlling the rotation of the connector portion.
- the system includes a second anchor 1410 b having a screw portion 1415 b for screwing into a wall of the heart and a connector portion.
- a tether 1420 having two free ends. One of the free ends is coupled to the connector portion of the first anchor, and the other free end is coupled to the connector portion of the second anchor.
- An external controller is also included. The external controller has a telemetric transmitter for communicating with the receiver and controls the rotation of the connector portion. Alternatively, the anchors may be placed with a torqueable catheter.
- a method of altering a geometry of a heart includes introducing a first coupler into a heart chamber.
- the first coupler has an anchor portion and a connector portion.
- the connector portion is rotatable around an axis of rotation and is connected to a power source to power rotation of the connector portion.
- the power source is in communication with a telemetric signal receiver.
- the first coupler is secured to the wall of the heart chamber by anchoring the anchor portion to the wall.
- a second coupler is introduced into the heart chamber.
- the second coupler includes an anchor portion and a connector portion. The second coupler is secured to the wall of the heart chamber by anchoring the anchor portion to the wall at a distance from the first coupler.
- a tensile member is introduced into the heart chamber.
- One end of the tensile member is connected to the connector portion of the first coupler, and another end of the tensile member is connected to the connector portion of the second coupler.
- the distance between the first and second couplers is adjusted by transmitting a telemetric signal to the receiver, thus causing the connector portion to rotate around the axis of rotation and threading the tensile member around the connector portion to reduce the distance between the first and second couplers.
- a system for altering the geometry of a heart chamber includes a planar tensile member having substantially inelastic material. At least two anchors are included for anchoring the planar tensile member to an inner wall of a heart chamber.
- the planar tensile member is substantially shorter in length than a left ventricle of a heart so that when the planar tensile member is anchored in a caudal direction along a length of the left ventricle a tensile force exerted by the planar tensile member between the two anchors prevents the left ventricle from dilating caudally.
- a method for altering the geometry of a heart includes providing a tensile member having a substantially inelastic material.
- the tensile member is substantially shorter in length than a left ventricle of a heart.
- the tensile member is inserted into the left ventricle of the heart and a proximal end of the tensile member is anchored to the left ventricle adjacent the mitral valve.
- a distal end of the tensile member is anchored to the left ventricle caudal the proximal end so that a tensile force exerted by the tensile member between the two anchors prevents the left ventricle from dilating caudally.
- a method of reinforcing the left ventricle includes injecting a strengthening agent into a wall of the left ventricle in an enlarged region of the ventricle, as shown in FIG. 15 .
- FIG. 15 shows a catheter 1510 that has been introduced into the heart.
- the catheter 1510 has an internal lumen through which the strengthening agent 1512 can be injected.
- a proximal end of the catheter is connected to a source of the strengthening agent and a distal end of the catheter is configured to release the strengthening agent.
- the distal end of the catheter is positioned at or near a wall of the heart and the strengthening agent 1512 is injected into the wall of the heart.
- a method is directed to altering the geometry of a heart.
- the method includes injecting a polymerizing agent into a pericardial space adjacent a left ventricle, thereby exerting a medial (inward) force against the left ventricle.
- a method of altering the geometry of a heart includes inserting a balloon into a pericardial space adjacent to a left ventricle of the heart, or extend into the pericardium of the heart.
- the balloon is inflated by injecting it with a fluid, and it exerts a medial force against the left ventricle upon inflation.
- the balloon can be inflated at the time of implantation, or at a later time. If inflated at a later time, the balloon would be self-sealing, and may be inflated by accessing the balloon with a needle placed through the chest wall.
- FIG. 16 shows a schematic view of the heart showing the papillary muscles PM.
- a method of treating heart disease includes inserting an anchor, cuff or sleeve 1205 into the left ventricle of an individual's heart, and sliding a cuff or sleeve around a papillary muscle P. The size of the cuff or sleeve is reduced so that the cuff or sleeve squeezes the papillary muscle. As the size of the cuff or sleeve is reduced, the papillary muscle stretches and increased in length.
- a method of treating heart disease includes obtaining access to a papillary muscle in a left ventricle of the heart.
- the papillary muscle is cut and reattached at a new location on an inner wall of the ventricle closer to the mitral valve.
- FIGS. 17-19 show cross-sectional views of the heart.
- one or more magnets 1705 are implanted or otherwise attached to a wall 1710 of the left ventricle LV.
- One or more other magnets 1715 are implanted or otherwise attached to a wall 1720 of the right ventricle.
- the magnets 1705 and 1715 are attached to the walls 1710 and 1720 such that they assert an attractive magnetic force (as represented by the arrows 1725 in FIG. 17 ) toward each other.
- the magnetic force 1725 assists in remodeling of the left ventricle during pumping of the heart.
- the magnets 1705 and 1715 are urged toward one another (thereby also urging the walls 1710 and 1720 toward one another) to re-shape either the annulus AN or the left ventricle LV.
- the annulus or the left ventricle LV are re-shaped in a manner that reduces or eliminates backflow through the mitral valve MV. It should be appreciated that a similar procedure can be performed on the right ventricle RV and associated valves.
- FIG. 18A shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle.
- One or more magnets 1705 are implanted or otherwise attached to a first wall 1710 a of the left ventricle LV.
- One or more magnets 1705 are also implanted or otherwise attached to a second, opposed wall 1710 b of the left ventricle.
- the magnets on the opposed walls 1710 a , 1710 b exert an attractive magnetic force toward one another to draw the walls 1710 a , 1710 b toward one another and re-shape the left ventricle LV or the annulus AN.
- Another embodiment of a procedure uses magnets to anchor tethers within the heart at various locations to optimize the shape of cardiac structures to improve cardiac function.
- the tethers are placed to either reshape the cardiac structure or to prevent dilatation of the structure over time.
- the tethers must be securely anchored to the heart structures.
- a method of anchoring which enables tethering in various positions and directions within the cardiac structures is important for the clinician to optimize cardiac reshaping based on each individual patient anatomy and disease state.
- a method of anchoring which is atraumatic is also desirable.
- FIG. 18B shows a side view of the heart with sets of magnets A, A 1 , B, and B 1 positioned to various locations of the heart or to anatomical structures adjacent the heart.
- at least one magnet A is placed on the interventricular septum within the right ventricle RV.
- At least one magnet A 1 is placed within the left ventricle LV opposite magnet A.
- the magnetic force between A and A 1 maintains the position of the magnets.
- the magnets may be enclosed in materials that will promote tissue in-growth and healing to the interventricular septum to ensure stability of location and to eliminate the need for long term anti-coagulation. Additionally, the enclosure material which is flexible and can be delivered in a low profile can be significantly larger in size than the magnets to increase the surface area of contact with the heart wall which will increase the tension that can ultimately be placed on the anchor over time.
- a second set of magnets B and B 1 are then delivered to another location selected within or adjacent to the heart.
- the set of magnets A/A 1 are attached to the set of magnets B/B 1 using at least one tether 1805 , as shown in FIG. 18B .
- the tether 1805 can be attached to either or both of the magnets A/A 1 at one end and to either of both of the magnets B/B 1 at an opposite end.
- FIG. 18B shows magnet B positioned in the LV and B 1 positioned in a blood vessel BV adjacent to the heart.
- Magnets B and B 1 are delivered on or within materials and structures which promote healing and increase the amount of tension that can be placed on the anchor over time.
- magnet B 1 can be delivered on a stent which is of a length, diameter and material which will heal within the BV to provide sufficient resistance to forces placed on it by the tethers.
- the tethers may be pre-attached to the magnets A and B 1 or they may be attached after A and B 1 have been positioned.
- the tether length may be shortened and/or adjusted after placement of the anchors.
- the final tether length may be pre-selected based on the patient's cardiac structure geometry and the effect the clinician desires. Placing sets of magnets in this method, enables anchoring of tethers within the heart in various positions and angles which provides increased flexibility and variation for clinicians to select optimal re-shaping of the cardiac structures based on specific patient characteristics.
- Examples which demonstrate the flexibility of this approach include placing anchors at the annulus and at the apex of the heart and tethered to shorten the length of the LV; anchors can be placed in the around the annulus and tethered to change the shape of the annulus. More specifically, one or more sets of magnets can be placed in the RA and LA at the level of the mitral valve annulus (on the anterior side of the annulus) and one or more sets of magnets can be placed in the LA and LV on opposite sides of the annulus on the posterior portion of the annulus. The posterior sets of magnets can then be tethered to the anterior sets of magnets to change the shape of the annulus. Alternatively, the magnet anchors can be placed at the level of the annulus in the LA and in a BV adjacent to the heart at the level of the annulus and these then tethered to the anterior annulus magnet anchor described above.
- the magnets A and A 1 can also be a single magnet that extends through the interventricular septum. Moreover, only one of the magnets A or A 1 need be implanted.
- One or more magnets B and/or B 2 are located opposite the location of the magnet(s) A and/or A 1 .
- the magnet(s) B is located within the left ventricle opposite the magnets A/A 1 , such as on the left ventricular wall.
- the magnet B 1 is located on an anatomical structure adjacent the heart, such as on a blood vessel BV.
- the magnets A, A 1 , B, and B 1 are implanted in the heart without tethers.
- the magnets A, A 1 , B, and B 1 can be positioned in various combinations so as to exert magnetic attractions to one another to re-shape the left ventricle or the mitral valve annulus.
- the magnets A and B can be implanted such that they exert an attractive magnetic force relative to one another.
- the magnets A and B 2 can alternately be implanted. Other possible combinations are the magnets A 1 and B or the magnets A 1 and B 2 .
- the magnets can be implanted without tethers such that an attractive magnetic force F causes the magnets and the attached region of the heart to move toward one another to re-shape the heart.
- the magnets can be attached to one another with tethers.
- one or more magnets 1705 are implanted in the walls 1710 of the left ventricle LV and/or the right ventricle RV, as shown in FIG. 19 .
- the magnets 1705 are positioned in opposed locations on the walls 1710 and one or more tethers 1905 attach opposed pairs of magnets 1705 to one another.
- One or more of the tethers 1905 extend through the interventricular septum to connect a first magnet disposed in the left ventricle and a second magnet disposed in the right ventricle.
- magnet elements do not include tethers, but rely on the magnetic attraction to each other to remodel the tissue between them.
- a magnetic element may be placed on either side of the interventricular septum, or one element within the septum.
- Another magnetic element may be placed on or within the opposite left ventricular wall, or in an adjacent vessel on the left ventricular wall. The electromagnetic field of such elements can then interact to cause a remodeling of the left ventricle to assist with ventricular function.
- the tethers 1905 can be elastic so to exert an attractive force between the attached magnets 1705 and re-shape the left ventricle LV or annulus AN. Alternately, or in combination with elastic tethers, the tethers 1905 can be shortened in length after placement to thereby pull the walls of the left ventricle LV toward one another and re-shape the left ventricle LV or the annulus AN. In combination with the force provided by the tethers 1905 , the magnets 1705 exert an attractive magnetic force toward one another to assist in pulling the heart walls toward each other.
- one or more magnets can be positioned in other locations of the heart or adjacent anatomical structures for re-shaping of the heart.
- one or more magnets can be positioned around the annulus AN or can be positioned in the coronary sinus in such a manner that the magnets exert attractive forces toward one another to cause re-shaping of a desired portion of the heart.
- cardiac re-shaping is achieved through percutaneous placement of one or more tethers that are cinched or anchored in the walls of the left ventricle LV.
- the tethers provide tension between the walls of the left ventricle to reshape the left ventricle LV in a desired manner.
- FIG. 20 shows a cross-sectional view of the left ventricle LV with a tether 2010 positioned therein.
- the tether 2010 has a first end anchored to a first wall of the left ventricle LV and a second end anchored to an opposed wall of the left ventricle LV.
- the tether 2010 is tensioned to pull the walls toward one another (as represented by the phantom lines 2012 in FIG.
- the left ventricle LV can be re-shaped in various manners and the amount of re-shaping can vary depending on the tension applied to the tether 2010 and the location of attachment to the walls of the left ventricle LV.
- the tether may be inelastic or somewhat elastic.
- the tether 2010 can be anchored or otherwise attached to the walls in various manners.
- a patch 2015 shown in FIG. 20
- a similar patch can also be positioned on the opposed wall and attached to the opposite end of the tether.
- the patch is delivered to a desired location using a catheter 2105 having a sharpened distal end 2110 that is positioned within the left ventricle LV.
- the catheter 2105 can be delivered to the left ventricle LV in various manners, including trans-aortically (via the aorta), trans-septally (by piercing the interventricular septum), and trans-atrially (via the left atrium) pursuant to well-known methods.
- the sharpened distal end 2110 pierces the ventricular wall such that the distal end 2110 is positioned exterior to the ventricular wall.
- the catheter 2105 has an internal delivery lumen having an opening at the distal end 2110 .
- the patch 2015 is configured to be transported in a contracted state through the delivery lumen and delivered out of the opening at the distal end 2110 , where the patch 2015 expands into an expanded state at the exterior of the ventricular wall to seal against the exterior of the left ventricular wall.
- the patch 2015 When positioned at the exterior of the ventricular wall, the patch 2015 is configured to act as a reservoir that receives a fluid material that can be delivered to the patch via the delivery lumen of the catheter 2105 .
- the fluid material has a first viscous state of sufficient fluidity such that the material can flow through the delivery lumen of the catheter 2105 and out of the distal end 2110 to the location of the patch 2015 .
- the fluid material changes to a second viscous state when positioned exterior to the ventricular wall at the patch 2015 .
- the second viscous state is of greater viscosity (i.e., more resistant to flow) than the first viscous state such that the fluid material provides support and a level of rigidity to the patch 2015 and to the left ventricular wall.
- the fluid material can change to the second viscous state after a predetermined time period, after contact with the patch, or when the patch is completely filled.
- a catalyst can be injected into the fluid material to cause it to change to the second viscous state.
- the catheter 2105 can then be disengaged from the patch 2015 such that the patch 2015 is disposed exterior to the ventricular wall.
- the patch 2015 can be firmly attached to the ventricular wall (such as using an adhesive) to minimize wear or friction between the patch and the ventricular wall.
- an end of the tether 2010 is attached to the patch 2015 .
- the catheter 2105 can be used to deliver the tether 2010 to the patch 2015 or, alternately, a second catheter can be used.
- the tether 2015 is already positioned in a delivery lumen of the catheter 2010 while the patch 2015 is being delivered.
- the catheter 2010 is then pulled back while the end of the tether 2015 remains attached to the patch 2015 to thereby let the tether 2010 out from the catheter 2010 , as shown in FIG. 23 .
- a second patch 2415 is deployed in or exterior to an opposed ventricular wall in a manner similar to that described above.
- the opposite end of the tether 2010 is then attached to the second anchor 2415 such that the tether 2010 extends between the two anchors, as shown in FIG. 20 .
- a second tether 2420 is attached at a first end to the second anchor 2415 .
- the two tethers 2010 and 2420 can then be attached together at opposite ends from the patches, such as by using a clip 2510 , to form a single attachment tether between the patches 2015 and 2415 .
- the tether 2510 can be twisted or adjusted within the clip to tension the resulting attachment tether between the patches 2415 and 2015 and pull the ventricular walls toward one another via the tether. Once properly tensioned, the tether can be clipped or clamped to maintain its position.
- a needle 2610 or delivery catheter is passed trans-thoracically into the left ventricle LV to deliver a patch 2615 to the exterior of the ventricular wall, as described above.
- a sealing means such as a sealing balloon, can be used to seal one or more puncture holes in the wall of the left ventricle caused by the needle 26 during delivery of the patch 2615 .
- Visualization means such as fluoroscopy, can be used to visualize proper placement of the needle 2610 .
- a second patch is attached to an opposed wall to form a tether attachment between the walls, as shown in FIG. 20 . The tether is then tensioned to pull the walls together and re-shape the left ventricle or annulus of the mitral valve in a desired manner.
- FIG. 27 shows a schematic, cross-sectional view of the left ventricle LV in a healthy state with the mitral valve closed.
- the valve chordae CH connect the leaflets LF of the mitral valve to the papillary muscles PM.
- the papillary muscles PM and the and chordae CH are positioned such that at least a portion of the leaflets LF contact one another when the mitral valve is in the closed state, resulting in functional coaptation of the leaflets.
- FIG. 28 shows the left ventricle LV in a dysfunctional state.
- the valve chordae CH or the papillary muscles PM are damaged or otherwise dysfunctional such that the leaflets LF do not properly coapt (contact one another).
- the dysfunction can be manifested by excess tension in the chordae CH such that a gap is located between the leaflets LF, or in some cases one leaflet may function at a different level from the other (e.g. lower (prolapse) or higher (flail)) thereby limiting the ability of the mitral valve to close resulting in mitral regurgitation.
- the dysfunctional left ventricle LV and in some cases leaflet prolapse or flail can be treated by manipulating papillary muscles PM to adjust the position of the leaflets LF.
- the papillary muscles PM are repositioned toward one another to reduce the distance between the papillary muscles PM.
- a biasing member such as a rod of adjustable length, or a spring 2910
- a spring 2910 is mounted between the papillary muscles PM with a first end of the spring 2910 attached to a first papillary muscle and a second end of the spring 2910 attached to a second papillary muscle.
- the spring 2910 has a pre-load such that the spring 2910 provides a biasing force (represented by the arrows 2915 in FIG. 29 ) that pulls the papillary muscles PM toward one another.
- a spring may be covered with polyester fabric or other coating to promote ingrowth into the muscle tissue and minimize the potential for clot formation.
- the repositioning of the papillary muscles PM re-shapes the left ventricle and/or changes the distance that the leaflets need to move on the chordae CH such that the leaflets LF contact one another to close the mitral valve.
- the tension provided by the spring 2910 can be varied or different springs can be used to achieve a proper repositioning of the papillary muscles PM. The tension may be modified at the time of the procedure or during a subsequent procedure if it is determined that additional coaptation is required.
- a suture 3010 is mounted between the papillary muscles PM with a first end of the suture 3010 attached to a first papillary muscle and a second end of the suture 3010 attached to a second papillary muscle.
- the suture 3010 can be attached to the papillary muscles in various manners.
- an attachment device 3015 such as an anchor, cuff or sleeve, can be positioned around or partially around each of the papillary muscles.
- the ends of the suture 3010 are attached to the attachment devices 3015 to secure the suture 3010 to the suture to the papillary muscles.
- the suture 3010 is tensioned such that it provides a force that pulls the papillary muscles PM toward one another.
- the suture 3010 can be tensioned, for example, by twisting the suture 3010 to reduce its the overall length and thereby reduce the distance between the papillary muscles PM, and fixing the suture with a crimping element or other stay element.
- the amount of twisting or shortening can be varied to vary the tension provided by the suture 3010 .
- a crimping member may be used to fix the sutures once a desired tension between the muscles is reached. Exemplary crimping members are described in International Patent Application Number PCT/US03/06149, which is incorporated herein by reference in its entirety.
- the repositioning of the papillary muscles PM re-shapes the left ventricle and/or changes the tension on the chordae CH such that the leaflets LF contact one another to close the mitral valve.
- Cuffs or sleeves may be placed around the papillary muscles PM to such as those previously described, to affect the repositioning.
- the papillary muscles PM can also be repositioned by snaring the papillary muscles.
- a snare 3110 comprised of a looped strand of material is positioned around the chordae CH at or near the location where the chordae attach with the papillary muscles PM.
- the snare 3110 is tightened to draw the papillary muscles PM toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve.
- one or more clips 3610 are clipped to each of the papillary muscles PM.
- the structure of the clips 3610 can vary.
- a tether 3615 attaches the clips 3610 to one another.
- the tether 3615 is cinched to shorten the length of the tether 3615 and pull the papillary muscles PM toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve.
- one or more clips 3610 are clipped to opposed walls of the left ventricle LV.
- the clips 3610 can be delivered to the left ventricle using a delivery catheter 2105 .
- a tether attaches the clips to one another.
- the tether is cinched to shorten the length of the tether and pull the ventricular walls toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve.
- a mitral valve clip may be deployed to augment the desired valve function, either before papillary or chordal manipulation, or after, if the desired leaflet coaptation is not achieved with one particular approach.
- a dysfunctional left ventricle can be manifested by excess tension in the chordae CH such that a gap is positioned between the valve leaflets LF. It can be desirable to eliminate or relieve the excess tension by cutting the chordae CH, and/or cutting the chordae and replacing them with artificial chordae. Prior to cutting the chordae, it can be desirable to evaluate the placement of the artificial chordae to confirm that implantation of the chordae will indeed provide the desired clinical result. This process is now described with reference to FIGS. 32-35 .
- FIG. 32 shows a leaflet grasping device 1100 that is configured to grasp and secure the leaflets of the mitral valve.
- the device 1100 and corresponding methods of use are described in more detail in U.S. patent application Ser. No. 10/635,776, entitled “Methods and Apparatus For Cardiac Valve Repair”, which is incorporated herein by reference in its entirety. Additional leaflet grasping devices are described in U.S. patent application Ser. No. 10/441,508, filed May 19, 2003, U.S. Pat. No. 6,269,819, issued Aug. 7, 2001, and U.S. Pat. No. 6,461,366, issued Oct. 8, 2002, all of which are expressly incorporated by reference herein.
- the device 1100 is comprised of a catheter shaft 1102 having a distal end 1104 and a proximal end 1106 .
- the catheter shaft 1102 is comprised of, among others, a conduit 1108 , a coaxial outer sheath 1110 , a central lumen 1111 through which a double-jaw grasper 1113 may be inserted, and a central guidewire lumen 1105 .
- the catheter shaft 1102 can have additional lumens for the passage of one or more needles, as described more fully below.
- an optional pair of stabilizers 1112 are fixedly mounted on the outer sheath 1110 at their proximal end 1114 and fixedly attached to extenders 1116 at their distal end 1118 .
- the stabilizers 1112 are shown in an outwardly bowed position, however they may be inwardly collapsed by either extending the extenders 1116 or retracting the outer sheath 1110 . Bowing may be achieved by the reverse process.
- the double-jaw grasper 1113 is comprised of two articulating jaw arms 1120 which may be opened and closed against the central shaft 1122 (movement depicted by arrows) either independently or in tandem.
- the grasper 1113 is shown in the open position in FIG. 32 .
- the surfaces of the jaw arms 1120 and central shaft 1122 may be toothed, as shown, or may have differing surface textures for varying degrees of friction.
- the jaw arms 1120 each include a needle passageway 1121 comprised of a cutout or a slot that extends at least partially along the length of each jaw arm 1120 . As described in more detail below, the needle passageway provides a location where a needle can pass through the jaw arm 1120 during manipulation of the papillary muscle.
- the above described components may be manipulated and controlled by a handle 1126 connected to the proximal end 1106 of the catheter shaft 1102 , as shown in FIG. 86 .
- the handle 1026 permits independent control of the components described above.
- the device 1100 may be used at least temporarily grasp and restrain the valve leaflets LF of the mitral valve MV.
- the double-jaw grasper 1113 extends through the valve such that the leaflets L 1 , L 2 are grasped from below.
- the device 1100 is termed “atrial-ventricular.”
- the atrial device 1100 may be stabilized against the mitral valve MV.
- the stabilizers 1112 may be positioned on the superior surface of the valve leaflets LF 1 , LF 2 at a 90 degree angle to the line of coaptation.
- the grasper 1113 may be advanced in its closed position from the conduit 1108 between the leaflets LF 1 , LF 2 until the jaw arms 1120 are fully below the leaflets in the ventricle. At this point, the grasper 1113 may be opened and retracted so that the jaw arms 1120 engage the inferior surface of the leaflets LF 1 , LF 2 . In this manner, the leaflets are secured between the stabilizers 1112 and the jaw arms 1120 .
- the grasper 1113 will gradually close, drawing the leaflets LF 1 , LF 2 together while maintaining a secure hold on the leaflets between the jaw arms 1120 and the stabilizers 1112 .
- the stabilizers 1112 may be gradually collapsed by either extending the extenders 1116 or retracting the outer sheath 1110 .
- the jaw arms 1120 may collapse due to spring loading to gradually close the grasper 1113 .
- the jaw arms 1120 may be actuated to close against the central shaft 1122 applying force to the stabilizers 1112 causing them to collapse.
- a needle 3410 is advanced from the left atrium into the left ventricle.
- the needle 3410 can be passed through a lumen in the device 1100 or it can be passed external to the device 1100 .
- the needle 3410 passes through a leaflet LF and into a papillary muscle PM.
- the jaw arms 1120 have needle passageways 1121 (shown in FIG. 32 ) that permit passage of the needle through the jaw arms 1120 .
- the needle 3410 is attached to a suture 3415 that extends distally through the device 1100 .
- the suture 3415 is then anchored to the papillary muscle PM such that the suture 3415 provides an attachment for holding, pulling, or otherwise manipulating the papillary muscle PM.
- the tension in the suture 3415 can be adjusted to re-position the papillary muscle PM such that the leaflets LF contact one another to close the mitral valve. The same process can be performed with the other papillary muscle.
- chordae CH may be cut.
- the sutures 3415 function as artificial chordae that retain the leaflets LF and papillary muscles PM in a desired orientation.
- a fixation device such as a clip can then be attached to the leaflets using methods and device described in U.S. patent application Ser. No. 10/635,776, filed Aug. 5, 2003, U.S. patent application Ser. No. 10/441,508, filed May 19, 2003, U.S. Pat. No. 6,269,819, issued Aug. 7, 2001, and U.S. Pat. No. 6,461,366, issued Oct. 8, 2002, all of which are expressly incorporated by reference herein.
- the sutures 3415 can be attached to the clip 3510 or directly to the leaflets LF. It should be appreciated that any quantity of sutures 3415 can be used as artificial chordae between the leaflets and the papillary muscles. It should be appreciated that the leaflet clips can also be used in conjunction with cutting, elongating, or shortening of the chordae pursuant to the methods described above.
- the result Prior to permanently placing the chordae or clips, the result can be previewed on ultrasound (TEE, ICE, echocardiography), to determine if the appropriate valve coaptation is restored.
- TEE ultrasound
- ICE echocardiography
Abstract
Description
- This application claims priority of co-pending U.S. Provisional Patent Application Ser. No. 60/650,918 entitled “Methods, Systems and Devices for Cardiac Valve Repair”, filed Feb. 7, 2005 and co-pending U.S. Provisional Patent Application Ser. No. 60/692,802 entitled “Methods, Systems and Devices for Cardiac Valve Repair”, filed Jun. 21, 2005. Priority of the aforementioned filing dates is hereby claimed, and the disclosures of the Provisional Patent Applications are hereby incorporated by reference in their entirety.
- The present invention relates generally to medical methods, devices, and systems. In particular, the present invention relates to methods, devices, and systems for the endovascular or minimally invasive surgical repair of the atrioventricular valves of the heart, particularly the mitral valve.
- Mitral valve regurgitation is characterized by retrograde flow from the left ventricle of a heart through an incompetent mitral valve into the left atrium. During a normal cycle of heart contraction (systole), the mitral valve acts as a check valve to prevent flow of oxygenated blood back into the left atrium. In this way, the oxygenated blood is pumped into the aorta through the aortic valve. Regurgitation of the valve can significantly decrease the pumping efficiency of the heart, placing the patient at risk of severe, progressive heart failure.
- Mitral valve regurgitation can result from a number of different mechanical defects in the mitral valve. The valve leaflets, the valve chordae which connect the leaflets to the papillary muscles, or the papillary muscles themselves may be damaged or otherwise dysfunctional. Commonly, the valve annulus may be damaged, dilated, or weakened limiting the ability of the mitral valve to close adequately against the high pressures of the left ventricle. In some cases the mitral valve leaflets detach from the chordae tendinae, the structure that tethers them to the ventricular wall so that they are positioned to coapt or close against the other valve leaflet during systole. In this case, the leaflet “flails” or billows into the left atrium during systole instead of coapting or sealing against the neighboring leaflet allowing blood from the ventricle to surge into the left atrium during systole. In addition, mitral valve disease can include functional mitral valve disease which is usually characterized by the failure of the mitral valve leaflets to coapt due to an enlarged ventricle, or other impediment to the leaflets rising up far enough toward each other to close the gap or seal against each other during systole.
- The most common treatments for mitral valve regurgitation rely on valve replacement or strengthening of the valve annulus by implanting a mechanical support ring or other structure. The latter is generally referred to as valve annuloplasty. A recent technique for mitral valve repair which relies on suturing adjacent segments of the opposed valve leaflets together is referred to as the “bow-tie” or “edge-to-edge” technique. While all these techniques can be very effective, they usually rely on open heart surgery where the patient's chest is opened, typically via a sternotomy, and the patient placed on cardiopulmonary bypass. The need to both open the chest and place the patient on bypass is traumatic and has associated morbidity.
- For the foregoing reasons, it would be desirable to provide alternative and additional methods, devices, and systems for performing the repair of mitral and other cardiac valves, including the tricuspid valve, which is the other atrioventricular valve. In some embodiments of the present invention, methods and devices may be deployed directly into the heart chambers via a trans-thoracic approach, utilizing a small incision in the chest wall, or the placement of a cannula or a port. In other embodiments, such methods, devices, and systems may not require open chest access and be capable of being performed endovascularly, i.e., using devices which are advanced to the heart from a point in the patient's vasculature remote from the heart. Still more preferably, the methods, devices, and systems should not require that the heart be bypassed, although the methods, devices, and systems should be useful with patients who are bypassed and/or whose heart may be temporarily stopped by drugs or other techniques. At least some of these objectives will be met by the inventions described hereinbelow.
- In one aspect, there is disclosed a method of treating a heart, comprising attaching a first device to a first location of a wall of a left ventricle of the heart; attaching a second device to a second location of the heart, wherein the second location is located opposite the first location; and moving the first device and the second device toward one another to cause the first location and second location to move toward one another so as to re-shape at least one of the mitral valve annulus or the left ventricle in a manner that reduces backflow through the mitral valve.
- In another aspect, there is disclosed a method of treating a heart, comprising coupling at least one valve to a steerable delivery device; percutaneously introducing the valve into the heart using the steerable delivery device; and placing the valve in a pulmonary vein of the heart, wherein the valve regulates blood flow into the left ventricle of the heart.
- In another aspect, there is disclosed a method of treating a heart, comprising coupling a first wedge-shaped device to a steerable delivery device, wherein the first device has a contact surface adapted to be positioned adjacent a first mitral valve leaflet of the heart; percutaneously introducing the first device into the heart using the steerable delivery device; and securing the first device to the heart such that the first mitral valve leaflet is positioned adjacent the contact surface of the device.
- In another aspect, there is disclosed a device for treating heart disease comprising a prosthetic comprising a wedge having a length that is about equal to a length of a line of coaptation of a mitral valve and a depth sufficient to prevent prolapse of a mitral valve when the wedge is placed atop an annulus of the mitral valve along the line of coaptation; and one or more anchors protruding from the wedge for coupling the wedge to the annulus of the mitral valve.
- Other features and advantages should be apparent from the following description of various embodiments, which illustrate, by way of example, the principles of the disclosure.
-
FIG. 1A is a schematic illustration of the left ventricle of a heart showing blood flow during systole with arrows. -
FIG. 1B shows a cross-sectional view of the heart wherein a flexible stent is positioned at or near the mitral valve. -
FIG. 2A shows a cross-sectional view of the heart showing one or more magnets positioned around the annulus of the mitral valve. -
FIG. 2B shows an annular band with magnets that can be positioned on the mitral valve annulus. -
FIG. 3 shows a cross-sectional view of the heart identifying locations for placement of valves. -
FIG. 4 show a cross-sectional view of the heart with a pair of flaps mounted at or near the mitral valve. -
FIG. 5A shows a schematic side view of the mitral valve leaflets with a flap positioned immediately below each leaflet. -
FIG. 5B shows a downward view of the mitral valve with a pair of exemplary flaps superimposed over the leaflets. -
FIG. 5C shows a pair of mitral valve leaflet flaps having complementary shapes. -
FIG. 6A shows a cross-sectional view of the heart with a membrane ring positioned at the mitral valve annulus. -
FIG. 6B shows a schematic view of the membrane ring, which includes an annular ring on which is mounted a membrane. -
FIG. 7A shows a cross-sectional view of a heart with a bladder device positioned partially within the left ventricle and partially within the left atrium. -
FIG. 7B shows a schematic side view of the mitral valve leaflets failing to coapt. -
FIG. 7C shows a schematic side view of a the mitral valve leaflets with a bladder positioned between the leaflets. -
FIG. 7D shows a plan view of the mitral valve with the leaflets in an abnormal closure state such that a gap is present between the leaflets. -
FIG. 8 shows a cross-sectional view of the heart wherein a one-way valve device is located in the left atrium. -
FIG. 9A shows a prosthetic ring that is sized to fit within a mitral valve. -
FIG. 9B shows another embodiment of a prosthetic ring wherein a one-way valve is positioned inside the ring. -
FIG. 10 shows a prosthetic with one or more tongues or flaps that are configured to be positioned adjacent the flaps of the mitral valve -
FIG. 11A shows an exemplary embodiment of one or more clips that are positioned on free edges of the leaflets. -
FIG. 11B shows pair of leaflets with a magnetic clip attached to the underside of each leaflet. -
FIG. 11C shows the leaflets coapted as a result of the magnetic attraction between the magnetic clips. -
FIG. 11D shows a pair of leaflets with a single clip attached to one of the leaflets. -
FIG. 12 shows a schematic, cross-sectional view of the heart with a wedge positioned below at least one of the leaflets of the mitral valve. -
FIG. 13A shows an artificial chordae tendon. -
FIGS. 13B and 13C show attachment devices for attaching the artificial chordae tendon to a heart wall. -
FIG. 14 shows a cross-sectional view of the heart with a first and second anchor attached to a wall of the heart. -
FIG. 15 shows a catheter that has been introduced into the heart. -
FIG. 16 shows a schematic view of a papillary muscle with a ring positioned over the muscle. -
FIG. 17 shows a cross-sectional view of the heart with one or more magnets attached to a wall of the left ventricle. -
FIG. 18A shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle. -
FIG. 18B shows the heart wherein tethered magnets are implanted in various locations to geometrically reshape the annulus or the left ventricle. -
FIG. 18C shows the heart wherein magnets are implanted in various locations to geometrically reshape the annulus or the left ventricle. -
FIG. 19 shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle. -
FIG. 20 shows a cross-sectional view of the left ventricle with a tether positioned therein. -
FIG. 21 shows a cross-sectional view of the left ventricle with a delivery catheter positioned therein. -
FIG. 22 shows a cross-sectional view of the left ventricle with the delivery catheter penetrating a wall of the left ventricle. -
FIG. 23 shows a cross-sectional view of the left ventricle with the delivery catheter delivering a patch to the wall of the left ventricle. -
FIG. 24 shows a cross-sectional view of the left ventricle with the delivery penetrating delivering a second patch. -
FIG. 25 shows a cross-sectional view of the left ventricle with two tethers attached together at opposite ends from the patches mounted in the heart. -
FIG. 26 shows a cross-sectional view of the left ventricle with a needle or delivery catheter passed transthoracicaly into the left ventricle LV to deliver a patch to the exterior of the ventricular wall. -
FIG. 27 shows a schematic, cross-sectional view of the left ventricle in a healthy state with the mitral valve closed. -
FIG. 28 shows the left ventricle in a dysfunctional state. -
FIG. 29 shows the left ventricle with a biasing member mounted between the papillary muscles. -
FIG. 30 shows the left ventricle with a suture mounted between the papillary muscles. -
FIG. 31 shows the left ventricle with a snare positioned around the chordae at or near the location where the chordae attach with the papillary muscles. -
FIG. 32 shows a leaflet grasping device that is configured to grasp and secure the leaflets of the mitral valve. -
FIGS. 33A-33C show the leaflet grasping device grasping leaflets of the mitral valve. -
FIG. 34 shows the left ventricle with a needle being advanced from the left atrium into the left ventricle via the leaflet grasping device. -
FIG. 35 shows the left ventricle with sutures holding the papillary muscles in a desired position. -
FIG. 36 shows a cross-sectional view of the heart with one or more clips clipped to each of the papillary muscles. -
FIG. 37 shows a cross-sectional view of the heart with tethered clips attached to opposed walls of the left ventricle. - The present invention provides methods, systems, and devices for the endovascular repair of cardiac valves, particularly the atrioventricular valves which inhibit back flow of blood from a heart ventricle during contraction (systole), most particularly the mitral valve between the left atrium and the left ventricle. By “endovascular,” it is meant that the procedure(s) of the present invention are performed with interventional tools, guides and supporting catheters and other equipment introduced to the heart chambers from the patient's arterial or venous vasculature remote from the heart. The interventional tools and other equipment may be introduced percutaneously, i.e., through an access sheath, or may be introduced via a surgical cut down, and then advanced from the remote access site through the vasculature until they reach the heart. Thus, the procedures of the present invention will generally not require penetrations made directly through the exterior heart muscle, i.e., myocardium, although there may be some instances where penetrations will be made interior to the heart, e.g., through the interatrial septum to provide for a desired access route.
- While the procedures of the present invention will usually be percutaneous and intravascular, many of the tools will find use in minimally invasive and open surgical procedures as well that includes a surgical incision or port access through the heart wall. In particular, the tools for capturing the valve leaflets prior to attachment can find use in virtually any type of procedure for modifying cardiac valve function.
- The atrioventricular valves are located at the junctions of the atria and their respective ventricles. The atrioventricular valve between the right atrium and the right ventricle has three valve leaflets (cusps) and is referred to as the tricuspid or right atrioventricular valve. The atrioventricular valve between the left atrium and the left ventricle is a bicuspid valve having only two leaflets (cusps) and is generally referred to as the mitral valve. In both cases, the valve leaflets are connected to the base of the atrial chamber in a region referred to as the valve annulus, and the valve leaflets extend generally downwardly from the annulus into the associated ventricle. In this way, the valve leaflets open during diastole when the heart atria fill with blood, allowing the blood to pass into the ventricle.
- During systole, however, the valve leaflets are pushed together and closed to prevent back flow of blood into the atria. The lower ends of the valve leaflets are connected through tendon-like tissue structures called the chordae, which in turn are connected at their lower ends to the papillary muscles. Interventions according to the present invention may be directed at any one of the leaflets, chordae, annulus, or papillary muscles, or combinations thereof. It will be the general purpose of such interventions to modify the manner in which the valve leaflets coapt or close during systole so that back flow or regurgitation is minimized or prevented.
- The left ventricle LV of a normal heart H in systole is illustrated in
FIG. 1A . The left ventricle LV is contracting and blood flows outwardly through the tricuspid (aortic) valve AV in the direction of the arrows. Back flow of blood or “regurgitation” through the mitral valve MV is prevented since the mitral valve is configured as a “check valve” which prevents back flow when pressure in the left ventricle is higher than that in the left atrium LA. The mitral valve MV comprises a pair of leaflets having free edges FE which meet evenly to close, as illustrated inFIG. 1A . The opposite ends of the leaflets LF are attached to the surrounding heart structure along an annular region referred to as the annulus AN. The free edges FE of the leaflets LF are secured to the lower portions of the left ventricle LV through chordae tendineae CT (referred to hereinafter as the chordae) which include plurality of branching tendons secured over the lower surfaces of each of the valve leaflets LF. The chordae CT in turn, are attached to the papillary muscles PM which extend upwardly from the lower portions of the left ventricle and interventricular septum IVS. - While the procedures of the present invention will be most useful with the atrioventricular valves, at least some of the tools described hereinafter may be useful in the repair of other cardiac valves, such as peripheral valves or valves on the venous side of the cardiac circulation, or the aortic valve.
- The methods of the present invention can comprise accessing a patient's vasculature at a location remote from the heart, advancing an interventional tool through the vasculature to a ventricle and/or atrium, and engaging the tool against a tissue structure which forms or supports the atrioventricular valve. By engaging the tool against the tissue structure, the tissue structure is modified in a manner that reduces valve leakage or regurgitation during ventricular systole. The tissue structure may be any of one or more of the group consisting of the valve leaflets, chordae, the valve annulus, and the papillary muscles, atrial wall, ventricular wall or adjacent structures. Optionally, the interventional tool will be oriented relative to the atrioventricular valve and/or tissue structure prior to engaging the tool against the tissue structure. The interventional tool may be self-orienting (e.g., pre-shaped) or may include active mechanisms to steer, adjust, or otherwise position the tool.
- Alternatively, orientation of the interventional tool may be accomplished in whole or in part using a separate guide catheter, where the guide catheter may be pre-shaped and/or include active steering or other positioning means such as those devices set forth in U.S. patent application Ser. Nos. 10/441,753 filed May 19, 2003, Ser. No. 10/441,508 filed May 19, 2003 and Ser. No. 10/441,687 filed May 19, 2003, all of which are expressly incorporated by reference herein. In all cases, it will usually be desirable to confirm the position prior to engaging the valve leaflets or other tissue structures. Such orienting step may comprise positioning the tool relative to a line of coaptation in the atrioventricular valve, e.g., engaging positioning elements in the valve commissures and confirming the desired location using a variety of imaging means such as magnetic resonant imaging (MRI), intracardiac echocardiography (ICE), transesophageal echo (TEE), fluoroscopy, endoscopy, intravascular ultrasound (IVUS) and the like.
- In some embodiments, heart disease in general, and valve repair in particular, are treated by targeting the pacing of the heartbeat. In one embodiment, heart disease is treated by introducing one or more pacing leads into a heart chamber. The pacing leads are placed in contact with a heart muscle and are in electrical communication with a power source. The power source provides paced electrical stimuli to the heart muscle. The electrical stimuli are provided during or immediately after systole to extend systolic contraction of the heart, thereby extending the range of systole during each heartbeat. This extension of systole extends the amount of time in which the heart muscle tightens when it would otherwise be relaxing, when there is most mitral regurgitation in diseased mitral valves.
- Other embodiments are directed to annuloplasty to treat heart disease in general and valve repair in particular. In one embodiment, shown generally in
FIG. 1B , a stent is used to treat the mitral valve.FIG. 1B shows a cross-sectional view of the heart wherein aflexible stent 100 is positioned at or near the mitral valve MV. Thestent 100 is annular and is sized and shaped to be positioned on the annulus of the mitral valve. Thestent 100 can transition between a collapsed state of reduced size and an expanded state of enlarged size relative to the collapsed state. - The
flexible stent 100 can be percutaneously introduced into an individual's heart while being biased toward the collapsed state. The stent is advanced partially through the annulus of the mitral valve so that it is coaxially positioned within the annulus, as shown inFIG. 1B . Thestent 100 is then secured to the annulus such that the stent exerts an inward force on the annulus thereby causing the annulus to resist dilation during diastole of the heart. - In yet another embodiment, a device is disclosed for treating the mitral valve. The device can be a stent, such as the
stent 100, that is sized to fit coaxially within an annulus of a mitral valve. The stent includes a hollow frame. The frame can be annular such that it has a cross-sectional diameter that is sized such that an outer surface of the frame is in continuous coaxial contact with the annulus. The frame also includes one or more anchors protruding from it for securing the stent to the annulus. The anchors can be prongs, barbs, protrusions, or any structure adapted to secure the stent to the annulus. The stent is flexible between an expanded configuration and a contracted configuration and is biased toward the contracted configuration so that it exerts an inward force on the annulus. - In one embodiment, the
stent 100 is delivered using adelivery catheter 10 that is advanced from the inferior vena cava IVC into the right atrium RA. Once thecatheter 10 reaches the anterior side of the interatrial septum IAS, aneedle 12 may be advanced so that it penetrates through the septum at the fossa ovalis FO or the foramen ovale into the left atrium LA. At this point, a delivery device can be exchanged for the needle and the delivery device used to deliver thestent 100. Thecatheter 10 can also approach the heart in other manners. -
FIG. 2A shows a cross-sectional view of the heart showing one or more magnets 210 positioned around the annulus of the mitral valve MV. A corresponding method of treating heart disease involves the use of magnets. The method includes percutaneously introducing at least afirst magnet 205 into an individual's heart and securing it to the mitral valve MV annulus. At least a second magnet 210 is percutaneously introduced into the heart and advanced so that it is within a magnetic field of the first magnet. The second magnet is secured to the heart. The polarity of one of the two magnets is then cyclically changed in synchronization with the heart beat so that the magnets attract and repel each other in synchronization with the heart beat. The first magnet therefore moves in relation to the second magnet and exerts an inward closing force on the mitral valve during systole. The magnets 210 can be positioned on an annular band 215 (shown inFIG. 2B ) that is sized and shaped to be implanted on the annulus of the mitral valve. Theband 215 can be, for example, a stent. - In one embodiment, the magnets 210 or the
annular band 215 are delivered using adelivery catheter 10 that is advanced from the inferior vena cava IVC into the right atrium RA, as described above with reference toFIG. 1 . Any of the devices described herein can be percutaneously delivered into the heart by coupling the device to a delivery device, such as a steerable delivery catheter. - In yet another embodiment involving magnets, two or more magnets are percutaneously introduced into an individual's coronary sinus such that they attract or repel each other to reshape the coronary sinus and an underlying mitral valve annulus.
- Other embodiments involve various prosthetics for treating heart disease in general and defective or diseased mitral valves in particular. In one embodiment, a method of treatment includes placing one or more one-way valves in one or more pulmonary veins of an individual either near the ostium of the vein or at some point along the length of the PV. Valves that may be used, for example may be stentless valves such as designs similar to the TORONTO SPV® (Stentless Porcine Valve) valve, mechanical or tissue heart valves or percutaneous heart valves as are known in the art provided they are sized appropriately to fit within the lumen of the pulmonary vein, as shown in
FIG. 3 . InFIG. 3 , the locations in the left atrium LA where valves can be positioned in pulmonary vein orifices are represented by an “X”. In addition, certain venous valve devices and techniques may be employed such as those described in U.S. Pat. Nos. 6,299,637 and 6,585,761, and United States Patent Applications 20040215339 and 20050273160, the entire contents of which are incorporated herein by reference. A valve prosthesis for placement in the ostia of the pulmonary vein from the left atrium may be in the range of 6-20 mm in diameter. Placement of individual valves in the pulmonary vein ostia (where the pulmonary veins open or take off from the left atrium) may be achieved by obtaining trans septal access to the left atrium with a steerable catheter, positioning a guidewire through the catheter and into the targeted pulmonary vein, and deploying a valve delivery catheter over the guidewire and deploying the valve out of the delivery catheter. The valve may be formed of a deformable material, such as stainless steel, or of a self-expanding material such as NiTi, and include tissue leaflets or leaflets formed of a synthetic material, such as is known in the art. A line of +++++ symbols inFIG. 3 represents a mid-atrial location above the mitral valve where a single valve can be positioned as disclosed later in this specification. - The following references, all of which are expressly incorporated by reference herein, describe devices (such as steerable catheters) and methods for delivering interventional devices to a target location within a body: U.S. patent application Ser. Nos. 10/441,753 filed May 19, 2003, Ser. No. 10/441,508 filed May 19, 2003 and Ser. No. 10/441,687 filed May 19, 2003.
-
FIG. 4 show a cross-sectional view of the heart with a pair of flaps mounted at or near the mitral valve.FIG. 5A shows a schematic side view of the mitral valve leaflets LF with aflap 300 positioned immediately below each leaflet. Theflap 300 can be contoured so as to conform at least approximately to the shape of a leaflet, or theflap 300 can be straight as shown inFIG. 4 .FIG. 5B shows a downward view of the mitral valve with a pair of exemplary flaps superimposed over the leaflets LF. As shown inFIG. 5C , the flaps can have complementary shapes with a first flap having a protrusion that mates with a corresponding recess in a second flap. - In corresponding method of treatment, shown in
FIGS. 4 and 5 C, afirst flap 300 with anattachment end 305 and afree end 310 is provided. Theattachment end 305 of thefirst flap 300 is secured to the inside wall of the ventricle below the mitral valve. Asecond flap 315 with anattachment end 320 and afree end 330 is provided and is also secured to the inside wall of the ventricle below the mitral valve. The first andsecond flaps - In other embodiments, devices and methods that involve prosthetic discs are disclosed. For example,
FIG. 6A shows a cross-sectional view of the heart with amembrane ring 610 positioned at the mitral valve annulus.FIG. 6B shows a schematic view of themembrane ring 610, which includes an annular ring on which is mounted a membrane. The membrane includes a series ofperforations 615 extending through the membrane surface. One or more anchor devices, such as prongs, can be located on the ring for securing the ring to the mitral valve. - In one embodiment, a device for treating heart disease in general and defective or diseased mitral valves in particular includes a disc having a ring, a membrane stretched across an opening of the ring, and one or more anchors for securing the disc to an annulus of a mitral valve. The disc is sized to cover the annulus of the mitral valve, and the membrane includes one or more perforations that permit one way fluid flow through the disc. Methods of treatment using the device are also provided.
- In other embodiments, devices and methods that involve fluid-filled bladders are disclosed.
FIG. 7A shows a cross-sectional view of a heart with a bladder device positioned partially within the left ventricle and partially within the left atrium. A device for treating heart disease in general and defective or diseased mitral valves in particular includes a fluid-filledbladder 600. Thebladder 600 is placed across the mitral valve between the left atrium and the left ventricle. Upon compression of the left ventricle, the volume of the bladder is expanded on the left atrial side of the heart, providing a baffle or sealing volume to which the leaflets of the mitral valve coapt. The bladder may also act as a blocking device in the case of flail of a leaflet, blocking said flailing leaflet from billowing into the left atrium causing regurgitation. The bladder also includes one or more anchors for securing the bladder to an annulus of a mitral valve, or may be formed on a cage or other infrastructure to position it within the line of coaptation of the mitral valve. - A bladder can also be used to treat functional mitral valve disease. As mentioned, functional mitral valve disease is usually characterized by the failure of the mitral valve leaflets to coapt due to an enlarged ventricle, or other impediment to the leaflets rising up far enough toward each other to close the gap or seal against each other during systole.
FIG. 7B shows a schematic side view of the mitral valve leaflets LF failing to coapt such that regurgitation can occur (as represented by the arrow RF.) With reference toFIG. 7C , a baffle orbladder 630 is positioned between the leaflets LF along the line of coaptation of the leaflets. Thebladder 630 provides a surface against which at least a portion of the leaflets LF can seal against. Thebladder 630 thus serves as a coaptation device for the leaflets. The bladder can be attached to various locations adjacent to or on the mitral valve.FIG. 7D shows a plan view of the mitral valve with the leaflets LF in an abnormal closure state such that a gap G is present between the leaflets. In one embodiment, the bladder is attached or anchored to the mitral valve at opposite edges E of the gap G. - Methods of treatment using the bladder include providing the bladder and inserting it through an annulus of a mitral valve such that the bladder is coaxially positioned through the mitral valve. An atrial portion of the bladder extends into the left atrium, and a ventricular portion of the bladder extends into the left ventricle. A mid portion of the bladder may be secured to the annulus of the mitral valve such that the mid portion remains stationery while the atrial and ventricular portions expand and contract passively between the atrium and ventricle based on pressure differentials during systole and diastole.
-
FIG. 8 shows a cross-sectional view of the heart wherein a one-way valve device 700 is located in the left atrium. The valve device is represented schematically inFIG. 8 . A corresponding method of treating heart disease includes introducing a one-way valve device 700 into the left atrium of an individual's heart proximal the mitral valve. Thevalve device 700 is configured to permit fluid flow in one direction while preventing fluid flow in an opposite direction. The valve device can have various structures. For example, the device can comprise a valve that is mounted on a stent that is sized to be positioned in the left atrium. Valves that may be used, for example may be stentless valves such as the TORONTO SPV® (Stentless Porcine Valve) valve, mechanical or tissue heart valves or percutaneous heart valves as are known in the art. The outer wall of the one-way valve device is sealed to the inner wall of the atrium so that a fluid-tight seal is formed between the outer wall of the one-way valve device and the inner wall of the left atrium. In this regard, the valve device can include a seal member that is configured to seal to the inner wall of the atrium. - Another embodiment involves a prosthetic for treating heart disease in general and defective or diseased mitral valves in particular.
FIG. 9A shows aprosthetic ring 800 that is sized to fit within a mitral valve annulus The ring includes one ormore anchors 805 that extend around the periphery of thering 800. In addition, one ormore struts 810 struts extend across the diameter of the ring, and can be made of a material that includes nitinol or magnetic wires for selectively adjusting the shape of the ring. The struts can also be instrumental in baffling mitral valve leaflet “flail”.FIG. 9B shows another embodiment of aprosthetic ring 807 wherein a one-way valve 815 is positioned inside the ring such that blood flow BF can flow through the valve in only one direction. The valve can be manufactured of various materials, such as silicone. -
FIG. 10 shows a prosthetic with one or more tongues or flaps that are configured to be positioned adjacent the flaps of the mitral valve. The prosthetic includes aring 900 sized to fit within a mitral valve annulus. At least twotongues 910 project from thering 900 in a caudal direction when the ring is implanted into a heart of an individual. The ring is flexible between an expanded configuration and a contracted configuration and is biased toward the contracted configuration. One ormore anchors 920 protrude from the flexible ring for coupling the ring coaxially to the annulus such that the contracted configuration of the ring exerts an inward force to the annulus. Alternatively, or in addition, the two tongues can each have a length sufficient to prevent prolapse of a mitral valve when the ring is placed atop the leaflets of the mitral valve. In a further embodiment the tongue elements may be attached at a central point. - In yet another embodiment, a prosthetic for treating heart disease in general and a defective or diseased mitral valve in particular includes a wedge. The wedge has a length that is about equal to a length of the line of coaptation of a mitral valve. The wedge has a depth sufficient to prevent prolapse of a mitral valve when the wedge is placed atop an annulus of the mitral valve along the line of coaptation, and may provide a point of coaptation for each leaflet. One or more anchors protrude from the wedge for coupling the wedge to the annulus of the mitral valve. Methods of treatment using the wedge are also disclosed. The methods include inserting the wedge into an individual's heart, placing the wedge lengthwise along the line of coaptation of the mitral valve. The wedge is then secured to an annulus of the mitral valve along the line of coaptation. The wedge may be positioned also just under one segment of the leaflet (likely P2 in the case of functional MR).
- In yet another embodiment, a device for treating heart disease includes a clip for attachment to a free end of a heart valve leaflet.
FIG. 11A shows an exemplary embodiment of one ormore clips 1101 that are positioned on free edges of the leaflets LF. Each of theclips 1101 has a shape that prevents flail of the leaflet by catching against an underside of an opposing leaflet. Methods of treatment using the clip are also disclosed. The methods include introducing the clip into an individual's heart and attaching the clip to a free end of a heart valve leaflet opposite the free end of an opposing leaflet of the heart valve so that the clip catches to the underside of the opposing leaflet during systole. In a further embodiment, a clip may be placed on both leaflets such that the clips meet or catch when the leaflets are in proximity. The clips may attach momentarily during systole, and then detach during diastole, or may clip permanently resulting in a double orifice mitral valve anatomy. The clips of this embodiment may include a magnetic element, or one may be magnetic and the other of a metal material attracted to said electromagnetic field of the magnetic clip. - In the case of magnetic clips, the clip elements may be placed on the underside of the leaflets (e.g. not necessarily on the free edge of the leaflet), provided that the magnetic field of the clip is sufficient to attract the opposing magnetic or metal clip element. This is further described with reference to
FIG. 11B , which shows pair of leaflets LF with aclip 1101 attached to the underside of each leaflet. At least one of the clips is magnetic, while the other clip is of an opposite magnetic polarity than the first clip or of a metal attracted to the magnetic field of the first clip. The magnetic field is sufficiently strong such that theclips 1101 can attach to one another either momentarily or permanently to coapt the leaflets, as shown inFIG. 11C . - In another embodiment, shown in
FIG. 11D , asingle clip 1101 is attached to one of the leaflets. Theclip 1101 is sufficiently long to increase the likelihood that theclip 1101 will coapt with the opposite leaflet. - In yet another embodiment, a device for treating heart disease includes a wedge for placement under a heart valve leaflet.
FIG. 12 shows a schematic, cross-sectional view of the heart with awedge 1205 positioned below at least one of the leaflets of the mitral valve. Thewedge 1205 can be positioned below one or both of the leaflets. Thewedge 1205 is sized to fit under the valve leaflet and caudal the annulus of the heart valve. Thewedge 1205 can have a shape that is contoured so as to provide support to a lower surface of the leaflet. (InFIG. 12 , the left atrium is labeled LA and the left ventricle is labeled LV.) An anchor is attached to the wedge for coupling the wedge to a wall of the heart chamber adjacent the heart valve. The wedge forms a fixed backstop against the bottom side of the heart valve leaflet, thereby providing a location for the leaflet to coapt against, and/or providing support or “pushing up” a restricted leaflet. - Other embodiments are directed to altering the size, shape, chemistry, stiffness, or other physical attributes of heart valve leaflets. In one embodiment in particular, a method of treating heart disease includes obtaining access to a heart valve leaflet and injecting a stiffening agent into the leaflet to stiffen the leaflet and minimize flail.
- Other embodiments are directed to the chordae that connect heart valve leaflets to the inner walls of the heart. In one embodiment in particular, a method of treating heart disease includes obtaining access to a heart valve chord and cutting it mechanically or with energy such as a laser, or by heating the chordae to elongate them, thereby allowing the previously restricted leaflet to be less restricted so that it can coapt with the opposing leaflet.
- In another embodiment directed to the chordae that connect heart valve leaflets to the inner walls of the heart, a cam-shaped ring is disclosed. The cam-shaped ring is sized to fit within a left ventricle of a heart. The ring forms a hole that is sized to receive two or more chordae tendineae. The ring is formed by connecting two detachable ends of the ring.
- Methods of treatment using the cam-shaped ring are also disclosed. One method in particular includes introducing the ring into a left ventricle of a heart. One or more chordae tendineae are then surrounded by the ring, and the two ends of the ring are then attached to form a closed ring around the chordae tendineae. The ring is then rotated such that one or more of the chordae tendineae are shifted away from their initial orientation by the rotation of the cam-shaped ring. The ring may then be fixed in the rotated or tightened position.
- An embodiment directed at the chordae of heart valve leaflets is now described.
FIG. 13A shows a device that can be used to alter a chordae. A method includes obtaining access to a chordae tendinea (chord) within an individual's heart chamber. The chordae is then cut at a point along its length so that a length of the chorda tendinea is freed from the heart chamber leaving behind a length of chorda tendinea having a free end and an end attached to an edge of a heart valve. - With reference to
FIG. 13A , asynthetic chord 1005 of greater length than the free length of chordae is introduced into the heart chamber. One end of thesynthetic chordae 1005 is connected to awall 1305 of the heart chamber or to a muscle attached to the wall of the heart chamber. Another end of the synthetic chord is attached to the free end of the chorda tendinea or to the leaflet. - In this regard, the end of the
chord 1005 that is attached thewall 1305 can have any of a variety of devices that facilitate such attachment.FIGS. 13B and 13C show enlarged views of attachment devices contained withinbox 13 ofFIG. 13A . The attachment devices can be used to attach thechord 1005 to thewall 1305. InFIG. 13B , theattachment device 1310 is an enlarged ball having a distal trocar for penetrating thewall 1305. InFIG. 13C , theattachment device 1310 is a hook that is configured to penetrate through thewall 1305. It should be appreciated that theattachment device 1310 can have other structures and it not limited to the structures shown inFIGS. 13B and 13C . In variations of these embodiments, it may be advantageous to adjust the length of the chordae (synthetic, or modified), determine the therapeutic effect of the shortening or lengthening, and then fix the chordae at the most efficacious location. - Other embodiments are directed to atrial or ventricular remodeling to alter the shape of an atrium or ventricle.
FIG. 14 shows a cross-sectional view of the heart with a first and second anchor attached to a wall of the heart. The system includes afirst anchor 1410 a having a screw portion 1415 for screwing into a wall of the heart and a connector portion. The connector portion is rotatable around an axis of rotation. The first anchor includes a power source to power rotation of the connector portion and a receiver for receiving telemetric signals from an external controller for controlling the rotation of the connector portion. The system includes asecond anchor 1410 b having ascrew portion 1415 b for screwing into a wall of the heart and a connector portion. Also included is atether 1420 having two free ends. One of the free ends is coupled to the connector portion of the first anchor, and the other free end is coupled to the connector portion of the second anchor. An external controller is also included. The external controller has a telemetric transmitter for communicating with the receiver and controls the rotation of the connector portion. Alternatively, the anchors may be placed with a torqueable catheter. - In another embodiment, a method of altering a geometry of a heart includes introducing a first coupler into a heart chamber. The first coupler has an anchor portion and a connector portion. The connector portion is rotatable around an axis of rotation and is connected to a power source to power rotation of the connector portion. The power source is in communication with a telemetric signal receiver. The first coupler is secured to the wall of the heart chamber by anchoring the anchor portion to the wall. A second coupler is introduced into the heart chamber. The second coupler includes an anchor portion and a connector portion. The second coupler is secured to the wall of the heart chamber by anchoring the anchor portion to the wall at a distance from the first coupler.
- A tensile member is introduced into the heart chamber. One end of the tensile member is connected to the connector portion of the first coupler, and another end of the tensile member is connected to the connector portion of the second coupler. The distance between the first and second couplers is adjusted by transmitting a telemetric signal to the receiver, thus causing the connector portion to rotate around the axis of rotation and threading the tensile member around the connector portion to reduce the distance between the first and second couplers.
- In another embodiment, a system for altering the geometry of a heart chamber includes a planar tensile member having substantially inelastic material. At least two anchors are included for anchoring the planar tensile member to an inner wall of a heart chamber. The planar tensile member is substantially shorter in length than a left ventricle of a heart so that when the planar tensile member is anchored in a caudal direction along a length of the left ventricle a tensile force exerted by the planar tensile member between the two anchors prevents the left ventricle from dilating caudally.
- In another embodiment, a method for altering the geometry of a heart includes providing a tensile member having a substantially inelastic material. The tensile member is substantially shorter in length than a left ventricle of a heart. The tensile member is inserted into the left ventricle of the heart and a proximal end of the tensile member is anchored to the left ventricle adjacent the mitral valve. A distal end of the tensile member is anchored to the left ventricle caudal the proximal end so that a tensile force exerted by the tensile member between the two anchors prevents the left ventricle from dilating caudally.
- Other embodiments are directed to strengthening or reshaping the left ventricle of the heart. In one embodiment in particular, a method of reinforcing the left ventricle includes injecting a strengthening agent into a wall of the left ventricle in an enlarged region of the ventricle, as shown in
FIG. 15 .FIG. 15 shows acatheter 1510 that has been introduced into the heart. Thecatheter 1510 has an internal lumen through which thestrengthening agent 1512 can be injected. A proximal end of the catheter is connected to a source of the strengthening agent and a distal end of the catheter is configured to release the strengthening agent. As shown inFIG. 15 , the distal end of the catheter is positioned at or near a wall of the heart and thestrengthening agent 1512 is injected into the wall of the heart. - In another embodiment, a method is directed to altering the geometry of a heart. The method includes injecting a polymerizing agent into a pericardial space adjacent a left ventricle, thereby exerting a medial (inward) force against the left ventricle.
- In yet another embodiment, a method of altering the geometry of a heart includes inserting a balloon into a pericardial space adjacent to a left ventricle of the heart, or extend into the pericardium of the heart. The balloon is inflated by injecting it with a fluid, and it exerts a medial force against the left ventricle upon inflation. In certain embodiments, the balloon can be inflated at the time of implantation, or at a later time. If inflated at a later time, the balloon would be self-sealing, and may be inflated by accessing the balloon with a needle placed through the chest wall.
- Other embodiments are directed to adjusting the length or orientation of papillary muscles.
FIG. 16 shows a schematic view of the heart showing the papillary muscles PM. With reference toFIG. 16 , a method of treating heart disease includes inserting an anchor, cuff orsleeve 1205 into the left ventricle of an individual's heart, and sliding a cuff or sleeve around a papillary muscle P. The size of the cuff or sleeve is reduced so that the cuff or sleeve squeezes the papillary muscle. As the size of the cuff or sleeve is reduced, the papillary muscle stretches and increased in length. - In yet another embodiment, a method of treating heart disease includes obtaining access to a papillary muscle in a left ventricle of the heart. The papillary muscle is cut and reattached at a new location on an inner wall of the ventricle closer to the mitral valve.
- Additional embodiments that employ magnets in the heart are now described with reference to
FIGS. 17-19 , which show cross-sectional views of the heart. With reference toFIG. 17 , in one embodiment one ormore magnets 1705 are implanted or otherwise attached to awall 1710 of the left ventricle LV. One or moreother magnets 1715 are implanted or otherwise attached to awall 1720 of the right ventricle. Themagnets walls arrows 1725 inFIG. 17 ) toward each other. Themagnetic force 1725 assists in remodeling of the left ventricle during pumping of the heart. That is, themagnets walls -
FIG. 18A shows another embodiment of a procedure wherein magnets are implanted in the heart to geometrically reshape the annulus or the left ventricle. One ormore magnets 1705 are implanted or otherwise attached to afirst wall 1710 a of the left ventricle LV. One ormore magnets 1705 are also implanted or otherwise attached to a second, opposedwall 1710 b of the left ventricle. The magnets on theopposed walls walls - Another embodiment of a procedure uses magnets to anchor tethers within the heart at various locations to optimize the shape of cardiac structures to improve cardiac function. The tethers are placed to either reshape the cardiac structure or to prevent dilatation of the structure over time. The tethers must be securely anchored to the heart structures. A method of anchoring which enables tethering in various positions and directions within the cardiac structures is important for the clinician to optimize cardiac reshaping based on each individual patient anatomy and disease state. A method of anchoring which is atraumatic is also desirable.
-
FIG. 18B shows a side view of the heart with sets of magnets A, A1, B, and B1 positioned to various locations of the heart or to anatomical structures adjacent the heart. In one embodiment, at least one magnet A is placed on the interventricular septum within the right ventricle RV. At least one magnet A1 is placed within the left ventricle LV opposite magnet A. The magnetic force between A and A1 maintains the position of the magnets. The magnets may be enclosed in materials that will promote tissue in-growth and healing to the interventricular septum to ensure stability of location and to eliminate the need for long term anti-coagulation. Additionally, the enclosure material which is flexible and can be delivered in a low profile can be significantly larger in size than the magnets to increase the surface area of contact with the heart wall which will increase the tension that can ultimately be placed on the anchor over time. - A second set of magnets B and B1 are then delivered to another location selected within or adjacent to the heart. The set of magnets A/A1 are attached to the set of magnets B/B1 using at least one
tether 1805, as shown inFIG. 18B . Thetether 1805 can be attached to either or both of the magnets A/A1 at one end and to either of both of the magnets B/B1 at an opposite end. When the set of magnets B/B1 are tethered under tension to the set of magnets A/A1, a change in the shape of the cardiac structure results to improve cardiac function.FIG. 18B shows magnet B positioned in the LV and B1 positioned in a blood vessel BV adjacent to the heart. The magnetic force between B and B1 maintains the location of B and B1. Magnets B and B1 are delivered on or within materials and structures which promote healing and increase the amount of tension that can be placed on the anchor over time. For example, magnet B1 can be delivered on a stent which is of a length, diameter and material which will heal within the BV to provide sufficient resistance to forces placed on it by the tethers. - The tethers may be pre-attached to the magnets A and B1 or they may be attached after A and B1 have been positioned. The tether length may be shortened and/or adjusted after placement of the anchors. Alternatively the final tether length may be pre-selected based on the patient's cardiac structure geometry and the effect the clinician desires. Placing sets of magnets in this method, enables anchoring of tethers within the heart in various positions and angles which provides increased flexibility and variation for clinicians to select optimal re-shaping of the cardiac structures based on specific patient characteristics.
- Examples which demonstrate the flexibility of this approach include placing anchors at the annulus and at the apex of the heart and tethered to shorten the length of the LV; anchors can be placed in the around the annulus and tethered to change the shape of the annulus. More specifically, one or more sets of magnets can be placed in the RA and LA at the level of the mitral valve annulus (on the anterior side of the annulus) and one or more sets of magnets can be placed in the LA and LV on opposite sides of the annulus on the posterior portion of the annulus. The posterior sets of magnets can then be tethered to the anterior sets of magnets to change the shape of the annulus. Alternatively, the magnet anchors can be placed at the level of the annulus in the LA and in a BV adjacent to the heart at the level of the annulus and these then tethered to the anterior annulus magnet anchor described above.
- The magnets A and A1 can also be a single magnet that extends through the interventricular septum. Moreover, only one of the magnets A or A1 need be implanted. One or more magnets B and/or B2 are located opposite the location of the magnet(s) A and/or A1. The magnet(s) B is located within the left ventricle opposite the magnets A/A1, such as on the left ventricular wall. The magnet B1 is located on an anatomical structure adjacent the heart, such as on a blood vessel BV.
- In another embodiment shown in
FIG. 18C , the magnets A, A1, B, and B1, or combinations thereof, are implanted in the heart without tethers. The magnets A, A1, B, and B1 can be positioned in various combinations so as to exert magnetic attractions to one another to re-shape the left ventricle or the mitral valve annulus. For example, the magnets A and B can be implanted such that they exert an attractive magnetic force relative to one another. The magnets A and B2 can alternately be implanted. Other possible combinations are the magnets A1 and B or the magnets A1 and B2. The magnets can be implanted without tethers such that an attractive magnetic force F causes the magnets and the attached region of the heart to move toward one another to re-shape the heart. Alternately, the magnets can be attached to one another with tethers. - In yet another embodiment, one or
more magnets 1705 are implanted in thewalls 1710 of the left ventricle LV and/or the right ventricle RV, as shown inFIG. 19 . Themagnets 1705 are positioned in opposed locations on thewalls 1710 and one ormore tethers 1905 attach opposed pairs ofmagnets 1705 to one another. One or more of thetethers 1905 extend through the interventricular septum to connect a first magnet disposed in the left ventricle and a second magnet disposed in the right ventricle. In certain embodiments, magnet elements do not include tethers, but rely on the magnetic attraction to each other to remodel the tissue between them. For example, a magnetic element may be placed on either side of the interventricular septum, or one element within the septum. Another magnetic element may be placed on or within the opposite left ventricular wall, or in an adjacent vessel on the left ventricular wall. The electromagnetic field of such elements can then interact to cause a remodeling of the left ventricle to assist with ventricular function. - The
tethers 1905 can be elastic so to exert an attractive force between the attachedmagnets 1705 and re-shape the left ventricle LV or annulus AN. Alternately, or in combination with elastic tethers, thetethers 1905 can be shortened in length after placement to thereby pull the walls of the left ventricle LV toward one another and re-shape the left ventricle LV or the annulus AN. In combination with the force provided by thetethers 1905, themagnets 1705 exert an attractive magnetic force toward one another to assist in pulling the heart walls toward each other. - It should be appreciated that one or more magnets can be positioned in other locations of the heart or adjacent anatomical structures for re-shaping of the heart. For example, one or more magnets can be positioned around the annulus AN or can be positioned in the coronary sinus in such a manner that the magnets exert attractive forces toward one another to cause re-shaping of a desired portion of the heart.
- In another embodiment, cardiac re-shaping is achieved through percutaneous placement of one or more tethers that are cinched or anchored in the walls of the left ventricle LV. The tethers provide tension between the walls of the left ventricle to reshape the left ventricle LV in a desired manner.
FIG. 20 shows a cross-sectional view of the left ventricle LV with atether 2010 positioned therein. Thetether 2010 has a first end anchored to a first wall of the left ventricle LV and a second end anchored to an opposed wall of the left ventricle LV. Thetether 2010 is tensioned to pull the walls toward one another (as represented by thephantom lines 2012 inFIG. 20 ) and re-shape the left ventricle LV. It should be appreciated that thephantom lines 2012 inFIG. 20 are merely representative of the geometric re-shaping. The left ventricle LV can be re-shaped in various manners and the amount of re-shaping can vary depending on the tension applied to thetether 2010 and the location of attachment to the walls of the left ventricle LV. The tether may be inelastic or somewhat elastic. - The
tether 2010 can be anchored or otherwise attached to the walls in various manners. In an exemplary embodiment, a patch 2015 (shown inFIG. 20 ) of material is positioned on an exterior surface of the ventricular wall and is attached to one end of thetether 2010. A similar patch can also be positioned on the opposed wall and attached to the opposite end of the tether. - With reference to
FIG. 21 , the patch is delivered to a desired location using acatheter 2105 having a sharpeneddistal end 2110 that is positioned within the left ventricle LV. Thecatheter 2105 can be delivered to the left ventricle LV in various manners, including trans-aortically (via the aorta), trans-septally (by piercing the interventricular septum), and trans-atrially (via the left atrium) pursuant to well-known methods. As shown inFIG. 22 , the sharpeneddistal end 2110 pierces the ventricular wall such that thedistal end 2110 is positioned exterior to the ventricular wall. Thecatheter 2105 has an internal delivery lumen having an opening at thedistal end 2110. Thepatch 2015 is configured to be transported in a contracted state through the delivery lumen and delivered out of the opening at thedistal end 2110, where thepatch 2015 expands into an expanded state at the exterior of the ventricular wall to seal against the exterior of the left ventricular wall. - When positioned at the exterior of the ventricular wall, the
patch 2015 is configured to act as a reservoir that receives a fluid material that can be delivered to the patch via the delivery lumen of thecatheter 2105. The fluid material has a first viscous state of sufficient fluidity such that the material can flow through the delivery lumen of thecatheter 2105 and out of thedistal end 2110 to the location of thepatch 2015. The fluid material changes to a second viscous state when positioned exterior to the ventricular wall at thepatch 2015. The second viscous state is of greater viscosity (i.e., more resistant to flow) than the first viscous state such that the fluid material provides support and a level of rigidity to thepatch 2015 and to the left ventricular wall. The fluid material can change to the second viscous state after a predetermined time period, after contact with the patch, or when the patch is completely filled. A catalyst can be injected into the fluid material to cause it to change to the second viscous state. - As shown in
FIG. 23 , thecatheter 2105 can then be disengaged from thepatch 2015 such that thepatch 2015 is disposed exterior to the ventricular wall. Thepatch 2015 can be firmly attached to the ventricular wall (such as using an adhesive) to minimize wear or friction between the patch and the ventricular wall. Next, an end of thetether 2010 is attached to thepatch 2015. Thecatheter 2105 can be used to deliver thetether 2010 to thepatch 2015 or, alternately, a second catheter can be used. In one embodiment, thetether 2015 is already positioned in a delivery lumen of thecatheter 2010 while thepatch 2015 is being delivered. Thecatheter 2010 is then pulled back while the end of thetether 2015 remains attached to thepatch 2015 to thereby let thetether 2010 out from thecatheter 2010, as shown inFIG. 23 . - With reference now to
FIG. 24 , asecond patch 2415 is deployed in or exterior to an opposed ventricular wall in a manner similar to that described above. The opposite end of thetether 2010 is then attached to thesecond anchor 2415 such that thetether 2010 extends between the two anchors, as shown inFIG. 20 . Alternately, as shown inFIG. 24 , asecond tether 2420 is attached at a first end to thesecond anchor 2415. As shown inFIG. 25 , the twotethers clip 2510, to form a single attachment tether between thepatches tether 2510 can be twisted or adjusted within the clip to tension the resulting attachment tether between thepatches - In another embodiment, shown in
FIG. 26 , aneedle 2610 or delivery catheter is passed trans-thoracically into the left ventricle LV to deliver apatch 2615 to the exterior of the ventricular wall, as described above. A sealing means, such as a sealing balloon, can be used to seal one or more puncture holes in the wall of the left ventricle caused by the needle 26 during delivery of thepatch 2615. Visualization means, such as fluoroscopy, can be used to visualize proper placement of theneedle 2610. A second patch is attached to an opposed wall to form a tether attachment between the walls, as shown inFIG. 20 . The tether is then tensioned to pull the walls together and re-shape the left ventricle or annulus of the mitral valve in a desired manner. - In other embodiments, described with reference to
FIGS. 27-31 , cardiac re-shaping is achieved by manipulation of the papillary muscles.FIG. 27 shows a schematic, cross-sectional view of the left ventricle LV in a healthy state with the mitral valve closed. The valve chordae CH connect the leaflets LF of the mitral valve to the papillary muscles PM. The papillary muscles PM and the and chordae CH are positioned such that at least a portion of the leaflets LF contact one another when the mitral valve is in the closed state, resulting in functional coaptation of the leaflets. -
FIG. 28 shows the left ventricle LV in a dysfunctional state. The valve chordae CH or the papillary muscles PM are damaged or otherwise dysfunctional such that the leaflets LF do not properly coapt (contact one another). The dysfunction can be manifested by excess tension in the chordae CH such that a gap is located between the leaflets LF, or in some cases one leaflet may function at a different level from the other (e.g. lower (prolapse) or higher (flail)) thereby limiting the ability of the mitral valve to close resulting in mitral regurgitation. The dysfunctional left ventricle LV and in some cases leaflet prolapse or flail, can be treated by manipulating papillary muscles PM to adjust the position of the leaflets LF. In one embodiment, the papillary muscles PM are repositioned toward one another to reduce the distance between the papillary muscles PM. - In an embodiment described with reference to
FIG. 29 , a biasing member, such as a rod of adjustable length, or aspring 2910, is mounted between the papillary muscles PM with a first end of thespring 2910 attached to a first papillary muscle and a second end of thespring 2910 attached to a second papillary muscle. Thespring 2910 has a pre-load such that thespring 2910 provides a biasing force (represented by thearrows 2915 inFIG. 29 ) that pulls the papillary muscles PM toward one another. Such a spring may be covered with polyester fabric or other coating to promote ingrowth into the muscle tissue and minimize the potential for clot formation. The repositioning of the papillary muscles PM re-shapes the left ventricle and/or changes the distance that the leaflets need to move on the chordae CH such that the leaflets LF contact one another to close the mitral valve. The tension provided by thespring 2910 can be varied or different springs can be used to achieve a proper repositioning of the papillary muscles PM. The tension may be modified at the time of the procedure or during a subsequent procedure if it is determined that additional coaptation is required. - In another embodiment, described with reference to
FIG. 30 , asuture 3010 is mounted between the papillary muscles PM with a first end of thesuture 3010 attached to a first papillary muscle and a second end of thesuture 3010 attached to a second papillary muscle. Thesuture 3010 can be attached to the papillary muscles in various manners. For example, anattachment device 3015, such as an anchor, cuff or sleeve, can be positioned around or partially around each of the papillary muscles. The ends of thesuture 3010 are attached to theattachment devices 3015 to secure thesuture 3010 to the suture to the papillary muscles. - The
suture 3010 is tensioned such that it provides a force that pulls the papillary muscles PM toward one another. Thesuture 3010 can be tensioned, for example, by twisting thesuture 3010 to reduce its the overall length and thereby reduce the distance between the papillary muscles PM, and fixing the suture with a crimping element or other stay element. The amount of twisting or shortening can be varied to vary the tension provided by thesuture 3010. In addition, a crimping member may be used to fix the sutures once a desired tension between the muscles is reached. Exemplary crimping members are described in International Patent Application Number PCT/US03/06149, which is incorporated herein by reference in its entirety. As in the previous embodiment, the repositioning of the papillary muscles PM re-shapes the left ventricle and/or changes the tension on the chordae CH such that the leaflets LF contact one another to close the mitral valve. Cuffs or sleeves may be placed around the papillary muscles PM to such as those previously described, to affect the repositioning. - With reference now to
FIG. 31 , the papillary muscles PM can also be repositioned by snaring the papillary muscles. Asnare 3110 comprised of a looped strand of material is positioned around the chordae CH at or near the location where the chordae attach with the papillary muscles PM. Thesnare 3110 is tightened to draw the papillary muscles PM toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve. - In yet another embodiment, shown in
FIG. 36 , one ormore clips 3610 are clipped to each of the papillary muscles PM. The structure of theclips 3610 can vary. Atether 3615 attaches theclips 3610 to one another. Thetether 3615 is cinched to shorten the length of thetether 3615 and pull the papillary muscles PM toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve. - In yet another embodiment, shown in
FIG. 37 , one ormore clips 3610 are clipped to opposed walls of the left ventricle LV. Theclips 3610 can be delivered to the left ventricle using adelivery catheter 2105. A tether attaches the clips to one another. The tether is cinched to shorten the length of the tether and pull the ventricular walls toward one another and re-shape the left ventricle and/or changes the distance that the leaflets need to travel during systole such that the leaflets LF contact one another to close the mitral valve. - In all embodiments, once the papillary muscles are fixed or repositioned, it may be advantageous to further treat the area by selectively elongating or shortening the chordae tendinae to achieve further optimal valve function. In addition, a mitral valve clip may be deployed to augment the desired valve function, either before papillary or chordal manipulation, or after, if the desired leaflet coaptation is not achieved with one particular approach.
- As discussed above with reference to
FIG. 28 , a dysfunctional left ventricle can be manifested by excess tension in the chordae CH such that a gap is positioned between the valve leaflets LF. It can be desirable to eliminate or relieve the excess tension by cutting the chordae CH, and/or cutting the chordae and replacing them with artificial chordae. Prior to cutting the chordae, it can be desirable to evaluate the placement of the artificial chordae to confirm that implantation of the chordae will indeed provide the desired clinical result. This process is now described with reference toFIGS. 32-35 . -
FIG. 32 shows aleaflet grasping device 1100 that is configured to grasp and secure the leaflets of the mitral valve. Thedevice 1100 and corresponding methods of use are described in more detail in U.S. patent application Ser. No. 10/635,776, entitled “Methods and Apparatus For Cardiac Valve Repair”, which is incorporated herein by reference in its entirety. Additional leaflet grasping devices are described in U.S. patent application Ser. No. 10/441,508, filed May 19, 2003, U.S. Pat. No. 6,269,819, issued Aug. 7, 2001, and U.S. Pat. No. 6,461,366, issued Oct. 8, 2002, all of which are expressly incorporated by reference herein. - Referring to
FIG. 32 , thedevice 1100 is comprised of acatheter shaft 1102 having adistal end 1104 and aproximal end 1106. Thecatheter shaft 1102 is comprised of, among others, aconduit 1108, a coaxialouter sheath 1110, acentral lumen 1111 through which a double-jaw grasper 1113 may be inserted, and acentral guidewire lumen 1105. Thecatheter shaft 1102 can have additional lumens for the passage of one or more needles, as described more fully below. - Toward the
distal end 1104, an optional pair ofstabilizers 1112 are fixedly mounted on theouter sheath 1110 at theirproximal end 1114 and fixedly attached toextenders 1116 at theirdistal end 1118. Thestabilizers 1112 are shown in an outwardly bowed position, however they may be inwardly collapsed by either extending theextenders 1116 or retracting theouter sheath 1110. Bowing may be achieved by the reverse process. - The double-
jaw grasper 1113 is comprised of two articulatingjaw arms 1120 which may be opened and closed against the central shaft 1122 (movement depicted by arrows) either independently or in tandem. Thegrasper 1113 is shown in the open position inFIG. 32 . The surfaces of thejaw arms 1120 andcentral shaft 1122 may be toothed, as shown, or may have differing surface textures for varying degrees of friction. Thejaw arms 1120 each include aneedle passageway 1121 comprised of a cutout or a slot that extends at least partially along the length of eachjaw arm 1120. As described in more detail below, the needle passageway provides a location where a needle can pass through thejaw arm 1120 during manipulation of the papillary muscle. - The above described components may be manipulated and controlled by a
handle 1126 connected to theproximal end 1106 of thecatheter shaft 1102, as shown inFIG. 86 . the handle 1026 permits independent control of the components described above. - Referring to FIGS. 33A-C, the
device 1100 may be used at least temporarily grasp and restrain the valve leaflets LF of the mitral valve MV. The double-jaw grasper 1113 extends through the valve such that the leaflets L1, L2 are grasped from below. Thus, thedevice 1100 is termed “atrial-ventricular.” - Referring to
FIG. 33A , theatrial device 1100 may be stabilized against the mitral valve MV. Thestabilizers 1112 may be positioned on the superior surface of the valve leaflets LF1, LF2 at a 90 degree angle to the line of coaptation. Thegrasper 1113 may be advanced in its closed position from theconduit 1108 between the leaflets LF1, LF2 until thejaw arms 1120 are fully below the leaflets in the ventricle. At this point, thegrasper 1113 may be opened and retracted so that thejaw arms 1120 engage the inferior surface of the leaflets LF1, LF2. In this manner, the leaflets are secured between thestabilizers 1112 and thejaw arms 1120. - Referring to
FIG. 33B , thegrasper 1113 will gradually close, drawing the leaflets LF1, LF2 together while maintaining a secure hold on the leaflets between thejaw arms 1120 and thestabilizers 1112. This may be accomplished by number of methods. For example, thestabilizers 1112 may be gradually collapsed by either extending theextenders 1116 or retracting theouter sheath 1110. As thestabilizers 1112 collapse, thejaw arms 1120 may collapse due to spring loading to gradually close thegrasper 1113. Alternatively, thejaw arms 1120 may be actuated to close against thecentral shaft 1122 applying force to thestabilizers 1112 causing them to collapse. In either case, such action allows thestabilizers 1112 to simultaneously vertically retract and withdraw from the leaflets as the leaflets are clamped between thejaw arms 1120 and thecentral shaft 1122. In this manner, the leaflets are effectively “transferred” to thegrasper 1113. Referring toFIG. 33C , once thecollapsed stabilizers 1112 are completely withdrawn, the leaflets LF1, LF2 are held in vertical opposition by thegrasper 1113 in a more natural coaptation geometry. - With reference now to
FIG. 34 , aneedle 3410 is advanced from the left atrium into the left ventricle. Theneedle 3410 can be passed through a lumen in thedevice 1100 or it can be passed external to thedevice 1100. In any event, theneedle 3410 passes through a leaflet LF and into a papillary muscle PM. As mentioned, thejaw arms 1120 have needle passageways 1121 (shown inFIG. 32 ) that permit passage of the needle through thejaw arms 1120. - The
needle 3410 is attached to asuture 3415 that extends distally through thedevice 1100. Thesuture 3415 is then anchored to the papillary muscle PM such that thesuture 3415 provides an attachment for holding, pulling, or otherwise manipulating the papillary muscle PM. The tension in thesuture 3415 can be adjusted to re-position the papillary muscle PM such that the leaflets LF contact one another to close the mitral valve. The same process can be performed with the other papillary muscle. - With the
sutures 3415 holding the papillary muscles PM in a desired position, as shown inFIG. 35 , the chordae CH may be cut. Thesutures 3415 function as artificial chordae that retain the leaflets LF and papillary muscles PM in a desired orientation. - A fixation device such as a clip can then be attached to the leaflets using methods and device described in U.S. patent application Ser. No. 10/635,776, filed Aug. 5, 2003, U.S. patent application Ser. No. 10/441,508, filed May 19, 2003, U.S. Pat. No. 6,269,819, issued Aug. 7, 2001, and U.S. Pat. No. 6,461,366, issued Oct. 8, 2002, all of which are expressly incorporated by reference herein. The
sutures 3415 can be attached to theclip 3510 or directly to the leaflets LF. It should be appreciated that any quantity ofsutures 3415 can be used as artificial chordae between the leaflets and the papillary muscles. It should be appreciated that the leaflet clips can also be used in conjunction with cutting, elongating, or shortening of the chordae pursuant to the methods described above. - Prior to permanently placing the chordae or clips, the result can be previewed on ultrasound (TEE, ICE, echocardiography), to determine if the appropriate valve coaptation is restored. In addition, it is within the scope of the present invention to implant a mitral valve clip in addition to performed papillary muscle approximation or chordal implantation.
- Although embodiments of various methods and devices are described herein in detail with reference to certain versions, it should be appreciated that other versions, embodiments, methods of use, and combinations thereof are also possible. Therefore the spirit and scope of the appended claims should not be limited to the description of the embodiments contained herein.
Claims (18)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/349,742 US20060229708A1 (en) | 2005-02-07 | 2006-02-07 | Methods, systems and devices for cardiac valve repair |
US12/398,971 US20090177266A1 (en) | 2005-02-07 | 2009-03-05 | Methods, systems and devices for cardiac valve repair |
PCT/US2010/021411 WO2011034628A1 (en) | 2005-02-07 | 2010-01-19 | Methods, systems and devices for cardiac valve repair |
US12/690,027 US20100298929A1 (en) | 2005-02-07 | 2010-01-19 | Methods, systems and devices for cardiac valve repair |
US12/689,958 US8470028B2 (en) | 2005-02-07 | 2010-01-19 | Methods, systems and devices for cardiac valve repair |
EP10757366.9A EP2410948B1 (en) | 2005-02-07 | 2010-09-15 | Devices for cardiac valve repair |
US12/883,095 US20110060407A1 (en) | 2005-02-07 | 2010-09-15 | Methods, systems and devices for cardiac valve repair |
PCT/US2010/048999 WO2011034973A2 (en) | 2005-02-07 | 2010-09-15 | Methods, systems and devices for cardiac valve repair |
US15/082,137 US20160242909A1 (en) | 2005-02-07 | 2016-03-28 | Methods, systems and devices for cardiac valve repair |
US15/943,758 US10667911B2 (en) | 2005-02-07 | 2018-04-03 | Methods, systems and devices for cardiac valve repair |
US16/526,092 US20190350710A1 (en) | 2005-02-07 | 2019-07-30 | Methods, systems and devices for cardiac valve repair |
US17/319,808 US20210393404A1 (en) | 2005-02-07 | 2021-05-13 | Methods, systems and devices for cardiac valve repair |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65091805P | 2005-02-07 | 2005-02-07 | |
US69280205P | 2005-06-21 | 2005-06-21 | |
US11/349,742 US20060229708A1 (en) | 2005-02-07 | 2006-02-07 | Methods, systems and devices for cardiac valve repair |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/398,971 Continuation US20090177266A1 (en) | 2005-02-07 | 2009-03-05 | Methods, systems and devices for cardiac valve repair |
US12/690,027 Continuation-In-Part US20100298929A1 (en) | 2005-02-07 | 2010-01-19 | Methods, systems and devices for cardiac valve repair |
US12/883,095 Continuation-In-Part US20110060407A1 (en) | 2005-02-07 | 2010-09-15 | Methods, systems and devices for cardiac valve repair |
US13/852,459 Continuation-In-Part US20130282059A1 (en) | 2005-02-07 | 2013-03-28 | Methods, systems and devices for cardiac valve repair |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060229708A1 true US20060229708A1 (en) | 2006-10-12 |
Family
ID=36477759
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/349,742 Abandoned US20060229708A1 (en) | 2005-02-07 | 2006-02-07 | Methods, systems and devices for cardiac valve repair |
US12/398,971 Abandoned US20090177266A1 (en) | 2005-02-07 | 2009-03-05 | Methods, systems and devices for cardiac valve repair |
US13/852,459 Abandoned US20130282059A1 (en) | 2005-02-07 | 2013-03-28 | Methods, systems and devices for cardiac valve repair |
US15/082,137 Abandoned US20160242909A1 (en) | 2005-02-07 | 2016-03-28 | Methods, systems and devices for cardiac valve repair |
US15/943,758 Active US10667911B2 (en) | 2005-02-07 | 2018-04-03 | Methods, systems and devices for cardiac valve repair |
US16/526,092 Abandoned US20190350710A1 (en) | 2005-02-07 | 2019-07-30 | Methods, systems and devices for cardiac valve repair |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/398,971 Abandoned US20090177266A1 (en) | 2005-02-07 | 2009-03-05 | Methods, systems and devices for cardiac valve repair |
US13/852,459 Abandoned US20130282059A1 (en) | 2005-02-07 | 2013-03-28 | Methods, systems and devices for cardiac valve repair |
US15/082,137 Abandoned US20160242909A1 (en) | 2005-02-07 | 2016-03-28 | Methods, systems and devices for cardiac valve repair |
US15/943,758 Active US10667911B2 (en) | 2005-02-07 | 2018-04-03 | Methods, systems and devices for cardiac valve repair |
US16/526,092 Abandoned US20190350710A1 (en) | 2005-02-07 | 2019-07-30 | Methods, systems and devices for cardiac valve repair |
Country Status (5)
Country | Link |
---|---|
US (6) | US20060229708A1 (en) |
EP (3) | EP3967269A3 (en) |
AU (1) | AU2006212750B2 (en) |
CA (1) | CA2597066C (en) |
WO (1) | WO2006086434A1 (en) |
Cited By (238)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US7186265B2 (en) * | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
WO2007144121A1 (en) * | 2006-06-16 | 2007-12-21 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Device for treatment of mitral valve insufficiency |
US20070299513A1 (en) * | 2006-06-02 | 2007-12-27 | Ryan Timothy R | Annuloplasty ring and method |
US20080086203A1 (en) * | 2006-10-06 | 2008-04-10 | Roberts Harold G | Mitral and tricuspid annuloplasty rings |
US20080221672A1 (en) * | 2007-02-23 | 2008-09-11 | Endovalve, Inc. | Mitral Valve System |
US20090099410A1 (en) * | 2005-06-09 | 2009-04-16 | De Marchena Eduardo | Papillary Muscle Attachment for Left Ventricular Reduction |
US20090132036A1 (en) * | 2007-11-19 | 2009-05-21 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US20090157174A1 (en) * | 2005-12-15 | 2009-06-18 | Georgia Tech Reasearch Corporation | Systems and methods for enabling heart valve replacement |
US20090222081A1 (en) * | 2008-01-24 | 2009-09-03 | Coherex Medical, Inc. | Methods and apparatus for reducing valve prolapse |
US20090234318A1 (en) * | 2007-10-19 | 2009-09-17 | Guided Delivery Systems, Inc. | Systems and methods for cardiac remodeling |
US20090264995A1 (en) * | 2008-04-16 | 2009-10-22 | Subramanian Valavanur A | Transvalvular intraannular band for valve repair |
US20090292353A1 (en) * | 2005-12-15 | 2009-11-26 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US20090306622A1 (en) * | 2000-09-20 | 2009-12-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heat valve annulus |
US20100121437A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US20100121435A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US20100131057A1 (en) * | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US7736388B2 (en) | 1999-04-09 | 2010-06-15 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7753923B2 (en) | 1999-04-09 | 2010-07-13 | Evalve, Inc. | Leaflet suturing |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US7951197B2 (en) | 2005-04-08 | 2011-05-31 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US7959674B2 (en) | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US7972377B2 (en) | 2001-12-27 | 2011-07-05 | Medtronic, Inc. | Bioprosthetic heart valve |
US7981123B2 (en) | 1997-09-12 | 2011-07-19 | Evalve, Inc. | Surgical device for connecting soft tissue |
US7981153B2 (en) | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US7981139B2 (en) | 2002-03-01 | 2011-07-19 | Evalve, Inc | Suture anchors and methods of use |
US20110184510A1 (en) * | 2010-01-22 | 2011-07-28 | 4Tech, Sarl | Tricuspid valve repair using tension |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US8029518B2 (en) | 1999-04-09 | 2011-10-04 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8092525B2 (en) | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US8123703B2 (en) | 1999-04-09 | 2012-02-28 | Evalve, Inc. | Steerable access sheath and methods of use |
US8211169B2 (en) | 2005-05-27 | 2012-07-03 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US8216302B2 (en) | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
WO2012103173A2 (en) * | 2011-01-25 | 2012-08-02 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
US8343174B2 (en) | 1999-04-09 | 2013-01-01 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US20130096673A1 (en) * | 2008-04-23 | 2013-04-18 | Medtronic, Inc. | Prosthetic Heart Valve Devices And Methods Of Valve Replacement |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8470028B2 (en) | 2005-02-07 | 2013-06-25 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US8500798B2 (en) * | 2005-05-24 | 2013-08-06 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US8529620B2 (en) | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US8603161B2 (en) | 2003-10-08 | 2013-12-10 | Medtronic, Inc. | Attachment device and methods of using the same |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8784483B2 (en) | 2007-11-19 | 2014-07-22 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US8821569B2 (en) | 2006-04-29 | 2014-09-02 | Medtronic, Inc. | Multiple component prosthetic heart valve assemblies and methods for delivering them |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US20140379006A1 (en) * | 2013-06-25 | 2014-12-25 | Mitralign, Inc. | Percutaneous Valve Repair by Reshaping and Resizing Right Ventricle |
US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
US8961594B2 (en) | 2012-05-31 | 2015-02-24 | 4Tech Inc. | Heart valve repair system |
US8961596B2 (en) | 2010-01-22 | 2015-02-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US8986374B2 (en) | 2010-05-10 | 2015-03-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US9060858B2 (en) | 2009-09-15 | 2015-06-23 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US9078749B2 (en) | 2007-09-13 | 2015-07-14 | Georg Lutter | Truncated cone heart valve stent |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US9125742B2 (en) | 2005-12-15 | 2015-09-08 | Georgia Tech Research Foundation | Papillary muscle position control devices, systems, and methods |
US9173646B2 (en) | 2009-01-20 | 2015-11-03 | Guided Delivery Systems Inc. | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9241702B2 (en) | 2010-01-22 | 2016-01-26 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US9314334B2 (en) | 2008-11-25 | 2016-04-19 | Edwards Lifesciences Corporation | Conformal expansion of prosthetic devices to anatomical shapes |
US20160113762A1 (en) * | 2014-10-22 | 2016-04-28 | Medtronic, Inc. | Devices, systems and methods for tissue approximation, including approximating mitral valve leaflets |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
WO2016094490A3 (en) * | 2014-12-09 | 2016-08-04 | De Canniere Didier | Intracardiac device to correct mitral regurgitation |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US9480559B2 (en) | 2011-08-11 | 2016-11-01 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9545305B2 (en) | 2013-06-14 | 2017-01-17 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9597181B2 (en) | 2013-06-25 | 2017-03-21 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US20170095333A1 (en) * | 2006-10-04 | 2017-04-06 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US9636107B2 (en) | 2002-06-13 | 2017-05-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US9693865B2 (en) | 2013-01-09 | 2017-07-04 | 4 Tech Inc. | Soft tissue depth-finding tool |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US20170252154A1 (en) * | 2013-11-28 | 2017-09-07 | Mvalve Technologies Ltd. | Intracardiac devices comprising stabilizing elements having improved fatigue resistance |
US9763658B2 (en) | 2002-08-02 | 2017-09-19 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
US9801720B2 (en) | 2014-06-19 | 2017-10-31 | 4Tech Inc. | Cardiac tissue cinching |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
EP2408399A4 (en) * | 2009-03-17 | 2018-01-03 | Mitrassist Medical Ltd. | Heart valve prosthesis with collapsible valve and method of delivery thereof |
US9895221B2 (en) | 2012-07-28 | 2018-02-20 | Tendyne Holdings, Inc. | Multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US9907547B2 (en) | 2014-12-02 | 2018-03-06 | 4Tech Inc. | Off-center tissue anchors |
US9913706B2 (en) | 2014-07-17 | 2018-03-13 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
US10010315B2 (en) | 2015-03-18 | 2018-07-03 | Mitralign, Inc. | Tissue anchors and percutaneous tricuspid valve repair using a tissue anchor |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
CN108309504A (en) * | 2018-02-27 | 2018-07-24 | 宁波迪创医疗科技有限公司 | A kind of ventricular assist device enhancing heart function |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US10058428B1 (en) * | 2017-03-28 | 2018-08-28 | Cardiac Success Ltd. | Method of repositioning papillary muscles to improve cardiac function |
US10058321B2 (en) | 2015-03-05 | 2018-08-28 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
US10080657B2 (en) | 2013-03-07 | 2018-09-25 | Cedars-Sinai Medical Center | Catheter based apical approach heart prostheses delivery system |
US10105221B2 (en) | 2013-03-07 | 2018-10-23 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiovascular prosthesis |
US20180353181A1 (en) * | 2017-06-07 | 2018-12-13 | Evalve, Inc. | Tissue compression device for cardiac valve repair |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
US10201419B2 (en) | 2014-02-05 | 2019-02-12 | Tendyne Holdings, Inc. | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US20190069996A1 (en) * | 2017-09-07 | 2019-03-07 | Edwards Lifesciences Corporation | Integral flushing solution for blood stasis prevention in artificial heart valves |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10258466B2 (en) | 2015-02-13 | 2019-04-16 | Millipede, Inc. | Valve replacement using moveable restrains and angled struts |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US10314708B2 (en) * | 2014-06-30 | 2019-06-11 | Jiangsu University | Adaptively positioned mitral valve closure plate blocker for repairing mitral regurgitation |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10363392B2 (en) | 2008-05-07 | 2019-07-30 | Ancora Heart, Inc. | Deflectable guide |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
US10420645B2 (en) | 2012-02-15 | 2019-09-24 | Children's Medical Center Corporation | Right ventricular papillary approximation |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
US10456246B2 (en) | 2015-07-02 | 2019-10-29 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10463494B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US10478304B2 (en) | 2016-07-20 | 2019-11-19 | Abbott Cardiovascular Systems Inc. | Independent system for tricuspid valve repair |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
CN110520077A (en) * | 2017-03-06 | 2019-11-29 | 艾维有限责任公司 | For improving the implantation material and method of the engagement of atrioventricular valve |
US10517728B2 (en) | 2014-03-10 | 2019-12-31 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
US10537432B2 (en) | 2016-08-15 | 2020-01-21 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10548732B2 (en) | 2017-10-23 | 2020-02-04 | Cardiac Success Ltd. | Adjustable self-locking papillary muscle band |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US10555718B2 (en) | 2013-10-17 | 2020-02-11 | Tendyne Holdings, Inc. | Apparatus and methods for alignment and deployment of intracardiac devices |
US10610358B2 (en) | 2015-12-28 | 2020-04-07 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10610354B2 (en) | 2013-08-01 | 2020-04-07 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US10610356B2 (en) | 2015-02-05 | 2020-04-07 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
US10631871B2 (en) | 2003-05-19 | 2020-04-28 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US20200146854A1 (en) * | 2016-05-16 | 2020-05-14 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US20200155312A1 (en) * | 2005-03-17 | 2020-05-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US10667911B2 (en) | 2005-02-07 | 2020-06-02 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US10667804B2 (en) | 2014-03-17 | 2020-06-02 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US10667905B2 (en) | 2015-04-16 | 2020-06-02 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US10695170B2 (en) | 2015-07-02 | 2020-06-30 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
US10743876B2 (en) | 2011-09-13 | 2020-08-18 | Abbott Cardiovascular Systems Inc. | System for fixation of leaflets of a heart valve |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
US10758265B2 (en) | 2014-11-14 | 2020-09-01 | Cedars-Sinai Medical Center | Cardiovascular access and device delivery system |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10786351B2 (en) | 2015-01-07 | 2020-09-29 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
US10799359B2 (en) | 2014-09-10 | 2020-10-13 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiac valve prosthesis |
US10806579B2 (en) | 2017-10-20 | 2020-10-20 | Boston Scientific Scimed, Inc. | Heart valve repair implant for treating tricuspid regurgitation |
US10828160B2 (en) | 2015-12-30 | 2020-11-10 | Edwards Lifesciences Corporation | System and method for reducing tricuspid regurgitation |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
US10966696B2 (en) | 2005-04-22 | 2021-04-06 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11033391B2 (en) | 2016-12-22 | 2021-06-15 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US20210177582A1 (en) * | 2017-04-18 | 2021-06-17 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11039921B2 (en) | 2016-06-13 | 2021-06-22 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US11065116B2 (en) | 2016-07-12 | 2021-07-20 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US11090157B2 (en) | 2016-06-30 | 2021-08-17 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US11096782B2 (en) | 2015-12-03 | 2021-08-24 | Tendyne Holdings, Inc. | Frame features for prosthetic mitral valves |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US20210298899A1 (en) * | 2020-03-30 | 2021-09-30 | Tendyne Holdings, Inc. | Apparatus And Methods For Minimally Invasive Transapical Access |
US11135059B2 (en) | 2013-01-24 | 2021-10-05 | Cardiovalve Ltd. | Prosthetic valve and upstream support therefor |
US11141268B2 (en) | 2009-12-08 | 2021-10-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper and lower skirts |
US11154399B2 (en) | 2017-07-13 | 2021-10-26 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US11179236B2 (en) | 2009-12-08 | 2021-11-23 | Colorado State University Research Foundation | Device and system for transcatheter mitral valve replacement |
US11191639B2 (en) | 2017-08-28 | 2021-12-07 | Tendyne Holdings, Inc. | Prosthetic heart valves with tether coupling features |
US11202706B2 (en) | 2019-05-04 | 2021-12-21 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
US11207181B2 (en) * | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
US11241308B2 (en) | 2015-07-23 | 2022-02-08 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11273033B2 (en) | 2018-09-20 | 2022-03-15 | Vdyne, Inc. | Side-delivered transcatheter heart valve replacement |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
US11291544B2 (en) | 2018-02-02 | 2022-04-05 | Cedars-Sinai Medical Center | Delivery platforms, devices, and methods for tricuspid valve repair |
US11298227B2 (en) * | 2019-03-05 | 2022-04-12 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
US11298117B2 (en) | 2016-02-16 | 2022-04-12 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11304805B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors |
US11304715B2 (en) | 2004-09-27 | 2022-04-19 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US11318018B2 (en) | 2017-03-28 | 2022-05-03 | Cardiac Success Ltd. | Method of improving cardiac function |
US11331186B2 (en) | 2019-08-26 | 2022-05-17 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11337805B2 (en) | 2018-01-23 | 2022-05-24 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
US11344412B2 (en) | 2019-08-20 | 2022-05-31 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US11344410B2 (en) | 2011-08-05 | 2022-05-31 | Cardiovalve Ltd. | Implant for heart valve |
US11382746B2 (en) | 2017-12-13 | 2022-07-12 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11426155B2 (en) | 2010-07-21 | 2022-08-30 | Cardiovalve Ltd. | Helical anchor implantation |
US11439501B2 (en) | 2017-01-25 | 2022-09-13 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US11464638B2 (en) | 2017-10-23 | 2022-10-11 | Cardiac Success Ltd | Adjustable self-locking papillary muscle band |
US11504232B2 (en) | 2008-12-19 | 2022-11-22 | Edwards Lifesciences Corporation | Rapid implant prosthetic heart valve system |
US11517436B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Implant for heart valve |
US11571298B2 (en) | 2017-08-03 | 2023-02-07 | Cardiovalve Ltd. | Prosthetic valve with appendages |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11648110B2 (en) | 2019-12-05 | 2023-05-16 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US11672658B2 (en) | 2015-02-05 | 2023-06-13 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US11672524B2 (en) | 2019-07-15 | 2023-06-13 | Ancora Heart, Inc. | Devices and methods for tether cutting |
US11678980B2 (en) | 2020-08-19 | 2023-06-20 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
US11690709B2 (en) | 2015-09-02 | 2023-07-04 | Edwards Lifesciences Corporation | Methods for securing a transcatheter valve to a bioprosthetic cardiac structure |
US11701225B2 (en) | 2014-07-30 | 2023-07-18 | Cardiovalve Ltd. | Delivery of a prosthetic valve |
US11779458B2 (en) | 2016-08-10 | 2023-10-10 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
US11786366B2 (en) | 2018-04-04 | 2023-10-17 | Vdyne, Inc. | Devices and methods for anchoring transcatheter heart valve |
US11793638B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US11857417B2 (en) | 2020-08-16 | 2024-01-02 | Trilio Medical Ltd. | Leaflet support |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11944537B2 (en) | 2017-01-24 | 2024-04-02 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
US11957577B2 (en) | 2020-03-31 | 2024-04-16 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
Families Citing this family (188)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPC20000013A1 (en) | 2000-04-13 | 2000-07-13 | Paolo Ferrazzi | INTROVENTRICULAR DEVICE AND RELATED METHOD FOR THE TREATMENT AND CORRECTION OF MYOCARDIOPATHIES. |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US8502681B2 (en) | 2005-06-20 | 2013-08-06 | Biovigil, Llc | Hand cleanliness |
US7616122B2 (en) | 2005-06-20 | 2009-11-10 | Biovigil, Llc | Hand cleanliness |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
WO2008068756A2 (en) | 2006-12-05 | 2008-06-12 | Valtech Cardio, Ltd. | Segmented ring placement |
US11259924B2 (en) | 2006-12-05 | 2022-03-01 | Valtech Cardio Ltd. | Implantation of repair devices in the heart |
WO2010004546A1 (en) | 2008-06-16 | 2010-01-14 | Valtech Cardio, Ltd. | Annuloplasty devices and methods of delivery therefor |
US9974653B2 (en) | 2006-12-05 | 2018-05-22 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US9192471B2 (en) | 2007-01-08 | 2015-11-24 | Millipede, Inc. | Device for translumenal reshaping of a mitral valve annulus |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US8411564B2 (en) * | 2007-12-17 | 2013-04-02 | Indian Institute Of Technology, Bombay | Architectural framework of communication network and a method of establishing QOS connection |
US8382829B1 (en) | 2008-03-10 | 2013-02-26 | Mitralign, Inc. | Method to reduce mitral regurgitation by cinching the commissure of the mitral valve |
US8337390B2 (en) | 2008-07-30 | 2012-12-25 | Cube S.R.L. | Intracardiac device for restoring the functional elasticity of the cardiac structures, holding tool for the intracardiac device, and method for implantation of the intracardiac device in the heart |
US8652202B2 (en) | 2008-08-22 | 2014-02-18 | Edwards Lifesciences Corporation | Prosthetic heart valve and delivery apparatus |
US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
US8808368B2 (en) | 2008-12-22 | 2014-08-19 | Valtech Cardio, Ltd. | Implantation of repair chords in the heart |
US8545553B2 (en) | 2009-05-04 | 2013-10-01 | Valtech Cardio, Ltd. | Over-wire rotation tool |
US8940044B2 (en) | 2011-06-23 | 2015-01-27 | Valtech Cardio, Ltd. | Closure element for use with an annuloplasty structure |
CN102341063B (en) | 2008-12-22 | 2015-11-25 | 瓦尔泰克卡迪欧有限公司 | Adjustable annuloplasty device and governor motion thereof |
US8715342B2 (en) | 2009-05-07 | 2014-05-06 | Valtech Cardio, Ltd. | Annuloplasty ring with intra-ring anchoring |
US8241351B2 (en) | 2008-12-22 | 2012-08-14 | Valtech Cardio, Ltd. | Adjustable partial annuloplasty ring and mechanism therefor |
US9011530B2 (en) | 2008-12-22 | 2015-04-21 | Valtech Cardio, Ltd. | Partially-adjustable annuloplasty structure |
US8147542B2 (en) | 2008-12-22 | 2012-04-03 | Valtech Cardio, Ltd. | Adjustable repair chords and spool mechanism therefor |
US8926697B2 (en) | 2011-06-23 | 2015-01-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US8353956B2 (en) | 2009-02-17 | 2013-01-15 | Valtech Cardio, Ltd. | Actively-engageable movement-restriction mechanism for use with an annuloplasty structure |
US9968452B2 (en) | 2009-05-04 | 2018-05-15 | Valtech Cardio, Ltd. | Annuloplasty ring delivery cathethers |
US8523881B2 (en) | 2010-07-26 | 2013-09-03 | Valtech Cardio, Ltd. | Multiple anchor delivery tool |
US10098737B2 (en) | 2009-10-29 | 2018-10-16 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9180007B2 (en) | 2009-10-29 | 2015-11-10 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of an adjustable implant |
US8277502B2 (en) * | 2009-10-29 | 2012-10-02 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
US9011520B2 (en) | 2009-10-29 | 2015-04-21 | Valtech Cardio, Ltd. | Tissue anchor for annuloplasty device |
WO2011154942A2 (en) | 2010-06-07 | 2011-12-15 | Valtech Cardio, Ltd. | Apparatus and method for guide-wire based advancement of a rotation assembly |
US8940042B2 (en) | 2009-10-29 | 2015-01-27 | Valtech Cardio, Ltd. | Apparatus for guide-wire based advancement of a rotation assembly |
EP2506777B1 (en) | 2009-12-02 | 2020-11-25 | Valtech Cardio, Ltd. | Combination of spool assembly coupled to a helical anchor and delivery tool for implantation thereof |
US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
ES2365317B1 (en) | 2010-03-19 | 2012-08-03 | Xavier Ruyra Baliarda | PROTESTIC BAND, IN PARTICULAR FOR THE REPAIR OF A MITRAL VALVE. |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US8790394B2 (en) | 2010-05-24 | 2014-07-29 | Valtech Cardio, Ltd. | Adjustable artificial chordeae tendineae with suture loops |
US20120053680A1 (en) | 2010-08-24 | 2012-03-01 | Bolling Steven F | Reconfiguring Heart Features |
CA2822381C (en) | 2010-12-23 | 2019-04-02 | Foundry Newco Xii, Inc. | System for mitral valve repair and replacement |
US8845717B2 (en) | 2011-01-28 | 2014-09-30 | Middle Park Medical, Inc. | Coaptation enhancement implant, system, and method |
US8888843B2 (en) | 2011-01-28 | 2014-11-18 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valve regurgitation |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
CN107496054B (en) | 2011-06-21 | 2020-03-03 | 托尔福公司 | Prosthetic heart valve devices and related systems and methods |
US9918840B2 (en) | 2011-06-23 | 2018-03-20 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
US10792152B2 (en) | 2011-06-23 | 2020-10-06 | Valtech Cardio, Ltd. | Closed band for percutaneous annuloplasty |
EP3395298A1 (en) | 2011-06-27 | 2018-10-31 | University of Maryland, Baltimore | Transapical mitral valve repair device |
US9011468B2 (en) | 2011-09-13 | 2015-04-21 | Abbott Cardiovascular Systems Inc. | Independent gripper |
US9039757B2 (en) | 2011-10-19 | 2015-05-26 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
EP3943047B1 (en) | 2011-10-19 | 2023-08-30 | Twelve, Inc. | Device for heart valve replacement |
US9655722B2 (en) | 2011-10-19 | 2017-05-23 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
US11202704B2 (en) | 2011-10-19 | 2021-12-21 | Twelve, Inc. | Prosthetic heart valve devices, prosthetic mitral valves and associated systems and methods |
CN111000663B (en) | 2011-10-19 | 2022-04-15 | 托尔福公司 | Prosthetic heart valve devices, prosthetic mitral valves, and related systems and methods |
US8858623B2 (en) | 2011-11-04 | 2014-10-14 | Valtech Cardio, Ltd. | Implant having multiple rotational assemblies |
EP3970627B1 (en) | 2011-11-08 | 2023-12-20 | Edwards Lifesciences Innovation (Israel) Ltd. | Controlled steering functionality for implant-delivery tool |
US10076414B2 (en) | 2012-02-13 | 2018-09-18 | Mitraspan, Inc. | Method and apparatus for repairing a mitral valve |
CA2900930A1 (en) | 2012-02-13 | 2013-08-22 | Mitraspan, Inc. | Method and apparatus for repairing a mitral valve |
US9579198B2 (en) | 2012-03-01 | 2017-02-28 | Twelve, Inc. | Hydraulic delivery systems for prosthetic heart valve devices and associated methods |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
EP2900150B1 (en) | 2012-09-29 | 2018-04-18 | Mitralign, Inc. | Plication lock delivery system |
WO2014064695A2 (en) | 2012-10-23 | 2014-05-01 | Valtech Cardio, Ltd. | Percutaneous tissue anchor techniques |
US9949828B2 (en) | 2012-10-23 | 2018-04-24 | Valtech Cardio, Ltd. | Controlled steering functionality for implant-delivery tool |
US9730793B2 (en) | 2012-12-06 | 2017-08-15 | Valtech Cardio, Ltd. | Techniques for guide-wire based advancement of a tool |
US10449333B2 (en) | 2013-03-14 | 2019-10-22 | Valtech Cardio, Ltd. | Guidewire feeder |
EP2968847B1 (en) | 2013-03-15 | 2023-03-08 | Edwards Lifesciences Corporation | Translation catheter systems |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
FR3004336A1 (en) * | 2013-04-12 | 2014-10-17 | St George Medical Inc | MITRAL HEART VALVE PROSTHESIS AND RELIEF CATHETER |
CN108294846A (en) | 2013-05-20 | 2018-07-20 | 托尔福公司 | Implantable cardiac valve device, mitral valve repair device and related system and method |
US9020227B2 (en) * | 2013-06-13 | 2015-04-28 | Siemens Aktiengesellschaft | Automatic interatrial septum detection from pre-operative and intra-operative 3D medical images for accurate transseptal puncture |
EP3033047B1 (en) | 2013-08-14 | 2018-01-03 | Sorin Group Italia S.r.l. | Apparatus for chordal replacement |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
WO2015059699A2 (en) | 2013-10-23 | 2015-04-30 | Valtech Cardio, Ltd. | Anchor magazine |
US10166098B2 (en) | 2013-10-25 | 2019-01-01 | Middle Peak Medical, Inc. | Systems and methods for transcatheter treatment of valve regurgitation |
US9610162B2 (en) | 2013-12-26 | 2017-04-04 | Valtech Cardio, Ltd. | Implantation of flexible implant |
US9681864B1 (en) | 2014-01-03 | 2017-06-20 | Harpoon Medical, Inc. | Method and apparatus for transapical procedures on a mitral valve |
CA2958061A1 (en) | 2014-06-18 | 2015-12-23 | Middle Peak Medical, Inc. | Mitral valve implants for the treatment of valvular regurgitation |
EP3160396B1 (en) | 2014-06-24 | 2022-03-23 | Polares Medical Inc. | Systems for anchoring an implant |
EP3182907B1 (en) * | 2014-08-21 | 2022-04-27 | Koninklijke Philips N.V. | A connection rod for a tongue manipulation system |
WO2016050751A1 (en) | 2014-09-29 | 2016-04-07 | Martin Quinn | A heart valve treatment device and method |
EP3206629B1 (en) | 2014-10-14 | 2021-07-14 | Valtech Cardio, Ltd. | Apparatus for heart valve leaflet restraining |
WO2016090308A1 (en) | 2014-12-04 | 2016-06-09 | Edwards Lifesciences Corporation | Percutaneous clip for repairing a heart valve |
US9480565B2 (en) | 2015-02-02 | 2016-11-01 | On-X Life Technologies, Inc. | Rapid deployment artificial chordae tendinae system |
US20160256269A1 (en) | 2015-03-05 | 2016-09-08 | Mitralign, Inc. | Devices for treating paravalvular leakage and methods use thereof |
CN114515173A (en) | 2015-04-30 | 2022-05-20 | 瓦尔泰克卡迪欧有限公司 | Valvuloplasty techniques |
EP3294219B1 (en) | 2015-05-14 | 2020-05-13 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10278819B2 (en) | 2015-06-01 | 2019-05-07 | Edwards Lifesciences Corporation | Cardiac valve repair devices configured for percutaneous delivery |
EP3337428A1 (en) * | 2015-08-21 | 2018-06-27 | Twelve Inc. | Implantable heart valve devices, mitral valve repair devices and associated systems and methods |
EP3753498B1 (en) | 2015-10-02 | 2023-12-06 | Harpoon Medical, Inc. | Distal anchor apparatus for mitral valve repair |
US9592121B1 (en) | 2015-11-06 | 2017-03-14 | Middle Peak Medical, Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US11833034B2 (en) | 2016-01-13 | 2023-12-05 | Shifamed Holdings, Llc | Prosthetic cardiac valve devices, systems, and methods |
US11478353B2 (en) | 2016-01-29 | 2022-10-25 | Bioventrix, Inc. | Percutaneous arterial access to position trans-myocardial implant devices and methods |
US10433952B2 (en) | 2016-01-29 | 2019-10-08 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10835714B2 (en) | 2016-03-21 | 2020-11-17 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10799675B2 (en) | 2016-03-21 | 2020-10-13 | Edwards Lifesciences Corporation | Cam controlled multi-direction steerable handles |
US11219746B2 (en) | 2016-03-21 | 2022-01-11 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
US10624743B2 (en) | 2016-04-22 | 2020-04-21 | Edwards Lifesciences Corporation | Beating-heart mitral valve chordae replacement |
WO2017189276A1 (en) | 2016-04-29 | 2017-11-02 | Medtronic Vascular Inc. | Prosthetic heart valve devices with tethered anchors and associated systems and methods |
US10702274B2 (en) | 2016-05-26 | 2020-07-07 | Edwards Lifesciences Corporation | Method and system for closing left atrial appendage |
WO2017210434A1 (en) | 2016-06-01 | 2017-12-07 | On-X Life Technologies, Inc. | Pull-through chordae tendineae system |
US10973638B2 (en) | 2016-07-07 | 2021-04-13 | Edwards Lifesciences Corporation | Device and method for treating vascular insufficiency |
GB201611910D0 (en) | 2016-07-08 | 2016-08-24 | Valtech Cardio Ltd | Adjustable annuloplasty device with alternating peaks and troughs |
US11185413B2 (en) | 2016-07-13 | 2021-11-30 | Medfree, Inc. | Tissue grasping devices and related methods |
US10653862B2 (en) | 2016-11-07 | 2020-05-19 | Edwards Lifesciences Corporation | Apparatus for the introduction and manipulation of multiple telescoping catheters |
AU2017361296B2 (en) | 2016-11-21 | 2022-09-29 | Neovasc Tiara Inc. | Methods and systems for rapid retraction of a transcatheter heart valve delivery system |
US10905554B2 (en) | 2017-01-05 | 2021-02-02 | Edwards Lifesciences Corporation | Heart valve coaptation device |
US10478303B2 (en) | 2017-03-13 | 2019-11-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN110913801B (en) | 2017-03-13 | 2022-04-15 | 宝来瑞斯医疗有限公司 | Coaptation assistance element for treating an adverse coaptation of a heart valve of a heart and system for delivering the same |
US10653524B2 (en) | 2017-03-13 | 2020-05-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
US11103351B2 (en) | 2017-04-05 | 2021-08-31 | Opus Medical Therapies, LLC | Transcatheter atrial sealing skirt and related method |
JP7179012B2 (en) * | 2017-04-05 | 2022-11-28 | オーパス メディカル セラピーズ、エルエルシー | Transcatheter atrial sealing skirt, anchor and tether and method of implantation |
US11123187B2 (en) | 2017-04-05 | 2021-09-21 | Opus Medical Therapies, LLC | Transcatheter atrial anchors and methods of implantation |
US10765515B2 (en) | 2017-04-06 | 2020-09-08 | University Of Maryland, Baltimore | Distal anchor apparatus and methods for mitral valve repair |
US11224511B2 (en) | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US10433961B2 (en) | 2017-04-18 | 2019-10-08 | Twelve, Inc. | Delivery systems with tethers for prosthetic heart valve devices and associated methods |
US10575950B2 (en) | 2017-04-18 | 2020-03-03 | Twelve, Inc. | Hydraulic systems for delivering prosthetic heart valve devices and associated methods |
US10702378B2 (en) | 2017-04-18 | 2020-07-07 | Twelve, Inc. | Prosthetic heart valve device and associated systems and methods |
US10799312B2 (en) | 2017-04-28 | 2020-10-13 | Edwards Lifesciences Corporation | Medical device stabilizing apparatus and method of use |
US10959846B2 (en) | 2017-05-10 | 2021-03-30 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US10792151B2 (en) | 2017-05-11 | 2020-10-06 | Twelve, Inc. | Delivery systems for delivering prosthetic heart valve devices and associated methods |
WO2018217921A1 (en) | 2017-05-23 | 2018-11-29 | Harmony Development Group, Inc. | Tethered implantable device having a vortical intracardiac velocity adjusting balloon |
US10646338B2 (en) | 2017-06-02 | 2020-05-12 | Twelve, Inc. | Delivery systems with telescoping capsules for deploying prosthetic heart valve devices and associated methods |
US10709591B2 (en) | 2017-06-06 | 2020-07-14 | Twelve, Inc. | Crimping device and method for loading stents and prosthetic heart valves |
EP3641699B1 (en) | 2017-06-19 | 2023-08-30 | Harpoon Medical, Inc. | Apparatus for cardiac procedures |
WO2019006152A1 (en) * | 2017-06-28 | 2019-01-03 | Harmony Development Group, Inc. | A force transducting inflatable implant system including a dual force annular transduction implant |
US10729541B2 (en) | 2017-07-06 | 2020-08-04 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US10786352B2 (en) | 2017-07-06 | 2020-09-29 | Twelve, Inc. | Prosthetic heart valve devices and associated systems and methods |
US11069220B2 (en) | 2017-07-10 | 2021-07-20 | Biovigil Hygiene Technologies, Llc | Hand cleanliness monitoring |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US11051940B2 (en) | 2017-09-07 | 2021-07-06 | Edwards Lifesciences Corporation | Prosthetic spacer device for heart valve |
US11065117B2 (en) | 2017-09-08 | 2021-07-20 | Edwards Lifesciences Corporation | Axisymmetric adjustable device for treating mitral regurgitation |
WO2019055214A1 (en) | 2017-09-12 | 2019-03-21 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
US11040174B2 (en) | 2017-09-19 | 2021-06-22 | Edwards Lifesciences Corporation | Multi-direction steerable handles for steering catheters |
EP3700434A1 (en) | 2017-10-24 | 2020-09-02 | University of Maryland, Baltimore | Method and apparatus for cardiac procedures |
US10835221B2 (en) | 2017-11-02 | 2020-11-17 | Valtech Cardio, Ltd. | Implant-cinching devices and systems |
US11135062B2 (en) | 2017-11-20 | 2021-10-05 | Valtech Cardio Ltd. | Cinching of dilated heart muscle |
US10245144B1 (en) | 2018-01-09 | 2019-04-02 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10973639B2 (en) | 2018-01-09 | 2021-04-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10105222B1 (en) | 2018-01-09 | 2018-10-23 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10231837B1 (en) | 2018-01-09 | 2019-03-19 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10111751B1 (en) | 2018-01-09 | 2018-10-30 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10123873B1 (en) | 2018-01-09 | 2018-11-13 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
CN111655198A (en) | 2018-01-09 | 2020-09-11 | 爱德华兹生命科学公司 | Native valve repair devices and procedures |
US10159570B1 (en) | 2018-01-09 | 2018-12-25 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10136993B1 (en) | 2018-01-09 | 2018-11-27 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10076415B1 (en) | 2018-01-09 | 2018-09-18 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
US10238493B1 (en) | 2018-01-09 | 2019-03-26 | Edwards Lifesciences Corporation | Native valve repair devices and procedures |
WO2019143726A1 (en) | 2018-01-16 | 2019-07-25 | Medfree, Inc. | Tissue grasping devices and related methods |
WO2019145947A1 (en) | 2018-01-24 | 2019-08-01 | Valtech Cardio, Ltd. | Contraction of an annuloplasty structure |
EP3743014B1 (en) | 2018-01-26 | 2023-07-19 | Edwards Lifesciences Innovation (Israel) Ltd. | Techniques for facilitating heart valve tethering and chord replacement |
JP7300455B2 (en) | 2018-02-09 | 2023-06-29 | ザ プロボースト,フェローズ,ファンデーション スカラーズ,アンド ジ アザー メンバーズ オブ ボード,オブ ザ カレッジ オブ ザ ホーリー アンド アンディバイデッド トリニティ オブ クイーン エリザベス ニア ダブリン | heart valve therapy device |
WO2019173385A1 (en) | 2018-03-05 | 2019-09-12 | Harmony Development Group, Inc. | A force transducting implant system for the mitigation of atrioventricular pressure gradient loss and the restoration of healthy ventricular geometry |
US11389297B2 (en) | 2018-04-12 | 2022-07-19 | Edwards Lifesciences Corporation | Mitral valve spacer device |
US11517435B2 (en) | 2018-05-04 | 2022-12-06 | Edwards Lifesciences Corporation | Ring-based prosthetic cardiac valve |
WO2019226803A1 (en) * | 2018-05-22 | 2019-11-28 | Boston Scientific Scimed, Inc. | Percutaneous papillary muscle relocation |
EP4140449A3 (en) | 2018-07-10 | 2023-05-10 | Syntach AG | An implantable cardiac valve system |
EP3593758A1 (en) | 2018-07-10 | 2020-01-15 | Syntach AG | An implantable cardiac valve device and system |
AU2019301967A1 (en) | 2018-07-12 | 2021-01-21 | Edwards Lifesciences Innovation (Israel) Ltd. | Annuloplasty systems and locking tools therefor |
US11413146B2 (en) * | 2018-10-03 | 2022-08-16 | Edwards Lifesciences Corporation | Spring and coil devices for papillary muscle approximation and ventricle remodeling |
CA3115270A1 (en) | 2018-10-05 | 2020-04-09 | Shifamed Holdings, Llc | Prosthetic cardiac valve devices, systems, and methods |
US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
CA3118599A1 (en) | 2018-11-08 | 2020-05-14 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
WO2020163504A1 (en) | 2019-02-06 | 2020-08-13 | inQB8 Medical Technologies, LLC | Intra-cardiac left atrial and dual support systems |
CR20210427A (en) | 2019-02-14 | 2022-03-30 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
EP3941391A4 (en) | 2019-03-19 | 2022-11-23 | Shifamed Holdings, LLC | Prosthetic cardiac valve devices, systems, and methods |
US11602429B2 (en) | 2019-04-01 | 2023-03-14 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
US11717319B2 (en) | 2019-05-10 | 2023-08-08 | Merit Medical Systems, Inc. | Drainage catheter exchange system and associated methods |
EP3972673A4 (en) | 2019-05-20 | 2023-06-07 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
US11534303B2 (en) | 2020-04-09 | 2022-12-27 | Evalve, Inc. | Devices and systems for accessing and repairing a heart valve |
WO2020257643A1 (en) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
WO2021011531A1 (en) | 2019-07-15 | 2021-01-21 | Evalve, Inc. | Wide clip with nondeformable wings |
CA3147410A1 (en) | 2019-07-15 | 2021-01-21 | Evalve, Inc. | Proximal element actuator fixation and release mechanisms |
CA3148739A1 (en) | 2019-08-05 | 2021-02-11 | Croivalve Ltd. | Apparatus and methods for treating a defective cardiac valve |
US11707228B2 (en) | 2019-09-26 | 2023-07-25 | Evalve, Inc. | Systems and methods for intra-procedural cardiac pressure monitoring |
US11844695B2 (en) | 2019-10-11 | 2023-12-19 | Opus Medical Therapies, LLC | Devices for transcatheter chordal implantation and methods of implantation |
WO2021072209A1 (en) | 2019-10-11 | 2021-04-15 | Evalve, Inc. | Repair clip for variable tissue thickness |
CR20210640A (en) | 2019-10-29 | 2022-05-30 | Valtech Cardio Ltd | Annuloplasty and tissue anchor technologies |
US11622859B2 (en) | 2019-11-08 | 2023-04-11 | Evalve, Inc. | Medical device delivery system with locking system |
WO2021097124A1 (en) | 2019-11-14 | 2021-05-20 | Evalve, Inc. | Catheter assembly with coaptation aid and methods for valve repair |
US11701229B2 (en) | 2019-11-14 | 2023-07-18 | Evalve, Inc. | Kit with coaptation aid and fixation system and methods for valve repair |
WO2021138339A1 (en) | 2019-12-31 | 2021-07-08 | Creative Heart Valve Solutions Llc | Methods, implants, and systems for treatment of mitral valve prolapse |
US11690717B2 (en) | 2020-03-30 | 2023-07-04 | Lepu Medical Technology (Beijing) Co., Ltd. | Heart valve clamp |
US11464634B2 (en) | 2020-12-16 | 2022-10-11 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation with secondary anchors |
US11759321B2 (en) | 2021-06-25 | 2023-09-19 | Polares Medical Inc. | Device, system, and method for transcatheter treatment of valvular regurgitation |
CN116327431A (en) * | 2021-12-22 | 2023-06-27 | 上海微创心通医疗科技有限公司 | Valve repair device and valve repair system |
US11654024B1 (en) | 2022-10-31 | 2023-05-23 | Capstan Medical Inc. | Heart valve clip |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2108206A (en) * | 1937-03-09 | 1938-02-15 | Lillian Pearl Mecker | Tenaculum |
US3378010A (en) * | 1965-07-28 | 1968-04-16 | Coldling | Surgical clip with means for releasing the clamping pressure |
US3874338A (en) * | 1972-10-09 | 1975-04-01 | Fritz Happel | Milking cup |
US4498476A (en) * | 1981-08-27 | 1985-02-12 | Ethicon, Inc. | Non-metallic, bio-compatible hemostatic clips with interlocking latch means |
US4510934A (en) * | 1983-05-13 | 1985-04-16 | Batra Subhash K | Suture |
US4641366A (en) * | 1984-10-04 | 1987-02-03 | Nec Corporation | Portable radio communication apparatus comprising an antenna member for a broad-band signal |
US4809695A (en) * | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5108368A (en) * | 1990-01-04 | 1992-04-28 | Pilot Cardiovascular System, Inc. | Steerable medical device |
US5190554A (en) * | 1992-04-08 | 1993-03-02 | Eastern Virginia Medical School | Appendix extractor |
US5195968A (en) * | 1990-02-02 | 1993-03-23 | Ingemar Lundquist | Catheter steering mechanism |
US5275578A (en) * | 1991-01-11 | 1994-01-04 | Adams Andy W | Clip |
US5383886A (en) * | 1992-10-13 | 1995-01-24 | Kensey Nash Corporation | Methods and instruments for performing medical procedures percutaneously without a trocar |
US5403312A (en) * | 1993-07-22 | 1995-04-04 | Ethicon, Inc. | Electrosurgical hemostatic device |
US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US5487746A (en) * | 1994-11-23 | 1996-01-30 | Yu; George W. | Surgical clip having a longitudinal opening through which clamped tissue protrudes |
US5507725A (en) * | 1992-12-23 | 1996-04-16 | Angeion Corporation | Steerable catheter |
US5507757A (en) * | 1992-04-30 | 1996-04-16 | Lasersurge, Inc. | Method of closing puncture wounds |
US5593435A (en) * | 1994-07-29 | 1997-01-14 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth |
US5593424A (en) * | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US5609598A (en) * | 1994-12-30 | 1997-03-11 | Vnus Medical Technologies, Inc. | Method and apparatus for minimally invasive treatment of chronic venous insufficiency |
US5618306A (en) * | 1994-02-14 | 1997-04-08 | Heartport, Inc. | Endoscopic microsurgical instruments and methods |
US5620452A (en) * | 1994-12-22 | 1997-04-15 | Yoon; Inbae | Surgical clip with ductile tissue penetrating members |
US5706824A (en) * | 1996-05-20 | 1998-01-13 | Symbiosis Corporation | Endoscopic biopsy forceps instrument having a constant force spring biasing the jaws closed |
US5713910A (en) * | 1992-09-04 | 1998-02-03 | Laurus Medical Corporation | Needle guidance system for endoscopic suture device |
US5715817A (en) * | 1993-06-29 | 1998-02-10 | C.R. Bard, Inc. | Bidirectional steering catheter |
US5716367A (en) * | 1995-10-18 | 1998-02-10 | Nissho Corporation | Catheter assembly for intracardiac suture |
US5718725A (en) * | 1992-12-03 | 1998-02-17 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5722421A (en) * | 1995-09-15 | 1998-03-03 | Symbiosis Corporation | Clevis having deflection limiting stops for use in an endoscopic biopsy forceps instrument |
US5741280A (en) * | 1994-01-18 | 1998-04-21 | Coral Medical | Knot tying method and apparatus |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5860990A (en) * | 1995-08-24 | 1999-01-19 | Nr Medical, Inc. | Method and apparatus for suturing |
US5868733A (en) * | 1995-02-14 | 1999-02-09 | Daig Corporation | Guiding introducer system for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
US5879307A (en) * | 1996-03-15 | 1999-03-09 | Pulse Metric, Inc. | Non-invasive method and apparatus for diagnosing and monitoring aortic valve abnormalities, such a aortic regurgitation |
US5885271A (en) * | 1997-03-14 | 1999-03-23 | Millennium Cardiac Strategies, Inc. | Device for regional immobilization of a compliant body |
US5891160A (en) * | 1996-02-23 | 1999-04-06 | Cardiovascular Technologies, Llc | Fastener delivery and deployment mechanism and method for placing the fastener in minimally invasive surgery |
US6019722A (en) * | 1997-09-17 | 2000-02-01 | Guidant Corporation | Device to permit offpump beating heart coronary bypass surgery |
US6033378A (en) * | 1990-02-02 | 2000-03-07 | Ep Technologies, Inc. | Catheter steering mechanism |
US6036699A (en) * | 1992-12-10 | 2000-03-14 | Perclose, Inc. | Device and method for suturing tissue |
US6045497A (en) * | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US6187003B1 (en) * | 1997-11-12 | 2001-02-13 | Sherwood Services Ag | Bipolar electrosurgical instrument for sealing vessels |
US6190408B1 (en) * | 1998-03-05 | 2001-02-20 | The University Of Cincinnati | Device and method for restructuring the heart chamber geometry |
US6203553B1 (en) * | 1999-09-08 | 2001-03-20 | United States Surgical | Stapling apparatus and method for heart valve replacement |
US6206893B1 (en) * | 1993-11-08 | 2001-03-27 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
US6210432B1 (en) * | 1999-06-29 | 2001-04-03 | Jan Otto Solem | Device and method for treatment of mitral insufficiency |
US20020013571A1 (en) * | 1999-04-09 | 2002-01-31 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US6355030B1 (en) * | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US20020035361A1 (en) * | 1999-06-25 | 2002-03-21 | Houser Russell A. | Apparatus and methods for treating tissue |
US6368326B1 (en) * | 1998-09-28 | 2002-04-09 | Daos Limited | Internal cord fixation device |
US20030050693A1 (en) * | 2001-09-10 | 2003-03-13 | Quijano Rodolfo C. | Minimally invasive delivery system for annuloplasty rings |
US6537314B2 (en) * | 2000-01-31 | 2003-03-25 | Ev3 Santa Rosa, Inc. | Percutaneous mitral annuloplasty and cardiac reinforcement |
US20030069570A1 (en) * | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US20030069593A1 (en) * | 2001-08-31 | 2003-04-10 | Tremulis William S. | Method and apparatus for valve repair |
US20030069636A1 (en) * | 1999-06-30 | 2003-04-10 | Solem Jan Otto | Method for treatment of mitral insufficiency |
US6551331B2 (en) * | 1995-08-24 | 2003-04-22 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
US20030078654A1 (en) * | 2001-08-14 | 2003-04-24 | Taylor Daniel C. | Method and apparatus for improving mitral valve function |
US20040003819A1 (en) * | 1999-04-09 | 2004-01-08 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20040019378A1 (en) * | 2001-04-24 | 2004-01-29 | Hlavka Edwin J. | Method and apparatus for performing catheter-based annuloplasty |
US20040019377A1 (en) * | 2002-01-14 | 2004-01-29 | Taylor Daniel C. | Method and apparatus for reducing mitral regurgitation |
US20040024414A1 (en) * | 2000-06-20 | 2004-02-05 | Downing Stephen W. | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US6689164B1 (en) * | 1999-10-12 | 2004-02-10 | Jacques Seguin | Annuloplasty device for use in minimally invasive procedure |
US6695866B1 (en) * | 1998-07-15 | 2004-02-24 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US20040039443A1 (en) * | 1999-06-30 | 2004-02-26 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20040044350A1 (en) * | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US6701929B2 (en) * | 1999-03-03 | 2004-03-09 | Hany Hussein | Device and method for treatment of congestive heart failure |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US20040049211A1 (en) * | 2002-06-12 | 2004-03-11 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US20040049207A1 (en) * | 1999-04-09 | 2004-03-11 | Evalve, Inc., A Delaware Corporation | Fixation device and methods for engaging tissue |
US6709382B1 (en) * | 1999-05-04 | 2004-03-23 | Simon Marcus Horner | Cardiac assist method and apparatus |
US20040073302A1 (en) * | 2002-02-05 | 2004-04-15 | Jonathan Rourke | Method and apparatus for improving mitral valve function |
US6723038B1 (en) * | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20040078053A1 (en) * | 1998-01-30 | 2004-04-22 | St. Jude Medical Atg, Inc. | Medical graft connector or plug structures, and methods of making and installing same |
US6726716B2 (en) * | 2001-08-24 | 2004-04-27 | Edwards Lifesciences Corporation | Self-molding annuloplasty ring |
US20050004583A1 (en) * | 1997-06-27 | 2005-01-06 | Oz Mehmet C. | Method and apparatus for circulatory valve repair |
US20050004665A1 (en) * | 2003-07-02 | 2005-01-06 | Lishan Aklog | Annuloplasty rings and methods for repairing cardiac valves |
US20050004668A1 (en) * | 2003-07-02 | 2005-01-06 | Flexcor, Inc. | Annuloplasty rings and methods for repairing cardiac valves |
US20050038508A1 (en) * | 2003-08-13 | 2005-02-17 | Shlomo Gabbay | Implantable cardiac prosthesis for mitigating prolapse of a heart valve |
US20050049698A1 (en) * | 2001-11-13 | 2005-03-03 | Bolling Steven F. | Methods of implanting a mitral valve annuloplasty ring to correct mitral regurgitation |
US20050055089A1 (en) * | 2000-09-20 | 2005-03-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US20050059351A1 (en) * | 2002-08-30 | 2005-03-17 | Patrick Cauwels | User-specified outputs in mobile wireless communication devices and methods therefor |
US20060004247A1 (en) * | 2004-06-30 | 2006-01-05 | Ethicon Incorporated | Systems and methods for assisting cardiac valve coaptation |
US6986775B2 (en) * | 2002-06-13 | 2006-01-17 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20060015003A1 (en) * | 2004-07-15 | 2006-01-19 | Micardia Corporation | Magnetic devices and methods for reshaping heart anatomy |
US20060020275A1 (en) * | 1999-04-09 | 2006-01-26 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US20060030866A1 (en) * | 2002-03-26 | 2006-02-09 | Stefan Schreck | Sequential heart valve leaflet repair device and method of use |
US20060030885A1 (en) * | 2002-10-15 | 2006-02-09 | Hyde Gregory M | Apparatuses and methods for heart valve repair |
US20060030867A1 (en) * | 2004-07-09 | 2006-02-09 | Reza Zadno | Device and method for repairing tissue |
US7011669B2 (en) * | 2000-08-11 | 2006-03-14 | Edwards Lifesciences Corporation | Device and method for treatment of atrioventricular regurgitation |
US20060058871A1 (en) * | 2004-09-14 | 2006-03-16 | Edwards Lifesciences, Ag | Device and method for treatment of heart valve regurgitation |
US20060064115A1 (en) * | 1999-10-21 | 2006-03-23 | Allen William J | Minimally invasive mitral valve repair method and apparatus |
US20070038293A1 (en) * | 1999-04-09 | 2007-02-15 | St Goar Frederick G | Device and methods for endoscopic annuloplasty |
Family Cites Families (236)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2097018A (en) | 1936-07-17 | 1937-10-26 | Coleman R Chamberlin | Multiple purpose guide and retention clip |
US3671979A (en) | 1969-09-23 | 1972-06-27 | Univ Utah | Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
GB1486351A (en) | 1975-06-06 | 1977-09-21 | Rocket Of London Ltd | Surgical clip applicator |
US4112951A (en) | 1976-01-26 | 1978-09-12 | Research Corporation | Surgical clip |
US4056854A (en) | 1976-09-28 | 1977-11-08 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Aortic heart valve catheter |
AU521676B2 (en) | 1977-02-23 | 1982-04-22 | Clark, Richard Edwin | Heart valve prosthesis |
US4297749A (en) | 1977-04-25 | 1981-11-03 | Albany International Corp. | Heart valve prosthesis |
NL7906691A (en) | 1979-09-07 | 1981-03-10 | Jansen Anton | MEDICAL DEVICE FOR COUPLING TWO Bowel Sections, Auxiliary Device For Using It And Method Of Laying A Gut Knot Using This Device. |
US4944295A (en) | 1981-10-21 | 1990-07-31 | Owen Gwathmay | Suturing assembly |
US4484579A (en) | 1982-07-19 | 1984-11-27 | University Of Pittsburgh | Commissurotomy catheter apparatus and method |
DE3344934A1 (en) | 1983-12-13 | 1985-06-20 | Richard Wolf Gmbh, 7134 Knittlingen | ENDOSCOPE WITH DISTALLY DEFLECTABLE AUXILIARY INSTRUMENT |
GB8424582D0 (en) | 1984-09-28 | 1984-11-07 | Univ Glasgow | Heart valve prosthesis |
CA1303298C (en) | 1986-08-06 | 1992-06-16 | Alain Carpentier | Flexible cardiac valvular support prosthesis |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US5542949A (en) | 1987-05-14 | 1996-08-06 | Yoon; Inbae | Multifunctional clip applier instrument |
WO1989009029A1 (en) | 1989-02-16 | 1989-10-05 | Taheri Syde A | Method and apparatus for removing venous valves |
US5092872A (en) | 1989-07-28 | 1992-03-03 | Jacob Segalowitz | Valvulotome catheter |
US5047041A (en) | 1989-08-22 | 1991-09-10 | Samuels Peter B | Surgical apparatus for the excision of vein valves in situ |
GB8924806D0 (en) | 1989-11-03 | 1989-12-20 | Neoligaments Ltd | Prosthectic ligament system |
US5015249A (en) | 1989-12-26 | 1991-05-14 | Nakao Naomi L | Endoscopic stapling device and method |
US5049153A (en) | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
DK124690D0 (en) | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
US5411552A (en) | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
US5001136A (en) | 1990-06-07 | 1991-03-19 | Pfizer Inc. | Leukotriene-synthesis-inhibiting 2-substitutedmethylamino-5-(hydroxy or alkoxy)pyridines |
US5389102A (en) | 1990-09-13 | 1995-02-14 | United States Surgical Corporation | Apparatus and method for subcuticular stapling of body tissue |
US5042707A (en) | 1990-10-16 | 1991-08-27 | Taheri Syde A | Intravascular stapler, and method of operating same |
US5125758A (en) | 1990-12-06 | 1992-06-30 | Dewan Thomas E | Piercing clamp |
US5163955A (en) | 1991-01-24 | 1992-11-17 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5171252A (en) | 1991-02-05 | 1992-12-15 | Friedland Thomas W | Surgical fastening clip formed of a shape memory alloy, a method of making such a clip and a method of using such a clip |
US5226429A (en) | 1991-06-20 | 1993-07-13 | Inamed Development Co. | Laparoscopic gastric band and method |
US5452733A (en) | 1993-02-22 | 1995-09-26 | Stanford Surgical Technologies, Inc. | Methods for performing thoracoscopic coronary artery bypass |
US5571215A (en) | 1993-02-22 | 1996-11-05 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US5769812A (en) | 1991-07-16 | 1998-06-23 | Heartport, Inc. | System for cardiac procedures |
US5226911A (en) | 1991-10-02 | 1993-07-13 | Target Therapeutics | Vasoocclusion coil with attached fibrous element(s) |
US5261916A (en) | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US5234437A (en) | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
US5423882A (en) | 1991-12-26 | 1995-06-13 | Cordis-Webster, Inc. | Catheter having electrode with annular recess and method of using same |
US5417700A (en) | 1992-03-30 | 1995-05-23 | Thomas D. Egan | Automatic suturing and ligating device |
US5314424A (en) | 1992-04-06 | 1994-05-24 | United States Surgical Corporation | Surgical instrument locking mechanism |
US5318525A (en) | 1992-04-10 | 1994-06-07 | Medtronic Cardiorhythm | Steerable electrode catheter |
US5254130A (en) | 1992-04-13 | 1993-10-19 | Raychem Corporation | Surgical device |
US5332402A (en) | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5389098A (en) | 1992-05-19 | 1995-02-14 | Olympus Optical Co., Ltd. | Surgical device for stapling and/or fastening body tissues |
US5658300A (en) | 1992-06-04 | 1997-08-19 | Olympus Optical Co., Ltd. | Tissue fixing surgical instrument, tissue-fixing device, and method of fixing tissues |
US5325845A (en) | 1992-06-08 | 1994-07-05 | Adair Edwin Lloyd | Steerable sheath for use with selected removable optical catheter |
US5368606A (en) | 1992-07-02 | 1994-11-29 | Marlow Surgical Technologies, Inc. | Endoscopic instrument system |
US5350397A (en) | 1992-11-13 | 1994-09-27 | Target Therapeutics, Inc. | Axially detachable embolic coil assembly |
US5250071A (en) | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5312415A (en) | 1992-09-22 | 1994-05-17 | Target Therapeutics, Inc. | Assembly for placement of embolic coils using frictional placement |
CA2106126A1 (en) | 1992-09-23 | 1994-03-24 | Ian M. Scott | Bipolar surgical instruments |
US5462527A (en) | 1993-06-29 | 1995-10-31 | C.R. Bard, Inc. | Actuator for use with steerable catheter |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5980455A (en) | 1993-02-22 | 1999-11-09 | Heartport, Inc. | Method for manipulating a tissue structure within a thoracic cavity |
US5972030A (en) | 1993-02-22 | 1999-10-26 | Heartport, Inc. | Less-invasive devices and methods for treatment of cardiac valves |
WO1994018893A1 (en) | 1993-02-22 | 1994-09-01 | Valleylab, Inc. | A laparoscopic dissection tension retractor device and method |
US5425705A (en) | 1993-02-22 | 1995-06-20 | Stanford Surgical Technologies, Inc. | Thoracoscopic devices and methods for arresting the heart |
US5636634A (en) | 1993-03-16 | 1997-06-10 | Ep Technologies, Inc. | Systems using guide sheaths for introducing, deploying, and stabilizing cardiac mapping and ablation probes |
DE4319829C1 (en) | 1993-06-16 | 1994-08-25 | Lerch Karl Dieter | Set for treating vascular deformities |
US6258021B1 (en) | 1993-06-17 | 2001-07-10 | Peter J. Wilk | Intrapericardial assist method |
US5450860A (en) | 1993-08-31 | 1995-09-19 | W. L. Gore & Associates, Inc. | Device for tissue repair and method for employing same |
US5423858A (en) | 1993-09-30 | 1995-06-13 | United States Surgical Corporation | Septoplasty fasteners and device for applying same |
US5472044A (en) | 1993-10-20 | 1995-12-05 | E. I. Du Pont De Nemours And Company | Method and apparatus for interacting a gas and liquid on a convoluted array of tubes |
US5437681A (en) | 1994-01-13 | 1995-08-01 | Suturtek Inc. | Suturing instrument with thread management |
US5359994A (en) | 1994-01-24 | 1994-11-01 | Welch Allyn, Inc. | Proximal steering cable adjustment |
US5431666A (en) | 1994-02-24 | 1995-07-11 | Lasersurge, Inc. | Surgical suture instrument |
CA2141911C (en) | 1994-02-24 | 2002-04-23 | Jude S. Sauer | Surgical crimping device and method of use |
US5476470A (en) | 1994-04-15 | 1995-12-19 | Fitzgibbons, Jr.; Robert J. | Trocar site suturing device |
US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
DE4418766C2 (en) | 1994-05-28 | 1996-11-07 | Karlsruhe Forschzent | Surgical thread for creating a surgical suture |
US5732872A (en) | 1994-06-17 | 1998-03-31 | Heartport, Inc. | Surgical stapling instrument |
US5554185A (en) | 1994-07-18 | 1996-09-10 | Block; Peter C. | Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same |
US5601576A (en) | 1994-08-10 | 1997-02-11 | Heartport Inc. | Surgical knot pusher and method of use |
US5456684A (en) | 1994-09-08 | 1995-10-10 | Hutchinson Technology Incorporated | Multifunctional minimally invasive surgical instrument |
US5599305A (en) | 1994-10-24 | 1997-02-04 | Cardiovascular Concepts, Inc. | Large-diameter introducer sheath having hemostasis valve and removable steering mechanism |
US5814029A (en) | 1994-11-03 | 1998-09-29 | Daig Corporation | Guiding introducer system for use in ablation and mapping procedures in the left ventricle |
US5690671A (en) | 1994-12-13 | 1997-11-25 | Micro Interventional Systems, Inc. | Embolic elements and methods and apparatus for their delivery |
JPH08231444A (en) | 1995-02-28 | 1996-09-10 | Daikin Ind Ltd | Production of 1,1,3,3-pentafluoropropane |
US5571085A (en) | 1995-03-24 | 1996-11-05 | Electro-Catheter Corporation | Steerable open lumen catheter |
US5540705A (en) | 1995-05-19 | 1996-07-30 | Suturtek, Inc. | Suturing instrument with thread management |
US5562678A (en) | 1995-06-02 | 1996-10-08 | Cook Pacemaker Corporation | Needle's eye snare |
US5846253A (en) | 1995-07-14 | 1998-12-08 | C. R. Bard, Inc. | Wound closure apparatus and method |
US6562052B2 (en) | 1995-08-24 | 2003-05-13 | Sutura, Inc. | Suturing device and method |
DE19534112A1 (en) | 1995-09-14 | 1997-03-20 | Wolf Gmbh Richard | Endoscopic instrument with steerable distal end |
US5797927A (en) | 1995-09-22 | 1998-08-25 | Yoon; Inbae | Combined tissue clamping and suturing instrument |
US5810876A (en) | 1995-10-03 | 1998-09-22 | Akos Biomedical, Inc. | Flexible forceps device |
US5634932A (en) | 1995-10-10 | 1997-06-03 | Industrial & Scientific Designs, Ltd. | Cantilever aneurysm clip system |
US5662704A (en) | 1995-12-01 | 1997-09-02 | Medtronic, Inc. | Physiologic mitral valve bioprosthesis |
US6162233A (en) | 1996-02-23 | 2000-12-19 | Cardiovascular Technologies, Llc | Wire fasteners for use in minimally invasive surgery and means and methods for handling those fasteners |
US5769859A (en) | 1996-04-09 | 1998-06-23 | Dorsey; William R. | Umbilical scissors |
US6149660A (en) | 1996-04-22 | 2000-11-21 | Vnus Medical Technologies, Inc. | Method and apparatus for delivery of an appliance in a vessel |
US5827237A (en) | 1996-06-17 | 1998-10-27 | Cardeon Corporation | Dual lumen catheter with controlled antegrade and retrograde fluid flow |
US5833671A (en) | 1996-06-17 | 1998-11-10 | Cardeon Corporation | Triple lumen catheter with controllable antegrade and retrograde fluid flow |
US6001796A (en) | 1996-07-03 | 1999-12-14 | Alliedsignal Inc. | Azeotrope-like compositions of 1,1,1,3,3-pentafluoropropane and hydrogen fluoride |
US5820592A (en) | 1996-07-16 | 1998-10-13 | Hammerslag; Gary R. | Angiographic and/or guide catheter |
US5782845A (en) | 1996-07-31 | 1998-07-21 | Shewchuk; Dwight | Trocar site suturing device |
US5820631A (en) | 1996-08-01 | 1998-10-13 | Nr Medical, Inc. | Device and method for suturing tissue adjacent to a blood vessel |
US6482224B1 (en) | 1996-08-22 | 2002-11-19 | The Trustees Of Columbia University In The City Of New York | Endovascular flexible stapling device |
EP1011460A4 (en) | 1996-12-02 | 2001-09-19 | Angiotrax Inc | Apparatus and methods for percutaneously performing surgery |
US6077214A (en) | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6074401A (en) | 1997-01-09 | 2000-06-13 | Coalescent Surgical, Inc. | Pinned retainer surgical fasteners, instruments and methods for minimally invasive vascular and endoscopic surgery |
US5928224A (en) | 1997-01-24 | 1999-07-27 | Hearten Medical, Inc. | Device for the treatment of damaged heart valve leaflets and methods of using the device |
US5989284A (en) | 1997-02-18 | 1999-11-23 | Hearten Medical, Inc. | Method and device for soft tissue modification |
IT1293068B1 (en) | 1997-07-01 | 1999-02-11 | Kempro Italiana S R L | PROCEDURE FOR OBTAINING A HIGH CONCENTRATION COLLOIDAL SILICA SUSPENSION AND PRODUCT SO OBTAINED |
CA2300049C (en) | 1997-08-08 | 2009-03-10 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
AU9225598A (en) | 1997-09-04 | 1999-03-22 | Endocore, Inc. | Artificial chordae replacement |
US6123699A (en) | 1997-09-05 | 2000-09-26 | Cordis Webster, Inc. | Omni-directional steerable catheter |
US5954732A (en) | 1997-09-10 | 1999-09-21 | Hart; Charles C. | Suturing apparatus and method |
FR2768324B1 (en) | 1997-09-12 | 1999-12-10 | Jacques Seguin | SURGICAL INSTRUMENT FOR PERCUTANEOUSLY FIXING TWO AREAS OF SOFT TISSUE, NORMALLY MUTUALLY REMOTE, TO ONE ANOTHER |
JPH1189937A (en) | 1997-09-19 | 1999-04-06 | Atsuo Mori | Catheter for mitral regurgitation test |
US5916147A (en) | 1997-09-22 | 1999-06-29 | Boury; Harb N. | Selectively manipulable catheter |
US6086600A (en) | 1997-11-03 | 2000-07-11 | Symbiosis Corporation | Flexible endoscopic surgical instrument for invagination and fundoplication |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6562037B2 (en) | 1998-02-12 | 2003-05-13 | Boris E. Paton | Bonding of soft biological tissues by passing high frequency electric current therethrough |
US7214230B2 (en) | 1998-02-24 | 2007-05-08 | Hansen Medical, Inc. | Flexible instrument |
US6143024A (en) | 1998-06-04 | 2000-11-07 | Sulzer Carbomedics Inc. | Annuloplasty ring having flexible anterior portion |
US6599311B1 (en) * | 1998-06-05 | 2003-07-29 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US6250308B1 (en) | 1998-06-16 | 2001-06-26 | Cardiac Concepts, Inc. | Mitral valve annuloplasty ring and method of implanting |
US6066146A (en) | 1998-06-24 | 2000-05-23 | Carroll; Brendan J. | Laparascopic incision closure device |
US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
US6547821B1 (en) | 1998-07-16 | 2003-04-15 | Cardiothoracic Systems, Inc. | Surgical procedures and devices for increasing cardiac output of the heart |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
US6685627B2 (en) | 1998-10-09 | 2004-02-03 | Swaminathan Jayaraman | Modification of properties and geometry of heart tissue to influence heart function |
US6319250B1 (en) | 1998-11-23 | 2001-11-20 | C.R. Bard, Inc | Tricuspid annular grasp catheter |
US6136010A (en) | 1999-03-04 | 2000-10-24 | Perclose, Inc. | Articulating suturing device and method |
US6267746B1 (en) | 1999-03-22 | 2001-07-31 | Biosense Webster, Inc. | Multi-directional steerable catheters and control handles |
US6464707B1 (en) | 1999-04-01 | 2002-10-15 | David B. Bjerken | Vacuum-assisted remote suture placement system |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
WO2006116558A2 (en) | 1999-04-09 | 2006-11-02 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
AU5003100A (en) | 1999-05-11 | 2000-11-21 | Craig Berky | Surgical clamp devices and methods especially useful in cardiac surgery |
US7887477B2 (en) | 1999-08-09 | 2011-02-15 | Cardiokinetix, Inc. | Method of improving cardiac function using a porous membrane |
US6299637B1 (en) | 1999-08-20 | 2001-10-09 | Samuel M. Shaolian | Transluminally implantable venous valve |
US6306133B1 (en) | 1999-10-02 | 2001-10-23 | Quantum Cor Incorporated | Ablation catheter system and methods for repairing a valvular annulus |
US6312447B1 (en) | 1999-10-13 | 2001-11-06 | The General Hospital Corporation | Devices and methods for percutaneous mitral valve repair |
EP1674040A3 (en) | 1999-10-21 | 2007-09-19 | Edwards Lifesciences Corporation | Minimally invasive mitral valve repair |
US6926730B1 (en) | 2000-10-10 | 2005-08-09 | Medtronic, Inc. | Minimally invasive valve repair procedure and apparatus |
US6641592B1 (en) | 1999-11-19 | 2003-11-04 | Lsi Solutions, Inc. | System for wound closure |
US7507252B2 (en) | 2000-01-31 | 2009-03-24 | Edwards Lifesciences Ag | Adjustable transluminal annuloplasty system |
US20050070999A1 (en) | 2000-02-02 | 2005-03-31 | Spence Paul A. | Heart valve repair apparatus and methods |
US6797002B2 (en) | 2000-02-02 | 2004-09-28 | Paul A. Spence | Heart valve repair apparatus and methods |
US6530897B2 (en) | 2000-04-28 | 2003-03-11 | Mahase Nardeo | Steerable medical catheter with bendable encapsulated metal spring tip fused to polymeric shaft |
US6869444B2 (en) * | 2000-05-22 | 2005-03-22 | Shlomo Gabbay | Low invasive implantable cardiac prosthesis and method for helping improve operation of a heart valve |
US6419696B1 (en) | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US7527646B2 (en) | 2000-09-20 | 2009-05-05 | Ample Medical, Inc. | Devices, systems, and methods for retaining a native heart valve leaflet |
US7381220B2 (en) * | 2000-09-20 | 2008-06-03 | Ample Medical, Inc. | Devices, systems, and methods for supplementing, repairing, or replacing a native heart valve leaflet |
US20050228422A1 (en) | 2002-11-26 | 2005-10-13 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US6616684B1 (en) * | 2000-10-06 | 2003-09-09 | Myocor, Inc. | Endovascular splinting devices and methods |
US6918917B1 (en) | 2000-10-10 | 2005-07-19 | Medtronic, Inc. | Minimally invasive annuloplasty procedure and apparatus |
JP4184794B2 (en) | 2001-02-05 | 2008-11-19 | ビアカー・インコーポレーテッド | Method and apparatus for improving mitral valve function |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
JP4295925B2 (en) | 2001-03-01 | 2009-07-15 | Hoya株式会社 | Bipolar high-frequency treatment instrument for endoscope |
US6585761B2 (en) | 2001-03-01 | 2003-07-01 | Syde A. Taheri | Prosthetic vein valve and method |
US20060069429A1 (en) * | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
US20050125011A1 (en) * | 2001-04-24 | 2005-06-09 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
AU2002311944A1 (en) | 2001-05-17 | 2002-11-25 | The Regents Of The University Of California | Retrieval catheter |
US6858039B2 (en) | 2002-07-08 | 2005-02-22 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring having a posterior bow |
JP4458845B2 (en) * | 2001-10-01 | 2010-04-28 | アンプル メディカル,インコーポレイテッド | Medical device |
US7144363B2 (en) | 2001-10-16 | 2006-12-05 | Extensia Medical, Inc. | Systems for heart treatment |
US6949122B2 (en) | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US6575971B2 (en) | 2001-11-15 | 2003-06-10 | Quantum Cor, Inc. | Cardiac valve leaflet stapler device and methods thereof |
US20050177180A1 (en) | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
EP1450732A1 (en) | 2001-12-04 | 2004-09-01 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template system |
US6978176B2 (en) | 2001-12-08 | 2005-12-20 | Lattouf Omar M | Treatment for patient with congestive heart failure |
US6740107B2 (en) | 2001-12-19 | 2004-05-25 | Trimedyne, Inc. | Device for treatment of atrioventricular valve regurgitation |
US20030120341A1 (en) | 2001-12-21 | 2003-06-26 | Hani Shennib | Devices and methods of repairing cardiac valves |
US20030120340A1 (en) | 2001-12-26 | 2003-06-26 | Jan Liska | Mitral and tricuspid valve repair |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7048754B2 (en) | 2002-03-01 | 2006-05-23 | Evalve, Inc. | Suture fasteners and methods of use |
US6797001B2 (en) | 2002-03-11 | 2004-09-28 | Cardiac Dimensions, Inc. | Device, assembly and method for mitral valve repair |
US8287555B2 (en) | 2003-02-06 | 2012-10-16 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US8348963B2 (en) | 2002-07-03 | 2013-01-08 | Hlt, Inc. | Leaflet reinforcement for regurgitant valves |
WO2004012583A2 (en) | 2002-08-01 | 2004-02-12 | The General Hospital Corporation | Cardiac devices and methods for minimally invasive repair of ischemic mitral regurgitation |
US8172856B2 (en) | 2002-08-02 | 2012-05-08 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
DE60318861T2 (en) | 2002-08-13 | 2009-01-08 | The General Hospital Corp., Boston | HEART DEVICES FOR THE PERCUTANEOUS REPAIR OF ATRIOVENTRICULAR FLAPS |
AU2003268220B8 (en) | 2002-08-28 | 2010-01-21 | Hlt, Inc. | Method and device for treating diseased valve |
US7297150B2 (en) | 2002-08-29 | 2007-11-20 | Mitralsolutions, Inc. | Implantable devices for controlling the internal circumference of an anatomic orifice or lumen |
AU2003277116A1 (en) | 2002-10-01 | 2004-04-23 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US20040133062A1 (en) | 2002-10-11 | 2004-07-08 | Suresh Pai | Minimally invasive cardiac force transfer structures |
NZ539136A (en) | 2002-10-21 | 2008-04-30 | Mitralign Inc | Method and apparatus for performing catheter-based annuloplasty using local plications |
US20050119735A1 (en) * | 2002-10-21 | 2005-06-02 | Spence Paul A. | Tissue fastening systems and methods utilizing magnetic guidance |
EP1553897A1 (en) | 2002-10-24 | 2005-07-20 | Boston Scientific Limited | Venous valve apparatus and method |
US20040097979A1 (en) | 2002-11-14 | 2004-05-20 | Oleg Svanidze | Aortic valve implantation device |
AU2003290979A1 (en) | 2002-11-15 | 2004-06-15 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method and device for catheter-based repair of cardiac valves |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US6945978B1 (en) | 2002-11-15 | 2005-09-20 | Advanced Cardiovascular Systems, Inc. | Heart valve catheter |
US20040133240A1 (en) | 2003-01-07 | 2004-07-08 | Cardiac Dimensions, Inc. | Electrotherapy system, device, and method for treatment of cardiac valve dysfunction |
US6997950B2 (en) * | 2003-01-16 | 2006-02-14 | Chawla Surendra K | Valve repair device |
US7381210B2 (en) | 2003-03-14 | 2008-06-03 | Edwards Lifesciences Corporation | Mitral valve repair system and method for use |
WO2004082538A2 (en) | 2003-03-18 | 2004-09-30 | St. Jude Medical, Inc. | Body tissue remodeling apparatus |
US20060271081A1 (en) * | 2003-03-30 | 2006-11-30 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US20040210240A1 (en) | 2003-04-21 | 2004-10-21 | Sean Saint | Method and repair device for treating mitral valve insufficiency |
US20040220593A1 (en) | 2003-05-01 | 2004-11-04 | Secant Medical, Llc | Restraining clip for mitral valve repair |
US20040220657A1 (en) | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc., A Washington Corporation | Tissue shaping device with conformable anchors |
US20070255396A1 (en) | 2003-06-20 | 2007-11-01 | Medtronic Vascular, Inc. | Chrodae Tendinae Girdle |
JP2007535335A (en) | 2003-06-20 | 2007-12-06 | メドトロニック ヴァスキュラー インコーポレイテッド | Annulus reduction system |
EP1646332B1 (en) | 2003-07-18 | 2015-06-17 | Edwards Lifesciences AG | Remotely activated mitral annuloplasty system |
WO2005032421A2 (en) | 2003-09-15 | 2005-04-14 | Medtronic Vascular, Inc. | Apparatus and method for elongation of a papillary muscle |
WO2005027797A1 (en) | 2003-09-23 | 2005-03-31 | Ersin Erek | A mitral web apparatus for mitral valve insufficiencies |
US7166127B2 (en) * | 2003-12-23 | 2007-01-23 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
KR100610249B1 (en) | 2003-12-23 | 2006-08-09 | 럭스피아 주식회사 | Yellow emitting phosphor and white semiconductor light emitting device incorporating the same |
US20050228495A1 (en) | 2004-01-15 | 2005-10-13 | Macoviak John A | Suspended heart valve devices, systems, and methods for supplementing, repairing, or replacing a native heart valve |
US20050159810A1 (en) | 2004-01-15 | 2005-07-21 | Farzan Filsoufi | Devices and methods for repairing cardiac valves |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US7641686B2 (en) | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
US7736379B2 (en) * | 2004-06-09 | 2010-06-15 | Usgi Medical, Inc. | Compressible tissue anchor assemblies |
EP1768601A4 (en) | 2004-07-15 | 2007-08-15 | Micardia Corp | Magnetic devices and methods for reshaping heart anatomy |
WO2006041877A2 (en) * | 2004-10-05 | 2006-04-20 | Ample Medical, Inc. | Atrioventricular valve annulus repair systems and methods including retro-chordal anchors |
US20060089711A1 (en) * | 2004-10-27 | 2006-04-27 | Medtronic Vascular, Inc. | Multifilament anchor for reducing a compass of a lumen or structure in mammalian body |
WO2006064490A1 (en) | 2004-12-15 | 2006-06-22 | Mednua Limited | A medical device suitable for use in treatment of a valve |
EP3967269A3 (en) | 2005-02-07 | 2022-07-13 | Evalve, Inc. | Systems and devices for cardiac valve repair |
WO2006089236A1 (en) * | 2005-02-18 | 2006-08-24 | The Cleveland Clinic Foundation | Apparatus and methods for replacing a cardiac valve |
CA2601818A1 (en) | 2005-03-25 | 2006-10-05 | Ample Medical, Inc. | Device, systems, and methods for reshaping a heart valve annulus |
SE531468C2 (en) * | 2005-04-21 | 2009-04-14 | Edwards Lifesciences Ag | An apparatus for controlling blood flow |
US20060241746A1 (en) | 2005-04-21 | 2006-10-26 | Emanuel Shaoulian | Magnetic implants and methods for reshaping tissue |
US7753934B2 (en) | 2005-04-22 | 2010-07-13 | Wilk Patent, Llc | Medical closure method and associated device |
WO2006127509A2 (en) | 2005-05-20 | 2006-11-30 | Mayo Foundation For Medical Education And Research | Devices and methods for reducing cardiac valve regurgitation |
US20060287716A1 (en) * | 2005-06-08 | 2006-12-21 | The Cleveland Clinic Foundation | Artificial chordae |
EP1752115A1 (en) | 2005-08-08 | 2007-02-14 | Daniele Maselli | Surgical device for connecting two anatomical structures |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US20070118151A1 (en) * | 2005-11-21 | 2007-05-24 | The Brigham And Women's Hospital, Inc. | Percutaneous cardiac valve repair with adjustable artificial chordae |
US8043368B2 (en) * | 2005-11-23 | 2011-10-25 | Traves Dean Crabtree | Methods and apparatus for atrioventricular valve repair |
WO2007078772A1 (en) | 2005-12-15 | 2007-07-12 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant valve |
DE602007012691D1 (en) * | 2006-05-15 | 2011-04-07 | Edwards Lifesciences Ag | SYSTEM FOR CHANGING THE GEOMETRY OF THE HEART |
US20080039935A1 (en) * | 2006-08-14 | 2008-02-14 | Wally Buch | Methods and apparatus for mitral valve repair |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
WO2009072114A2 (en) | 2007-12-02 | 2009-06-11 | Mor Research Applications Ltd. | Access to the left atrium and reduction of mitral valve leaflet mobility |
US9131928B2 (en) * | 2007-12-20 | 2015-09-15 | Mor Research Applications Ltd. | Elongated body for deployment in a heart |
US20110077733A1 (en) | 2009-09-25 | 2011-03-31 | Edwards Lifesciences Corporation | Leaflet contacting apparatus and method |
US20130317438A1 (en) | 2012-05-25 | 2013-11-28 | Arstasis, Inc. | Vascular access configuration |
WO2015073274A1 (en) | 2013-11-13 | 2015-05-21 | Albert Einstein College Of Medicine Of Yeshiva University | Wnt/beta-catenin inhibitor-eluting endovascular stent |
US10441508B2 (en) | 2015-04-24 | 2019-10-15 | SpecGx LLC | Systems and methods for high humidity curing within tablet coating system |
US10635776B1 (en) | 2017-07-14 | 2020-04-28 | Synopsys, Inc. | Producing mask layouts with rounded corners |
-
2006
- 2006-02-07 EP EP21185845.1A patent/EP3967269A3/en active Pending
- 2006-02-07 WO PCT/US2006/004368 patent/WO2006086434A1/en active Application Filing
- 2006-02-07 AU AU2006212750A patent/AU2006212750B2/en not_active Ceased
- 2006-02-07 US US11/349,742 patent/US20060229708A1/en not_active Abandoned
- 2006-02-07 CA CA2597066A patent/CA2597066C/en not_active Expired - Fee Related
- 2006-02-07 EP EP06734547.0A patent/EP1855623B1/en not_active Revoked
- 2006-02-07 EP EP19160744.9A patent/EP3539508B1/en active Active
-
2009
- 2009-03-05 US US12/398,971 patent/US20090177266A1/en not_active Abandoned
-
2013
- 2013-03-28 US US13/852,459 patent/US20130282059A1/en not_active Abandoned
-
2016
- 2016-03-28 US US15/082,137 patent/US20160242909A1/en not_active Abandoned
-
2018
- 2018-04-03 US US15/943,758 patent/US10667911B2/en active Active
-
2019
- 2019-07-30 US US16/526,092 patent/US20190350710A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2108206A (en) * | 1937-03-09 | 1938-02-15 | Lillian Pearl Mecker | Tenaculum |
US3378010A (en) * | 1965-07-28 | 1968-04-16 | Coldling | Surgical clip with means for releasing the clamping pressure |
US3874338A (en) * | 1972-10-09 | 1975-04-01 | Fritz Happel | Milking cup |
US4498476A (en) * | 1981-08-27 | 1985-02-12 | Ethicon, Inc. | Non-metallic, bio-compatible hemostatic clips with interlocking latch means |
US4809695A (en) * | 1981-10-21 | 1989-03-07 | Owen M. Gwathmey | Suturing assembly and method |
US4510934A (en) * | 1983-05-13 | 1985-04-16 | Batra Subhash K | Suture |
US4641366A (en) * | 1984-10-04 | 1987-02-03 | Nec Corporation | Portable radio communication apparatus comprising an antenna member for a broad-band signal |
US4917089A (en) * | 1988-08-29 | 1990-04-17 | Sideris Eleftherios B | Buttoned device for the transvenous occlusion of intracardiac defects |
US4994077A (en) * | 1989-04-21 | 1991-02-19 | Dobben Richard L | Artificial heart valve for implantation in a blood vessel |
US5108368A (en) * | 1990-01-04 | 1992-04-28 | Pilot Cardiovascular System, Inc. | Steerable medical device |
US6033378A (en) * | 1990-02-02 | 2000-03-07 | Ep Technologies, Inc. | Catheter steering mechanism |
US5195968A (en) * | 1990-02-02 | 1993-03-23 | Ingemar Lundquist | Catheter steering mechanism |
US5275578A (en) * | 1991-01-11 | 1994-01-04 | Adams Andy W | Clip |
US5190554A (en) * | 1992-04-08 | 1993-03-02 | Eastern Virginia Medical School | Appendix extractor |
US5507757A (en) * | 1992-04-30 | 1996-04-16 | Lasersurge, Inc. | Method of closing puncture wounds |
US5713910A (en) * | 1992-09-04 | 1998-02-03 | Laurus Medical Corporation | Needle guidance system for endoscopic suture device |
US5383886A (en) * | 1992-10-13 | 1995-01-24 | Kensey Nash Corporation | Methods and instruments for performing medical procedures percutaneously without a trocar |
US5718725A (en) * | 1992-12-03 | 1998-02-17 | Heartport, Inc. | Devices and methods for intracardiac procedures |
US6036699A (en) * | 1992-12-10 | 2000-03-14 | Perclose, Inc. | Device and method for suturing tissue |
US5507725A (en) * | 1992-12-23 | 1996-04-16 | Angeion Corporation | Steerable catheter |
US5403326A (en) * | 1993-02-01 | 1995-04-04 | The Regents Of The University Of California | Method for performing a gastric wrap of the esophagus for use in the treatment of esophageal reflux |
US5855614A (en) * | 1993-02-22 | 1999-01-05 | Heartport, Inc. | Method and apparatus for thoracoscopic intracardiac procedures |
US5715817A (en) * | 1993-06-29 | 1998-02-10 | C.R. Bard, Inc. | Bidirectional steering catheter |
US5403312A (en) * | 1993-07-22 | 1995-04-04 | Ethicon, Inc. | Electrosurgical hemostatic device |
US6206893B1 (en) * | 1993-11-08 | 2001-03-27 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
US5741280A (en) * | 1994-01-18 | 1998-04-21 | Coral Medical | Knot tying method and apparatus |
US5618306A (en) * | 1994-02-14 | 1997-04-08 | Heartport, Inc. | Endoscopic microsurgical instruments and methods |
US5593435A (en) * | 1994-07-29 | 1997-01-14 | Baxter International Inc. | Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accommodate patient growth |
US5593424A (en) * | 1994-08-10 | 1997-01-14 | Segmed, Inc. | Apparatus and method for reducing and stabilizing the circumference of a vascular structure |
US5487746A (en) * | 1994-11-23 | 1996-01-30 | Yu; George W. | Surgical clip having a longitudinal opening through which clamped tissue protrudes |
US5620452A (en) * | 1994-12-22 | 1997-04-15 | Yoon; Inbae | Surgical clip with ductile tissue penetrating members |
US5609598A (en) * | 1994-12-30 | 1997-03-11 | Vnus Medical Technologies, Inc. | Method and apparatus for minimally invasive treatment of chronic venous insufficiency |
US5868733A (en) * | 1995-02-14 | 1999-02-09 | Daig Corporation | Guiding introducer system for use in the treatment of accessory pathways around the mitral valve using a retrograde approach |
US6551331B2 (en) * | 1995-08-24 | 2003-04-22 | Sutura, Inc. | Suturing device and method for sealing an opening in a blood vessel or other biological structure |
US5860990A (en) * | 1995-08-24 | 1999-01-19 | Nr Medical, Inc. | Method and apparatus for suturing |
US5722421A (en) * | 1995-09-15 | 1998-03-03 | Symbiosis Corporation | Clevis having deflection limiting stops for use in an endoscopic biopsy forceps instrument |
US5716367A (en) * | 1995-10-18 | 1998-02-10 | Nissho Corporation | Catheter assembly for intracardiac suture |
US5891160A (en) * | 1996-02-23 | 1999-04-06 | Cardiovascular Technologies, Llc | Fastener delivery and deployment mechanism and method for placing the fastener in minimally invasive surgery |
US5879307A (en) * | 1996-03-15 | 1999-03-09 | Pulse Metric, Inc. | Non-invasive method and apparatus for diagnosing and monitoring aortic valve abnormalities, such a aortic regurgitation |
US5706824A (en) * | 1996-05-20 | 1998-01-13 | Symbiosis Corporation | Endoscopic biopsy forceps instrument having a constant force spring biasing the jaws closed |
US6045497A (en) * | 1997-01-02 | 2000-04-04 | Myocor, Inc. | Heart wall tension reduction apparatus and method |
US5885271A (en) * | 1997-03-14 | 1999-03-23 | Millennium Cardiac Strategies, Inc. | Device for regional immobilization of a compliant body |
US20050004583A1 (en) * | 1997-06-27 | 2005-01-06 | Oz Mehmet C. | Method and apparatus for circulatory valve repair |
US6019722A (en) * | 1997-09-17 | 2000-02-01 | Guidant Corporation | Device to permit offpump beating heart coronary bypass surgery |
US6187003B1 (en) * | 1997-11-12 | 2001-02-13 | Sherwood Services Ag | Bipolar electrosurgical instrument for sealing vessels |
US20040078053A1 (en) * | 1998-01-30 | 2004-04-22 | St. Jude Medical Atg, Inc. | Medical graft connector or plug structures, and methods of making and installing same |
US6190408B1 (en) * | 1998-03-05 | 2001-02-20 | The University Of Cincinnati | Device and method for restructuring the heart chamber geometry |
US6695866B1 (en) * | 1998-07-15 | 2004-02-24 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
US6355030B1 (en) * | 1998-09-25 | 2002-03-12 | Cardiothoracic Systems, Inc. | Instruments and methods employing thermal energy for the repair and replacement of cardiac valves |
US6368326B1 (en) * | 1998-09-28 | 2002-04-09 | Daos Limited | Internal cord fixation device |
US6701929B2 (en) * | 1999-03-03 | 2004-03-09 | Hany Hussein | Device and method for treatment of congestive heart failure |
US20040039442A1 (en) * | 1999-04-09 | 2004-02-26 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20040030382A1 (en) * | 1999-04-09 | 2004-02-12 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20020013571A1 (en) * | 1999-04-09 | 2002-01-31 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US20040044350A1 (en) * | 1999-04-09 | 2004-03-04 | Evalve, Inc. | Steerable access sheath and methods of use |
US20050021057A1 (en) * | 1999-04-09 | 2005-01-27 | Evalve, Inc. | Leaflet structuring |
US20040003819A1 (en) * | 1999-04-09 | 2004-01-08 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US20050033446A1 (en) * | 1999-04-09 | 2005-02-10 | Evalve, Inc. A California Corporation | Methods and apparatus for cardiac valve repair |
US20040049207A1 (en) * | 1999-04-09 | 2004-03-11 | Evalve, Inc., A Delaware Corporation | Fixation device and methods for engaging tissue |
US20060020275A1 (en) * | 1999-04-09 | 2006-01-26 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US20070038293A1 (en) * | 1999-04-09 | 2007-02-15 | St Goar Frederick G | Device and methods for endoscopic annuloplasty |
US6709382B1 (en) * | 1999-05-04 | 2004-03-23 | Simon Marcus Horner | Cardiac assist method and apparatus |
US20020035361A1 (en) * | 1999-06-25 | 2002-03-21 | Houser Russell A. | Apparatus and methods for treating tissue |
US6210432B1 (en) * | 1999-06-29 | 2001-04-03 | Jan Otto Solem | Device and method for treatment of mitral insufficiency |
US20040039443A1 (en) * | 1999-06-30 | 2004-02-26 | Solem Jan Otto | Method and device for treatment of mitral insufficiency |
US20030069636A1 (en) * | 1999-06-30 | 2003-04-10 | Solem Jan Otto | Method for treatment of mitral insufficiency |
US6203553B1 (en) * | 1999-09-08 | 2001-03-20 | United States Surgical | Stapling apparatus and method for heart valve replacement |
US20030069570A1 (en) * | 1999-10-02 | 2003-04-10 | Witzel Thomas H. | Methods for repairing mitral valve annulus percutaneously |
US6689164B1 (en) * | 1999-10-12 | 2004-02-10 | Jacques Seguin | Annuloplasty device for use in minimally invasive procedure |
US20060064115A1 (en) * | 1999-10-21 | 2006-03-23 | Allen William J | Minimally invasive mitral valve repair method and apparatus |
US20060064116A1 (en) * | 1999-10-21 | 2006-03-23 | Allen William J | Minimally invasive mitral valve repair method and apparatus |
US6537314B2 (en) * | 2000-01-31 | 2003-03-25 | Ev3 Santa Rosa, Inc. | Percutaneous mitral annuloplasty and cardiac reinforcement |
US6709456B2 (en) * | 2000-01-31 | 2004-03-23 | Ev3 Santa Rosa, Inc. | Percutaneous mitral annuloplasty with hemodynamic monitoring |
US20040024414A1 (en) * | 2000-06-20 | 2004-02-05 | Downing Stephen W. | Apparatuses and methods for performing minimally invasive diagnostic and surgical procedures inside of a beating heart |
US6702826B2 (en) * | 2000-06-23 | 2004-03-09 | Viacor, Inc. | Automated annular plication for mitral valve repair |
US7011669B2 (en) * | 2000-08-11 | 2006-03-14 | Edwards Lifesciences Corporation | Device and method for treatment of atrioventricular regurgitation |
US20060064118A1 (en) * | 2000-08-11 | 2006-03-23 | Kimblad Per O | Device and a method for treatment of atrioventricular regurgitation |
US20050055089A1 (en) * | 2000-09-20 | 2005-03-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US6723038B1 (en) * | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US20040019378A1 (en) * | 2001-04-24 | 2004-01-29 | Hlavka Edwin J. | Method and apparatus for performing catheter-based annuloplasty |
US20030078654A1 (en) * | 2001-08-14 | 2003-04-24 | Taylor Daniel C. | Method and apparatus for improving mitral valve function |
US6726716B2 (en) * | 2001-08-24 | 2004-04-27 | Edwards Lifesciences Corporation | Self-molding annuloplasty ring |
US20030069593A1 (en) * | 2001-08-31 | 2003-04-10 | Tremulis William S. | Method and apparatus for valve repair |
US20030050693A1 (en) * | 2001-09-10 | 2003-03-13 | Quijano Rodolfo C. | Minimally invasive delivery system for annuloplasty rings |
US20050049698A1 (en) * | 2001-11-13 | 2005-03-03 | Bolling Steven F. | Methods of implanting a mitral valve annuloplasty ring to correct mitral regurgitation |
US20040019377A1 (en) * | 2002-01-14 | 2004-01-29 | Taylor Daniel C. | Method and apparatus for reducing mitral regurgitation |
US20040073302A1 (en) * | 2002-02-05 | 2004-04-15 | Jonathan Rourke | Method and apparatus for improving mitral valve function |
US20060030866A1 (en) * | 2002-03-26 | 2006-02-09 | Stefan Schreck | Sequential heart valve leaflet repair device and method of use |
US20040049211A1 (en) * | 2002-06-12 | 2004-03-11 | Mitral Interventions, Inc. | Method and apparatus for tissue connection |
US6986775B2 (en) * | 2002-06-13 | 2006-01-17 | Guided Delivery Systems, Inc. | Devices and methods for heart valve repair |
US20050059351A1 (en) * | 2002-08-30 | 2005-03-17 | Patrick Cauwels | User-specified outputs in mobile wireless communication devices and methods therefor |
US20060030885A1 (en) * | 2002-10-15 | 2006-02-09 | Hyde Gregory M | Apparatuses and methods for heart valve repair |
US20050004668A1 (en) * | 2003-07-02 | 2005-01-06 | Flexcor, Inc. | Annuloplasty rings and methods for repairing cardiac valves |
US20050004665A1 (en) * | 2003-07-02 | 2005-01-06 | Lishan Aklog | Annuloplasty rings and methods for repairing cardiac valves |
US20050038508A1 (en) * | 2003-08-13 | 2005-02-17 | Shlomo Gabbay | Implantable cardiac prosthesis for mitigating prolapse of a heart valve |
US20060004247A1 (en) * | 2004-06-30 | 2006-01-05 | Ethicon Incorporated | Systems and methods for assisting cardiac valve coaptation |
US20060030867A1 (en) * | 2004-07-09 | 2006-02-09 | Reza Zadno | Device and method for repairing tissue |
US20060015003A1 (en) * | 2004-07-15 | 2006-01-19 | Micardia Corporation | Magnetic devices and methods for reshaping heart anatomy |
US20060058871A1 (en) * | 2004-09-14 | 2006-03-16 | Edwards Lifesciences, Ag | Device and method for treatment of heart valve regurgitation |
Cited By (463)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8740918B2 (en) | 1997-09-12 | 2014-06-03 | Evalve, Inc. | Surgical device for connecting soft tissue |
US7981123B2 (en) | 1997-09-12 | 2011-07-19 | Evalve, Inc. | Surgical device for connecting soft tissue |
US9510837B2 (en) | 1997-09-12 | 2016-12-06 | Evalve, Inc. | Surgical device for connecting soft tissue |
US8187299B2 (en) | 1999-04-09 | 2012-05-29 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US8057493B2 (en) | 1999-04-09 | 2011-11-15 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US8343174B2 (en) | 1999-04-09 | 2013-01-01 | Evalve, Inc. | Locking mechanisms for fixation devices and methods of engaging tissue |
US9044246B2 (en) | 1999-04-09 | 2015-06-02 | Abbott Vascular Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US9510829B2 (en) | 1999-04-09 | 2016-12-06 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US8740920B2 (en) | 1999-04-09 | 2014-06-03 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US8216256B2 (en) | 1999-04-09 | 2012-07-10 | Evalve, Inc. | Detachment mechanism for implantable fixation devices |
US7811296B2 (en) | 1999-04-09 | 2010-10-12 | Evalve, Inc. | Fixation devices for variation in engagement of tissue |
US8123703B2 (en) | 1999-04-09 | 2012-02-28 | Evalve, Inc. | Steerable access sheath and methods of use |
US8409273B2 (en) | 1999-04-09 | 2013-04-02 | Abbott Vascular Inc | Multi-catheter steerable guiding system and methods of use |
US8029518B2 (en) | 1999-04-09 | 2011-10-04 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US7998151B2 (en) | 1999-04-09 | 2011-08-16 | Evalve, Inc. | Leaflet suturing |
US8500761B2 (en) | 1999-04-09 | 2013-08-06 | Abbott Vascular | Fixation devices, systems and methods for engaging tissue |
US10327743B2 (en) | 1999-04-09 | 2019-06-25 | Evalve, Inc. | Device and methods for endoscopic annuloplasty |
US8734505B2 (en) | 1999-04-09 | 2014-05-27 | Evalve, Inc. | Methods and apparatus for cardiac valve repair |
US7736388B2 (en) | 1999-04-09 | 2010-06-15 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7753923B2 (en) | 1999-04-09 | 2010-07-13 | Evalve, Inc. | Leaflet suturing |
US9861475B2 (en) * | 2000-09-20 | 2018-01-09 | Mvrx Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US20090306622A1 (en) * | 2000-09-20 | 2009-12-10 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heat valve annulus |
US10624618B2 (en) | 2001-06-27 | 2020-04-21 | Evalve, Inc. | Methods and devices for capturing and fixing leaflets in valve repair |
US10653427B2 (en) | 2001-06-27 | 2020-05-19 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US7972377B2 (en) | 2001-12-27 | 2011-07-05 | Medtronic, Inc. | Bioprosthetic heart valve |
US7981139B2 (en) | 2002-03-01 | 2011-07-19 | Evalve, Inc | Suture anchors and methods of use |
US9636107B2 (en) | 2002-06-13 | 2017-05-02 | Ancora Heart, Inc. | Devices and methods for heart valve repair |
US8349003B2 (en) | 2002-07-16 | 2013-01-08 | Medtronic, Inc. | Suture locking assembly and method of use |
US7959674B2 (en) | 2002-07-16 | 2011-06-14 | Medtronic, Inc. | Suture locking assembly and method of use |
US9763658B2 (en) | 2002-08-02 | 2017-09-19 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
US10499905B2 (en) | 2002-08-02 | 2019-12-10 | Cedars-Sinai Medical Center | Methods and apparatus for atrioventricular valve repair |
US7981153B2 (en) | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US10595991B2 (en) | 2002-12-20 | 2020-03-24 | Medtronic, Inc. | Heart valve assemblies |
US9333078B2 (en) | 2002-12-20 | 2016-05-10 | Medtronic, Inc. | Heart valve assemblies |
US8025695B2 (en) | 2002-12-20 | 2011-09-27 | Medtronic, Inc. | Biologically implantable heart valve system |
US8623080B2 (en) | 2002-12-20 | 2014-01-07 | Medtronic, Inc. | Biologically implantable prosthesis and methods of using the same |
US8460373B2 (en) | 2002-12-20 | 2013-06-11 | Medtronic, Inc. | Method for implanting a heart valve within an annulus of a patient |
US8551162B2 (en) | 2002-12-20 | 2013-10-08 | Medtronic, Inc. | Biologically implantable prosthesis |
US20050107871A1 (en) * | 2003-03-30 | 2005-05-19 | Fidel Realyvasquez | Apparatus and methods for valve repair |
US10828042B2 (en) | 2003-05-19 | 2020-11-10 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US10667823B2 (en) | 2003-05-19 | 2020-06-02 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US10631871B2 (en) | 2003-05-19 | 2020-04-28 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US10646229B2 (en) | 2003-05-19 | 2020-05-12 | Evalve, Inc. | Fixation devices, systems and methods for engaging tissue |
US8747463B2 (en) | 2003-08-22 | 2014-06-10 | Medtronic, Inc. | Methods of using a prosthesis fixturing device |
US8021421B2 (en) | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US8603161B2 (en) | 2003-10-08 | 2013-12-10 | Medtronic, Inc. | Attachment device and methods of using the same |
US7186265B2 (en) * | 2003-12-10 | 2007-03-06 | Medtronic, Inc. | Prosthetic cardiac valves and systems and methods for implanting thereof |
US11484331B2 (en) | 2004-09-27 | 2022-11-01 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US11304715B2 (en) | 2004-09-27 | 2022-04-19 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8470028B2 (en) | 2005-02-07 | 2013-06-25 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US10667911B2 (en) | 2005-02-07 | 2020-06-02 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US20200155312A1 (en) * | 2005-03-17 | 2020-05-21 | Valtech Cardio, Ltd. | Mitral valve treatment techniques |
US11497605B2 (en) * | 2005-03-17 | 2022-11-15 | Valtech Cardio Ltd. | Mitral valve treatment techniques |
US7951197B2 (en) | 2005-04-08 | 2011-05-31 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US8500802B2 (en) | 2005-04-08 | 2013-08-06 | Medtronic, Inc. | Two-piece prosthetic valves with snap-in connection and methods for use |
US10966696B2 (en) | 2005-04-22 | 2021-04-06 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US10130468B2 (en) | 2005-05-24 | 2018-11-20 | Edwards Lifesciences Corporation | Replacement prosthetic heart valves |
US11284998B2 (en) | 2005-05-24 | 2022-03-29 | Edwards Lifesciences Corporation | Surgical methods of replacing prosthetic heart valves |
US8911493B2 (en) | 2005-05-24 | 2014-12-16 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valves |
US10456251B2 (en) | 2005-05-24 | 2019-10-29 | Edwards Lifesciences Corporation | Surgical methods of replacing prosthetic heart valves |
US9554903B2 (en) | 2005-05-24 | 2017-01-31 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US8500798B2 (en) * | 2005-05-24 | 2013-08-06 | Edwards Lifesciences Corporation | Rapid deployment prosthetic heart valve |
US8211169B2 (en) | 2005-05-27 | 2012-07-03 | Medtronic, Inc. | Gasket with collar for prosthetic heart valves and methods for using them |
US20090099410A1 (en) * | 2005-06-09 | 2009-04-16 | De Marchena Eduardo | Papillary Muscle Attachment for Left Ventricular Reduction |
US8052592B2 (en) | 2005-09-27 | 2011-11-08 | Evalve, Inc. | Methods and devices for tissue grasping and assessment |
US8486136B2 (en) | 2005-10-26 | 2013-07-16 | Cardiosolutions, Inc. | Mitral spacer |
US9232999B2 (en) | 2005-10-26 | 2016-01-12 | Cardiosolutions Inc. | Mitral spacer |
US8506623B2 (en) | 2005-10-26 | 2013-08-13 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US8778017B2 (en) | 2005-10-26 | 2014-07-15 | Cardiosolutions, Inc. | Safety for mitral valve implant |
US8092525B2 (en) | 2005-10-26 | 2012-01-10 | Cardiosolutions, Inc. | Heart valve implant |
US8888844B2 (en) | 2005-10-26 | 2014-11-18 | Cardiosolutions, Inc. | Heart valve implant |
US8894705B2 (en) | 2005-10-26 | 2014-11-25 | Cardiosolutions, Inc. | Balloon mitral spacer |
US8216302B2 (en) | 2005-10-26 | 2012-07-10 | Cardiosolutions, Inc. | Implant delivery and deployment system and method |
US9517129B2 (en) | 2005-10-26 | 2016-12-13 | Cardio Solutions, Inc. | Implant delivery and deployment system and method |
US8449606B2 (en) | 2005-10-26 | 2013-05-28 | Cardiosolutions, Inc. | Balloon mitral spacer |
US7785366B2 (en) | 2005-10-26 | 2010-08-31 | Maurer Christopher W | Mitral spacer |
US8568473B2 (en) | 2005-12-15 | 2013-10-29 | Georgia Tech Research Corporation | Systems and methods for enabling heart valve replacement |
US10039531B2 (en) | 2005-12-15 | 2018-08-07 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US9125742B2 (en) | 2005-12-15 | 2015-09-08 | Georgia Tech Research Foundation | Papillary muscle position control devices, systems, and methods |
US10010419B2 (en) | 2005-12-15 | 2018-07-03 | Georgia Tech Research Corporation | Papillary muscle position control devices, systems, and methods |
US20090157174A1 (en) * | 2005-12-15 | 2009-06-18 | Georgia Tech Reasearch Corporation | Systems and methods for enabling heart valve replacement |
US20090292353A1 (en) * | 2005-12-15 | 2009-11-26 | Georgia Tech Research Corporation | Systems and methods to control the dimension of a heart valve |
US7967857B2 (en) | 2006-01-27 | 2011-06-28 | Medtronic, Inc. | Gasket with spring collar for prosthetic heart valves and methods for making and using them |
US8821569B2 (en) | 2006-04-29 | 2014-09-02 | Medtronic, Inc. | Multiple component prosthetic heart valve assemblies and methods for delivering them |
US9283073B2 (en) * | 2006-06-02 | 2016-03-15 | Medtronic, Inc. | Annuloplasty ring and method |
US20070299513A1 (en) * | 2006-06-02 | 2007-12-27 | Ryan Timothy R | Annuloplasty ring and method |
WO2007144121A1 (en) * | 2006-06-16 | 2007-12-21 | Eberhard-Karls-Universität Tübingen Universitätsklinikum | Device for treatment of mitral valve insufficiency |
US20170095333A1 (en) * | 2006-10-04 | 2017-04-06 | Edwards Lifesciences Corporation | Method and apparatus for reshaping a ventricle |
US20080086203A1 (en) * | 2006-10-06 | 2008-04-10 | Roberts Harold G | Mitral and tricuspid annuloplasty rings |
US8382828B2 (en) * | 2006-10-06 | 2013-02-26 | Edwards Lifesciences Corporation | Mitral annuloplasty rings |
US20110093065A1 (en) * | 2006-10-06 | 2011-04-21 | Edwards Lifesciences Corporation | Mitral and Tricuspid Annuloplasty Rings |
US7879087B2 (en) * | 2006-10-06 | 2011-02-01 | Edwards Lifesciences Corporation | Mitral and tricuspid annuloplasty rings |
US8388680B2 (en) | 2006-10-18 | 2013-03-05 | Guided Delivery Systems, Inc. | Methods and devices for catheter advancement and delivery of substances therethrough |
US20080221672A1 (en) * | 2007-02-23 | 2008-09-11 | Endovalve, Inc. | Mitral Valve System |
US8070802B2 (en) * | 2007-02-23 | 2011-12-06 | The Trustees Of The University Of Pennsylvania | Mitral valve system |
US8529620B2 (en) | 2007-05-01 | 2013-09-10 | Ottavio Alfieri | Inwardly-bowed tricuspid annuloplasty ring |
US8480730B2 (en) | 2007-05-14 | 2013-07-09 | Cardiosolutions, Inc. | Solid construct mitral spacer |
US9730792B2 (en) | 2007-09-13 | 2017-08-15 | Georg Lutter | Truncated cone heart valve stent |
US11213387B2 (en) | 2007-09-13 | 2022-01-04 | Georg Lutter | Truncated cone heart valve stent |
US10456248B2 (en) | 2007-09-13 | 2019-10-29 | Georg Lutter | Truncated cone heart valve stent |
US9078749B2 (en) | 2007-09-13 | 2015-07-14 | Georg Lutter | Truncated cone heart valve stent |
US9254192B2 (en) | 2007-09-13 | 2016-02-09 | Georg Lutter | Truncated cone heart valve stent |
US9125632B2 (en) | 2007-10-19 | 2015-09-08 | Guided Delivery Systems, Inc. | Systems and methods for cardiac remodeling |
US20090234318A1 (en) * | 2007-10-19 | 2009-09-17 | Guided Delivery Systems, Inc. | Systems and methods for cardiac remodeling |
US8597347B2 (en) | 2007-11-15 | 2013-12-03 | Cardiosolutions, Inc. | Heart regurgitation method and apparatus |
US9770330B2 (en) | 2007-11-15 | 2017-09-26 | Cardiosolutions, Inc. | Implant delivery system and method |
US8852270B2 (en) | 2007-11-15 | 2014-10-07 | Cardiosolutions, Inc. | Implant delivery system and method |
US20090132036A1 (en) * | 2007-11-19 | 2009-05-21 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US8216303B2 (en) | 2007-11-19 | 2012-07-10 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US8784483B2 (en) | 2007-11-19 | 2014-07-22 | The Cleveland Clinic Foundation | Apparatus and method for treating a regurgitant heart valve |
US20090222081A1 (en) * | 2008-01-24 | 2009-09-03 | Coherex Medical, Inc. | Methods and apparatus for reducing valve prolapse |
US8480732B2 (en) | 2008-04-16 | 2013-07-09 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for valve repair |
US10456259B2 (en) | 2008-04-16 | 2019-10-29 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for mitral valve repair |
US20100121437A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Transvalvular intraannular band and chordae cutting for ischemic and dilated cardiomyopathy |
US20100131057A1 (en) * | 2008-04-16 | 2010-05-27 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for aortic valve repair |
US20100121435A1 (en) * | 2008-04-16 | 2010-05-13 | Cardiovascular Technologies, Llc | Percutaneous transvalvular intrannular band for mitral valve repair |
US8262725B2 (en) | 2008-04-16 | 2012-09-11 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
US10238488B2 (en) | 2008-04-16 | 2019-03-26 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US20130090724A1 (en) * | 2008-04-16 | 2013-04-11 | Cardiovascular Technologies, Llc | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US20090264995A1 (en) * | 2008-04-16 | 2009-10-22 | Subramanian Valavanur A | Transvalvular intraannular band for valve repair |
US8956406B2 (en) * | 2008-04-16 | 2015-02-17 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US20100076550A1 (en) * | 2008-04-16 | 2010-03-25 | Cardiovascular Technologies, Llc | Transvalvular intraannular band for valve repair |
US9168137B2 (en) | 2008-04-16 | 2015-10-27 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for aortic valve repair |
US11013599B2 (en) | 2008-04-16 | 2021-05-25 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US11083579B2 (en) | 2008-04-16 | 2021-08-10 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US9585753B2 (en) | 2008-04-16 | 2017-03-07 | Heart Repair Technologies, Inc. | Transvalvular intraannular band for valve repair |
US8961597B2 (en) | 2008-04-16 | 2015-02-24 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US10219903B2 (en) | 2008-04-16 | 2019-03-05 | Heart Repair Technologies, Inc. | Transvalvular intraanular band and chordae cutting for ischemic and dilated cardiomyopathy |
US9615925B2 (en) * | 2008-04-16 | 2017-04-11 | Heart Repair Technologies, Inc. | Transvalvular intraanular band for ischemic and dilated cardiomyopathy |
US9468526B2 (en) | 2008-04-16 | 2016-10-18 | Heart Repair Technologies, Inc. | Percutaneous transvalvular intraannular band for mitral valve repair |
US20130096673A1 (en) * | 2008-04-23 | 2013-04-18 | Medtronic, Inc. | Prosthetic Heart Valve Devices And Methods Of Valve Replacement |
US9827090B2 (en) * | 2008-04-23 | 2017-11-28 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve replacement |
US10548723B2 (en) | 2008-04-23 | 2020-02-04 | Medtronic, Inc. | Prosthetic heart valve devices and methods of valve replacement |
US10363392B2 (en) | 2008-05-07 | 2019-07-30 | Ancora Heart, Inc. | Deflectable guide |
US8591460B2 (en) | 2008-06-13 | 2013-11-26 | Cardiosolutions, Inc. | Steerable catheter and dilator and system and method for implanting a heart implant |
US9259317B2 (en) | 2008-06-13 | 2016-02-16 | Cardiosolutions, Inc. | System and method for implanting a heart implant |
US9314334B2 (en) | 2008-11-25 | 2016-04-19 | Edwards Lifesciences Corporation | Conformal expansion of prosthetic devices to anatomical shapes |
US10667906B2 (en) | 2008-11-25 | 2020-06-02 | Edwards Lifesciences Corporation | Methods of conformal expansion of prosthetic heart valves |
US11504232B2 (en) | 2008-12-19 | 2022-11-22 | Edwards Lifesciences Corporation | Rapid implant prosthetic heart valve system |
US9616197B2 (en) | 2009-01-20 | 2017-04-11 | Ancora Heart, Inc. | Anchor deployment devices and related methods |
US10625047B2 (en) | 2009-01-20 | 2020-04-21 | Ancora Heart, Inc. | Anchor deployment devices and related methods |
US9173646B2 (en) | 2009-01-20 | 2015-11-03 | Guided Delivery Systems Inc. | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
US11202883B2 (en) | 2009-01-20 | 2021-12-21 | Ancora Heart, Inc. | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
US10625046B2 (en) | 2009-01-20 | 2020-04-21 | Ancora Heart, Inc. | Diagnostic catheters, guide catheters, visualization devices and chord manipulation devices, and related kits and methods |
EP2408399A4 (en) * | 2009-03-17 | 2018-01-03 | Mitrassist Medical Ltd. | Heart valve prosthesis with collapsible valve and method of delivery thereof |
US10555810B2 (en) | 2009-06-26 | 2020-02-11 | Edwards Lifesciences Corporation | Prosthetic heart valve deployment systems |
US9005277B2 (en) | 2009-06-26 | 2015-04-14 | Edwards Lifesciences Corporation | Unitary quick-connect prosthetic heart valve deployment system |
US8348998B2 (en) | 2009-06-26 | 2013-01-08 | Edwards Lifesciences Corporation | Unitary quick connect prosthetic heart valve and deployment system and methods |
US8696742B2 (en) | 2009-06-26 | 2014-04-15 | Edwards Lifesciences Corporation | Unitary quick-connect prosthetic heart valve deployment methods |
US9060858B2 (en) | 2009-09-15 | 2015-06-23 | Evalve, Inc. | Methods, systems and devices for cardiac valve repair |
US11839541B2 (en) | 2009-12-08 | 2023-12-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper skirt |
US11179236B2 (en) | 2009-12-08 | 2021-11-23 | Colorado State University Research Foundation | Device and system for transcatheter mitral valve replacement |
US11141268B2 (en) | 2009-12-08 | 2021-10-12 | Cardiovalve Ltd. | Prosthetic heart valve with upper and lower skirts |
US11351026B2 (en) | 2009-12-08 | 2022-06-07 | Cardiovalve Ltd. | Rotation-based anchoring of an implant |
US10405978B2 (en) | 2010-01-22 | 2019-09-10 | 4Tech Inc. | Tricuspid valve repair using tension |
US8961596B2 (en) | 2010-01-22 | 2015-02-24 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US8475525B2 (en) * | 2010-01-22 | 2013-07-02 | 4Tech Inc. | Tricuspid valve repair using tension |
US10617522B2 (en) | 2010-01-22 | 2020-04-14 | 4Tech Inc. | Atrioventricular valve repair using tension |
US20110184510A1 (en) * | 2010-01-22 | 2011-07-28 | 4Tech, Sarl | Tricuspid valve repair using tension |
US9241702B2 (en) | 2010-01-22 | 2016-01-26 | 4Tech Inc. | Method and apparatus for tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
US10238491B2 (en) | 2010-01-22 | 2019-03-26 | 4Tech Inc. | Tricuspid valve repair using tension |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US10433963B2 (en) | 2010-01-22 | 2019-10-08 | 4Tech Inc. | Tissue anchor and delivery tool |
US11109964B2 (en) | 2010-03-10 | 2021-09-07 | Cardiovalve Ltd. | Axially-shortening prosthetic valve |
US10702383B2 (en) | 2010-05-10 | 2020-07-07 | Edwards Lifesciences Corporation | Methods of delivering and implanting resilient prosthetic surgical heart valves |
US11571299B2 (en) | 2010-05-10 | 2023-02-07 | Edwards Lifesciences Corporation | Methods for manufacturing resilient prosthetic surgical heart valves |
US8986374B2 (en) | 2010-05-10 | 2015-03-24 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US11653910B2 (en) | 2010-07-21 | 2023-05-23 | Cardiovalve Ltd. | Helical anchor implantation |
US11426155B2 (en) | 2010-07-21 | 2022-08-30 | Cardiovalve Ltd. | Helical anchor implantation |
US11197757B2 (en) | 2010-09-10 | 2021-12-14 | Edwards Lifesciences Corporation | Methods of safely expanding prosthetic heart valves |
US10548728B2 (en) | 2010-09-10 | 2020-02-04 | Edwards Lifesciences Corporation | Safety systems for expansion of prosthetic heart valves |
US9504563B2 (en) | 2010-09-10 | 2016-11-29 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US10039641B2 (en) | 2010-09-10 | 2018-08-07 | Edwards Lifesciences Corporation | Methods of rapidly deployable surgical heart valves |
US10722358B2 (en) | 2010-09-10 | 2020-07-28 | Edwards Lifesciences Corporation | Systems for rapidly deployable surgical heart valves |
US9125741B2 (en) | 2010-09-10 | 2015-09-08 | Edwards Lifesciences Corporation | Systems and methods for ensuring safe and rapid deployment of prosthetic heart valves |
US11775613B2 (en) | 2010-09-10 | 2023-10-03 | Edwards Lifesciences Corporation | Methods of safely expanding prosthetic heart valves |
US11471279B2 (en) | 2010-09-10 | 2022-10-18 | Edwards Lifesciences Corporation | Systems for rapidly deployable surgical heart valves |
US9370418B2 (en) | 2010-09-10 | 2016-06-21 | Edwards Lifesciences Corporation | Rapidly deployable surgical heart valves |
US9968450B2 (en) | 2010-09-10 | 2018-05-15 | Edwards Lifesciences Corporation | Methods for ensuring safe and rapid deployment of prosthetic heart valves |
US8641757B2 (en) | 2010-09-10 | 2014-02-04 | Edwards Lifesciences Corporation | Systems for rapidly deploying surgical heart valves |
US10736741B2 (en) | 2010-09-27 | 2020-08-11 | Edwards Lifesciences Corporation | Methods of delivery of heart valves |
US8845720B2 (en) | 2010-09-27 | 2014-09-30 | Edwards Lifesciences Corporation | Prosthetic heart valve frame with flexible commissures |
US9861479B2 (en) | 2010-09-27 | 2018-01-09 | Edwards Lifesciences Corporation | Methods of delivery of flexible heart valves |
US11207178B2 (en) | 2010-09-27 | 2021-12-28 | Edwards Lifesciences Corporation | Collapsible-expandable heart valves |
US8932350B2 (en) | 2010-11-30 | 2015-01-13 | Edwards Lifesciences Corporation | Reduced dehiscence annuloplasty ring |
US9474607B2 (en) | 2010-11-30 | 2016-10-25 | Edwards Lifesciences Corporation | Methods of implanting an annuloplasty ring for reduced dehiscence |
US11872132B2 (en) | 2010-11-30 | 2024-01-16 | Edwards Lifesciences Corporation | Methods of implanting an annuloplasty ring for reduced dehiscence |
US10543089B2 (en) | 2010-11-30 | 2020-01-28 | Edwards Lifesciences Corporation | Annuloplasty ring with reduced dehiscence |
US9662208B2 (en) | 2011-01-25 | 2017-05-30 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
WO2012103173A3 (en) * | 2011-01-25 | 2012-11-22 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
WO2012103173A2 (en) * | 2011-01-25 | 2012-08-02 | Emory University | Devices and methods for surgical and percutaneous repair of heart valve lesions |
US11517429B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Apparatus for use at a heart valve |
US11864995B2 (en) | 2011-08-05 | 2024-01-09 | Cardiovalve Ltd. | Implant for heart valve |
US11517436B2 (en) | 2011-08-05 | 2022-12-06 | Cardiovalve Ltd. | Implant for heart valve |
US11690712B2 (en) | 2011-08-05 | 2023-07-04 | Cardiovalve Ltd. | Clip-secured implant for heart valve |
US11369469B2 (en) | 2011-08-05 | 2022-06-28 | Cardiovalve Ltd. | Method for use at a heart valve |
US11291545B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Implant for heart valve |
US11291547B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US11291546B2 (en) | 2011-08-05 | 2022-04-05 | Cardiovalve Ltd. | Leaflet clip with collars |
US11951005B2 (en) | 2011-08-05 | 2024-04-09 | Cardiovalve Ltd. | Implant for heart valve |
US11344410B2 (en) | 2011-08-05 | 2022-05-31 | Cardiovalve Ltd. | Implant for heart valve |
US11364116B2 (en) | 2011-08-11 | 2022-06-21 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US9480559B2 (en) | 2011-08-11 | 2016-11-01 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11123181B2 (en) | 2011-08-11 | 2021-09-21 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11123180B2 (en) | 2011-08-11 | 2021-09-21 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US10639145B2 (en) | 2011-08-11 | 2020-05-05 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US9833315B2 (en) | 2011-08-11 | 2017-12-05 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11135055B2 (en) | 2011-08-11 | 2021-10-05 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11311374B2 (en) | 2011-08-11 | 2022-04-26 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US10617519B2 (en) | 2011-08-11 | 2020-04-14 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11484404B2 (en) | 2011-08-11 | 2022-11-01 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US11382737B2 (en) | 2011-08-11 | 2022-07-12 | Tendyne Holdings, Inc. | Prosthetic valves and related inventions |
US10743876B2 (en) | 2011-09-13 | 2020-08-18 | Abbott Cardiovascular Systems Inc. | System for fixation of leaflets of a heart valve |
US10792039B2 (en) | 2011-09-13 | 2020-10-06 | Abbott Cardiovascular Systems Inc. | Gripper pusher mechanism for tissue apposition systems |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US10952844B2 (en) | 2011-12-16 | 2021-03-23 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
US10849752B2 (en) | 2011-12-21 | 2020-12-01 | Edwards Lifesciences Corporation | Methods for anchoring a device at a native heart valve annulus |
US11452602B2 (en) | 2011-12-21 | 2022-09-27 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a native heart valve annulus |
US10238489B2 (en) | 2011-12-21 | 2019-03-26 | Edwards Lifesciences Corporation | Anchoring device and method for replacing or repairing a heart valve |
US9078747B2 (en) | 2011-12-21 | 2015-07-14 | Edwards Lifesciences Corporation | Anchoring device for replacing or repairing a heart valve |
US10420645B2 (en) | 2012-02-15 | 2019-09-24 | Children's Medical Center Corporation | Right ventricular papillary approximation |
US8961594B2 (en) | 2012-05-31 | 2015-02-24 | 4Tech Inc. | Heart valve repair system |
US10206673B2 (en) | 2012-05-31 | 2019-02-19 | 4Tech, Inc. | Suture-securing for cardiac valve repair |
US9895221B2 (en) | 2012-07-28 | 2018-02-20 | Tendyne Holdings, Inc. | Multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US11759318B2 (en) | 2012-07-28 | 2023-09-19 | Tendyne Holdings, Inc. | Multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US10219900B2 (en) | 2012-07-30 | 2019-03-05 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US11090155B2 (en) | 2012-07-30 | 2021-08-17 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US10543088B2 (en) | 2012-09-14 | 2020-01-28 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US10849755B2 (en) | 2012-09-14 | 2020-12-01 | Boston Scientific Scimed, Inc. | Mitral valve inversion prostheses |
US9693865B2 (en) | 2013-01-09 | 2017-07-04 | 4 Tech Inc. | Soft tissue depth-finding tool |
US9788948B2 (en) | 2013-01-09 | 2017-10-17 | 4 Tech Inc. | Soft tissue anchors and implantation techniques |
US10449050B2 (en) | 2013-01-09 | 2019-10-22 | 4 Tech Inc. | Soft tissue depth-finding tool |
US11844691B2 (en) | 2013-01-24 | 2023-12-19 | Cardiovalve Ltd. | Partially-covered prosthetic valves |
US11135059B2 (en) | 2013-01-24 | 2021-10-05 | Cardiovalve Ltd. | Prosthetic valve and upstream support therefor |
US9724084B2 (en) | 2013-02-26 | 2017-08-08 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US10130356B2 (en) | 2013-02-26 | 2018-11-20 | Mitralign, Inc. | Devices and methods for percutaneous tricuspid valve repair |
US10918374B2 (en) | 2013-02-26 | 2021-02-16 | Edwards Lifesciences Corporation | Devices and methods for percutaneous tricuspid valve repair |
US10105221B2 (en) | 2013-03-07 | 2018-10-23 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiovascular prosthesis |
US11730591B2 (en) | 2013-03-07 | 2023-08-22 | Cedars-Sinai Medical | Method and apparatus for percutaneous delivery and deployment of a cardiovascular prosthesis |
US10898323B2 (en) | 2013-03-07 | 2021-01-26 | Cedars-Sinai Medical Center | Catheter based apical approach heart prostheses delivery system |
US10080657B2 (en) | 2013-03-07 | 2018-09-25 | Cedars-Sinai Medical Center | Catheter based apical approach heart prostheses delivery system |
US9907681B2 (en) | 2013-03-14 | 2018-03-06 | 4Tech Inc. | Stent with tether interface |
US9833316B2 (en) | 2013-03-15 | 2017-12-05 | Cardiosolutions, Inc. | Trans-apical implant systems, implants and methods |
US9289297B2 (en) | 2013-03-15 | 2016-03-22 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9232998B2 (en) | 2013-03-15 | 2016-01-12 | Cardiosolutions Inc. | Trans-apical implant systems, implants and methods |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US11311379B2 (en) | 2013-04-02 | 2022-04-26 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10463494B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
US11364119B2 (en) | 2013-04-04 | 2022-06-21 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
US11617645B2 (en) | 2013-05-30 | 2023-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US10405976B2 (en) | 2013-05-30 | 2019-09-10 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
US10314706B2 (en) | 2013-06-12 | 2019-06-11 | Edwards Lifesciences Corporation | Methods of implanting a cardiac implant with integrated suture fasteners |
US9468527B2 (en) | 2013-06-12 | 2016-10-18 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US11464633B2 (en) | 2013-06-12 | 2022-10-11 | Edwards Lifesciences Corporation | Heart valve implants with side slits |
US9968451B2 (en) | 2013-06-12 | 2018-05-15 | Edwards Lifesciences Corporation | Cardiac implant with integrated suture fasteners |
US9545305B2 (en) | 2013-06-14 | 2017-01-17 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US9980812B2 (en) | 2013-06-14 | 2018-05-29 | Cardiosolutions, Inc. | Mitral valve spacer and system and method for implanting the same |
US11471281B2 (en) | 2013-06-25 | 2022-10-18 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
US9597181B2 (en) | 2013-06-25 | 2017-03-21 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
US9937044B2 (en) | 2013-06-25 | 2018-04-10 | Mitralign, Inc. | Percutaneous valve repair by reshaping and resizing right ventricle |
US9999507B2 (en) * | 2013-06-25 | 2018-06-19 | Mitralign, Inc. | Percutaneous valve repair by reshaping and resizing right ventricle |
US20140379006A1 (en) * | 2013-06-25 | 2014-12-25 | Mitralign, Inc. | Percutaneous Valve Repair by Reshaping and Resizing Right Ventricle |
US10595996B2 (en) | 2013-06-25 | 2020-03-24 | Tendyne Holdings, Inc. | Thrombus management and structural compliance features for prosthetic heart valves |
US11612480B2 (en) | 2013-08-01 | 2023-03-28 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US10610354B2 (en) | 2013-08-01 | 2020-04-07 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US10702680B2 (en) | 2013-08-28 | 2020-07-07 | Edwards Lifesciences Corporation | Method of operating an integrated balloon catheter inflation system |
US9919137B2 (en) | 2013-08-28 | 2018-03-20 | Edwards Lifesciences Corporation | Integrated balloon catheter inflation system |
US11246562B2 (en) | 2013-10-17 | 2022-02-15 | Tendyne Holdings, Inc. | Apparatus and methods for alignment and deployment of intracardiac devices |
US10555718B2 (en) | 2013-10-17 | 2020-02-11 | Tendyne Holdings, Inc. | Apparatus and methods for alignment and deployment of intracardiac devices |
US10363135B2 (en) | 2013-10-29 | 2019-07-30 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US11096783B2 (en) | 2013-10-29 | 2021-08-24 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
US10052095B2 (en) | 2013-10-30 | 2018-08-21 | 4Tech Inc. | Multiple anchoring-point tension system |
US10039643B2 (en) | 2013-10-30 | 2018-08-07 | 4Tech Inc. | Multiple anchoring-point tension system |
US10022114B2 (en) | 2013-10-30 | 2018-07-17 | 4Tech Inc. | Percutaneous tether locking |
US20170252154A1 (en) * | 2013-11-28 | 2017-09-07 | Mvalve Technologies Ltd. | Intracardiac devices comprising stabilizing elements having improved fatigue resistance |
US10182908B2 (en) * | 2013-11-28 | 2019-01-22 | Mvalve Technologies Ltd. | Intracardiac devices comprising stabilizing elements having improved fatigue resistance |
US10201419B2 (en) | 2014-02-05 | 2019-02-12 | Tendyne Holdings, Inc. | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US11464628B2 (en) | 2014-02-05 | 2022-10-11 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
US11589985B2 (en) | 2014-02-05 | 2023-02-28 | Tendyne Holdings, Inc. | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
US11045183B2 (en) | 2014-02-11 | 2021-06-29 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
US10517728B2 (en) | 2014-03-10 | 2019-12-31 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US11382753B2 (en) | 2014-03-10 | 2022-07-12 | Tendyne Holdings, Inc. | Devices and methods for positioning and monitoring tether load for prosthetic mitral valve |
US10667804B2 (en) | 2014-03-17 | 2020-06-02 | Evalve, Inc. | Mitral valve fixation device removal devices and methods |
US10390943B2 (en) | 2014-03-17 | 2019-08-27 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
US11666433B2 (en) | 2014-03-17 | 2023-06-06 | Evalve, Inc. | Double orifice device for transcatheter mitral valve replacement |
US10307249B2 (en) | 2014-04-30 | 2019-06-04 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9585752B2 (en) | 2014-04-30 | 2017-03-07 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US11376122B2 (en) | 2014-04-30 | 2022-07-05 | Edwards Lifesciences Corporation | Holder and deployment system for surgical heart valves |
US9801720B2 (en) | 2014-06-19 | 2017-10-31 | 4Tech Inc. | Cardiac tissue cinching |
US10314708B2 (en) * | 2014-06-30 | 2019-06-11 | Jiangsu University | Adaptively positioned mitral valve closure plate blocker for repairing mitral regurgitation |
US10695160B2 (en) | 2014-07-17 | 2020-06-30 | Boston Scientific Scimed, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US10136985B2 (en) | 2014-07-17 | 2018-11-27 | Millipede, Inc. | Method of reconfiguring a mitral valve annulus |
US9913706B2 (en) | 2014-07-17 | 2018-03-13 | Millipede, Inc. | Adjustable endolumenal implant for reshaping the mitral valve annulus |
US11701225B2 (en) | 2014-07-30 | 2023-07-18 | Cardiovalve Ltd. | Delivery of a prosthetic valve |
US11872130B2 (en) | 2014-07-30 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic heart valve implant |
US10799359B2 (en) | 2014-09-10 | 2020-10-13 | Cedars-Sinai Medical Center | Method and apparatus for percutaneous delivery and deployment of a cardiac valve prosthesis |
US10105225B2 (en) * | 2014-10-22 | 2018-10-23 | Medtronic, Inc. | Devices, systems and methods for tissue approximation, including approximating mitral valve leaflets |
US20160113762A1 (en) * | 2014-10-22 | 2016-04-28 | Medtronic, Inc. | Devices, systems and methods for tissue approximation, including approximating mitral valve leaflets |
US10758265B2 (en) | 2014-11-14 | 2020-09-01 | Cedars-Sinai Medical Center | Cardiovascular access and device delivery system |
US11653948B2 (en) | 2014-11-14 | 2023-05-23 | Cedars-Sinai Medical Center | Cardiovascular access and device delivery system |
US11389152B2 (en) | 2014-12-02 | 2022-07-19 | 4Tech Inc. | Off-center tissue anchors with tension members |
US9907547B2 (en) | 2014-12-02 | 2018-03-06 | 4Tech Inc. | Off-center tissue anchors |
WO2016094490A3 (en) * | 2014-12-09 | 2016-08-04 | De Canniere Didier | Intracardiac device to correct mitral regurgitation |
US10188392B2 (en) | 2014-12-19 | 2019-01-29 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
US11229435B2 (en) | 2014-12-19 | 2022-01-25 | Abbott Cardiovascular Systems Inc. | Grasping for tissue repair |
US11006956B2 (en) | 2014-12-19 | 2021-05-18 | Abbott Cardiovascular Systems Inc. | Grasping for tissue repair |
US11109863B2 (en) | 2014-12-19 | 2021-09-07 | Abbott Cardiovascular Systems, Inc. | Grasping for tissue repair |
US10786351B2 (en) | 2015-01-07 | 2020-09-29 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
US11801135B2 (en) | 2015-02-05 | 2023-10-31 | Cardiovalve Ltd. | Techniques for deployment of a prosthetic valve |
US11793635B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with angularly offset frames |
US10610356B2 (en) | 2015-02-05 | 2020-04-07 | Tendyne Holdings, Inc. | Expandable epicardial pads and devices and methods for delivery of same |
US11672658B2 (en) | 2015-02-05 | 2023-06-13 | Cardiovalve Ltd. | Prosthetic valve with aligned inner and outer frames |
US11793638B2 (en) | 2015-02-05 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic valve with pivoting tissue anchor portions |
US10258466B2 (en) | 2015-02-13 | 2019-04-16 | Millipede, Inc. | Valve replacement using moveable restrains and angled struts |
US11918462B2 (en) | 2015-02-13 | 2024-03-05 | Boston Scientific Scimed, Inc. | Valve replacement using moveable restraints and angled struts |
US10980529B2 (en) | 2015-03-05 | 2021-04-20 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
US10058321B2 (en) | 2015-03-05 | 2018-08-28 | Ancora Heart, Inc. | Devices and methods of visualizing and determining depth of penetration in cardiac tissue |
US10010315B2 (en) | 2015-03-18 | 2018-07-03 | Mitralign, Inc. | Tissue anchors and percutaneous tricuspid valve repair using a tissue anchor |
US10524912B2 (en) | 2015-04-02 | 2020-01-07 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
US10893941B2 (en) | 2015-04-02 | 2021-01-19 | Abbott Cardiovascular Systems, Inc. | Tissue fixation devices and methods |
US10667905B2 (en) | 2015-04-16 | 2020-06-02 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US11523902B2 (en) | 2015-04-16 | 2022-12-13 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US11590321B2 (en) | 2015-06-19 | 2023-02-28 | Evalve, Inc. | Catheter guiding system and methods |
US10376673B2 (en) | 2015-06-19 | 2019-08-13 | Evalve, Inc. | Catheter guiding system and methods |
US10856988B2 (en) | 2015-06-29 | 2020-12-08 | Evalve, Inc. | Self-aligning radiopaque ring |
US10238494B2 (en) | 2015-06-29 | 2019-03-26 | Evalve, Inc. | Self-aligning radiopaque ring |
US10695170B2 (en) | 2015-07-02 | 2020-06-30 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US10456246B2 (en) | 2015-07-02 | 2019-10-29 | Edwards Lifesciences Corporation | Integrated hybrid heart valves |
US11690714B2 (en) | 2015-07-02 | 2023-07-04 | Edwards Lifesciences Corporation | Hybrid heart valves adapted for post-implant expansion |
US11654020B2 (en) | 2015-07-02 | 2023-05-23 | Edwards Lifesciences Corporation | Hybrid heart valves |
US11759209B2 (en) | 2015-07-21 | 2023-09-19 | Evalve, Inc. | Tissue grasping devices and related methods |
US10667815B2 (en) | 2015-07-21 | 2020-06-02 | Evalve, Inc. | Tissue grasping devices and related methods |
US11096691B2 (en) | 2015-07-21 | 2021-08-24 | Evalve, Inc. | Tissue grasping devices and related methods |
US11241308B2 (en) | 2015-07-23 | 2022-02-08 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US10413408B2 (en) | 2015-08-06 | 2019-09-17 | Evalve, Inc. | Delivery catheter systems, methods, and devices |
US11690709B2 (en) | 2015-09-02 | 2023-07-04 | Edwards Lifesciences Corporation | Methods for securing a transcatheter valve to a bioprosthetic cardiac structure |
US11318012B2 (en) | 2015-09-18 | 2022-05-03 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of prosthetic mitral valve |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
US10335275B2 (en) | 2015-09-29 | 2019-07-02 | Millipede, Inc. | Methods for delivery of heart valve devices using intravascular ultrasound imaging |
US11109972B2 (en) | 2015-10-09 | 2021-09-07 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10238495B2 (en) | 2015-10-09 | 2019-03-26 | Evalve, Inc. | Delivery catheter handle and methods of use |
US11931263B2 (en) | 2015-10-09 | 2024-03-19 | Evalve, Inc. | Delivery catheter handle and methods of use |
US10555813B2 (en) | 2015-11-17 | 2020-02-11 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
US11096782B2 (en) | 2015-12-03 | 2021-08-24 | Tendyne Holdings, Inc. | Frame features for prosthetic mitral valves |
US11464629B2 (en) | 2015-12-28 | 2022-10-11 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10610358B2 (en) | 2015-12-28 | 2020-04-07 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10751182B2 (en) | 2015-12-30 | 2020-08-25 | Edwards Lifesciences Corporation | System and method for reshaping right heart |
US10828160B2 (en) | 2015-12-30 | 2020-11-10 | Edwards Lifesciences Corporation | System and method for reducing tricuspid regurgitation |
US11660192B2 (en) | 2015-12-30 | 2023-05-30 | Edwards Lifesciences Corporation | System and method for reshaping heart |
US11298117B2 (en) | 2016-02-16 | 2022-04-12 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11937795B2 (en) | 2016-02-16 | 2024-03-26 | Cardiovalve Ltd. | Techniques for providing a replacement valve and transseptal communication |
US11253354B2 (en) | 2016-05-03 | 2022-02-22 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US10973662B2 (en) | 2016-05-16 | 2021-04-13 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US11191656B2 (en) | 2016-05-16 | 2021-12-07 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US10456245B2 (en) | 2016-05-16 | 2019-10-29 | Edwards Lifesciences Corporation | System and method for applying material to a stent |
US20200146854A1 (en) * | 2016-05-16 | 2020-05-14 | Elixir Medical Corporation | Methods and devices for heart valve repair |
US11039921B2 (en) | 2016-06-13 | 2021-06-22 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
US11701226B2 (en) | 2016-06-30 | 2023-07-18 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US11090157B2 (en) | 2016-06-30 | 2021-08-17 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US10736632B2 (en) | 2016-07-06 | 2020-08-11 | Evalve, Inc. | Methods and devices for valve clip excision |
US11065116B2 (en) | 2016-07-12 | 2021-07-20 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US10478304B2 (en) | 2016-07-20 | 2019-11-19 | Abbott Cardiovascular Systems Inc. | Independent system for tricuspid valve repair |
US11304807B2 (en) | 2016-07-20 | 2022-04-19 | Abbott Cardiovascular Systems Inc. | Independent system for tricuspid valve repair |
US11779458B2 (en) | 2016-08-10 | 2023-10-10 | Cardiovalve Ltd. | Prosthetic valve with leaflet connectors |
US10537432B2 (en) | 2016-08-15 | 2020-01-21 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
US11241313B2 (en) | 2016-08-15 | 2022-02-08 | The Cleveland Clinic Foundation | Apparatuses and methods for at least partially supporting a valve leaflet of a regurgitant heart valve |
US11071564B2 (en) | 2016-10-05 | 2021-07-27 | Evalve, Inc. | Cardiac valve cutting device |
US11653947B2 (en) | 2016-10-05 | 2023-05-23 | Evalve, Inc. | Cardiac valve cutting device |
US11166818B2 (en) | 2016-11-09 | 2021-11-09 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10363138B2 (en) | 2016-11-09 | 2019-07-30 | Evalve, Inc. | Devices for adjusting the curvature of cardiac valve structures |
US10398553B2 (en) | 2016-11-11 | 2019-09-03 | Evalve, Inc. | Opposing disk device for grasping cardiac valve tissue |
US10426616B2 (en) | 2016-11-17 | 2019-10-01 | Evalve, Inc. | Cardiac implant delivery system |
US10779837B2 (en) | 2016-12-08 | 2020-09-22 | Evalve, Inc. | Adjustable arm device for grasping tissues |
US10314586B2 (en) | 2016-12-13 | 2019-06-11 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
US11406388B2 (en) | 2016-12-13 | 2022-08-09 | Evalve, Inc. | Rotatable device and method for fixing tricuspid valve tissue |
USD846122S1 (en) | 2016-12-16 | 2019-04-16 | Edwards Lifesciences Corporation | Heart valve sizer |
US11033391B2 (en) | 2016-12-22 | 2021-06-15 | Heart Repair Technologies, Inc. | Percutaneous delivery systems for anchoring an implant in a cardiac valve annulus |
US11944537B2 (en) | 2017-01-24 | 2024-04-02 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
US11439501B2 (en) | 2017-01-25 | 2022-09-13 | Cedars-Sinai Medical Center | Device for securing heart valve leaflets |
US10548731B2 (en) | 2017-02-10 | 2020-02-04 | Boston Scientific Scimed, Inc. | Implantable device and delivery system for reshaping a heart valve annulus |
CN110520077A (en) * | 2017-03-06 | 2019-11-29 | 艾维有限责任公司 | For improving the implantation material and method of the engagement of atrioventricular valve |
US10517729B2 (en) | 2017-03-28 | 2019-12-31 | Cardiac Success Ltd. | Method of improving cardiac function |
US11344417B2 (en) | 2017-03-28 | 2022-05-31 | Cardiac Success Ltd. | Device for transcatheterly delivering a band around papillary muscles |
JP2020515375A (en) * | 2017-03-28 | 2020-05-28 | カーディアック・サクセス・リミテッド | How to improve heart function |
US11318018B2 (en) | 2017-03-28 | 2022-05-03 | Cardiac Success Ltd. | Method of improving cardiac function |
US11564798B2 (en) | 2017-03-28 | 2023-01-31 | Cardiac Success Ltd. | Device for improving cardiac function by implanting trabecular band |
US10058428B1 (en) * | 2017-03-28 | 2018-08-28 | Cardiac Success Ltd. | Method of repositioning papillary muscles to improve cardiac function |
US10271950B2 (en) | 2017-03-28 | 2019-04-30 | Cardiac Success Ltd. | Method of improving cardiac function involving looping a band around papillary muscles |
US11850153B2 (en) * | 2017-04-18 | 2023-12-26 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11883611B2 (en) | 2017-04-18 | 2024-01-30 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US20210177582A1 (en) * | 2017-04-18 | 2021-06-17 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
US11045627B2 (en) | 2017-04-18 | 2021-06-29 | Edwards Lifesciences Corporation | Catheter system with linear actuation control mechanism |
US11065119B2 (en) | 2017-05-12 | 2021-07-20 | Evalve, Inc. | Long arm valve repair clip |
US10779829B2 (en) * | 2017-06-07 | 2020-09-22 | Evalve, Inc. | Tissue compression device for cardiac valve repair |
US20180353181A1 (en) * | 2017-06-07 | 2018-12-13 | Evalve, Inc. | Tissue compression device for cardiac valve repair |
US11154399B2 (en) | 2017-07-13 | 2021-10-26 | Tendyne Holdings, Inc. | Prosthetic heart valves and apparatus and methods for delivery of same |
US11793633B2 (en) | 2017-08-03 | 2023-10-24 | Cardiovalve Ltd. | Prosthetic heart valve |
US11571298B2 (en) | 2017-08-03 | 2023-02-07 | Cardiovalve Ltd. | Prosthetic valve with appendages |
US11246704B2 (en) | 2017-08-03 | 2022-02-15 | Cardiovalve Ltd. | Prosthetic heart valve |
US11191639B2 (en) | 2017-08-28 | 2021-12-07 | Tendyne Holdings, Inc. | Prosthetic heart valves with tether coupling features |
US20190069996A1 (en) * | 2017-09-07 | 2019-03-07 | Edwards Lifesciences Corporation | Integral flushing solution for blood stasis prevention in artificial heart valves |
US11337803B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Prosthetic valve with inner and outer frames connected at a location of tissue anchor portion |
US11304805B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with inflatable cuff configured to fill a volume between atrial and ventricular tissue anchors |
US11318015B2 (en) | 2017-09-19 | 2022-05-03 | Cardiovalve Ltd. | Prosthetic valve configured to fill a volume between tissue anchors with native valve tissue |
US11304804B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve, Ltd. | Prosthetic valve with connecting struts of variable size and tissue anchoring legs of variable size that extend from junctions |
US11819405B2 (en) | 2017-09-19 | 2023-11-21 | Cardiovalve Ltd. | Prosthetic valve with inflatable cuff configured for radial extension |
US11304806B2 (en) | 2017-09-19 | 2022-04-19 | Cardiovalve Ltd. | Prosthetic valve with atrial tissue anchors having variable flexibility and ventricular tissue anchors having constant flexibility |
US11337804B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Prosthetic valve with radially-deformable tissue anchors configured to restrict axial valve migration |
US11864996B2 (en) | 2017-09-19 | 2024-01-09 | Cardiovalve Ltd. | Prosthetic valve with protective sleeve around an outlet rim |
US11337802B2 (en) | 2017-09-19 | 2022-05-24 | Cardiovalve Ltd. | Heart valve delivery systems and methods |
US11318014B2 (en) | 2017-09-19 | 2022-05-03 | Cardiovalve Ltd. | Prosthetic valve delivery system with multi-planar steering |
US10806579B2 (en) | 2017-10-20 | 2020-10-20 | Boston Scientific Scimed, Inc. | Heart valve repair implant for treating tricuspid regurgitation |
US11464638B2 (en) | 2017-10-23 | 2022-10-11 | Cardiac Success Ltd | Adjustable self-locking papillary muscle band |
US11318019B2 (en) | 2017-10-23 | 2022-05-03 | Cardiac Success Ltd. | Papillary muscle band with smooth closure |
US11628064B2 (en) | 2017-10-23 | 2023-04-18 | Cardiac Success Ltd. | Adjustable self-locking papillary muscle band |
US10548732B2 (en) | 2017-10-23 | 2020-02-04 | Cardiac Success Ltd. | Adjustable self-locking papillary muscle band |
US11382746B2 (en) | 2017-12-13 | 2022-07-12 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11872131B2 (en) | 2017-12-13 | 2024-01-16 | Cardiovalve Ltd. | Prosthetic valve and delivery tool therefor |
US11337805B2 (en) | 2018-01-23 | 2022-05-24 | Edwards Lifesciences Corporation | Prosthetic valve holders, systems, and methods |
US11291544B2 (en) | 2018-02-02 | 2022-04-05 | Cedars-Sinai Medical Center | Delivery platforms, devices, and methods for tricuspid valve repair |
CN108309504A (en) * | 2018-02-27 | 2018-07-24 | 宁波迪创医疗科技有限公司 | A kind of ventricular assist device enhancing heart function |
US11931261B2 (en) | 2018-03-20 | 2024-03-19 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11701228B2 (en) | 2018-03-20 | 2023-07-18 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11786366B2 (en) | 2018-04-04 | 2023-10-17 | Vdyne, Inc. | Devices and methods for anchoring transcatheter heart valve |
US11207181B2 (en) * | 2018-04-18 | 2021-12-28 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
USD995774S1 (en) | 2018-07-11 | 2023-08-15 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
USD908874S1 (en) | 2018-07-11 | 2021-01-26 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
USD952143S1 (en) | 2018-07-11 | 2022-05-17 | Edwards Lifesciences Corporation | Collapsible heart valve sizer |
US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
US11273033B2 (en) | 2018-09-20 | 2022-03-15 | Vdyne, Inc. | Side-delivered transcatheter heart valve replacement |
US11344413B2 (en) | 2018-09-20 | 2022-05-31 | Vdyne, Inc. | Transcatheter deliverable prosthetic heart valves and methods of delivery |
US11278437B2 (en) | 2018-12-08 | 2022-03-22 | Vdyne, Inc. | Compression capable annular frames for side delivery of transcatheter heart valve replacement |
US11253359B2 (en) | 2018-12-20 | 2022-02-22 | Vdyne, Inc. | Proximal tab for side-delivered transcatheter heart valves and methods of delivery |
US11273032B2 (en) | 2019-01-26 | 2022-03-15 | Vdyne, Inc. | Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis |
US11298227B2 (en) * | 2019-03-05 | 2022-04-12 | Vdyne, Inc. | Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis |
US11202706B2 (en) | 2019-05-04 | 2021-12-21 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
US11712335B2 (en) | 2019-05-04 | 2023-08-01 | Vdyne, Inc. | Cinch device and method for deployment of a side-delivered prosthetic heart valve in a native annulus |
US11672524B2 (en) | 2019-07-15 | 2023-06-13 | Ancora Heart, Inc. | Devices and methods for tether cutting |
US11344412B2 (en) | 2019-08-20 | 2022-05-31 | Vdyne, Inc. | Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves |
US11331186B2 (en) | 2019-08-26 | 2022-05-17 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11337807B2 (en) | 2019-08-26 | 2022-05-24 | Vdyne, Inc. | Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same |
US11648110B2 (en) | 2019-12-05 | 2023-05-16 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11234813B2 (en) | 2020-01-17 | 2022-02-01 | Vdyne, Inc. | Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery |
US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
US11751995B2 (en) * | 2020-03-30 | 2023-09-12 | Tendyne Holdings, Inc. | Apparatus and methods for minimally invasive transapical access |
US20210298899A1 (en) * | 2020-03-30 | 2021-09-30 | Tendyne Holdings, Inc. | Apparatus And Methods For Minimally Invasive Transapical Access |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
US11957577B2 (en) | 2020-03-31 | 2024-04-16 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
US11857417B2 (en) | 2020-08-16 | 2024-01-02 | Trilio Medical Ltd. | Leaflet support |
US11678980B2 (en) | 2020-08-19 | 2023-06-20 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
US11957358B2 (en) | 2020-09-21 | 2024-04-16 | Evalve, Inc. | Adjustable arm device for grasping tissues |
Also Published As
Publication number | Publication date |
---|---|
EP3539508B1 (en) | 2021-07-28 |
EP1855623B1 (en) | 2019-04-17 |
EP3967269A2 (en) | 2022-03-16 |
WO2006086434A1 (en) | 2006-08-17 |
US20160242909A1 (en) | 2016-08-25 |
EP3539508A1 (en) | 2019-09-18 |
US20180250132A1 (en) | 2018-09-06 |
US10667911B2 (en) | 2020-06-02 |
EP1855623A1 (en) | 2007-11-21 |
CA2597066A1 (en) | 2006-08-17 |
CA2597066C (en) | 2014-04-15 |
US20130282059A1 (en) | 2013-10-24 |
AU2006212750B2 (en) | 2011-11-17 |
US20190350710A1 (en) | 2019-11-21 |
EP3967269A3 (en) | 2022-07-13 |
AU2006212750A1 (en) | 2006-08-17 |
US20090177266A1 (en) | 2009-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210393404A1 (en) | Methods, systems and devices for cardiac valve repair | |
US10667911B2 (en) | Methods, systems and devices for cardiac valve repair | |
US9060858B2 (en) | Methods, systems and devices for cardiac valve repair | |
EP2410948B1 (en) | Devices for cardiac valve repair | |
US8470028B2 (en) | Methods, systems and devices for cardiac valve repair | |
US20100298929A1 (en) | Methods, systems and devices for cardiac valve repair | |
CA2822801A1 (en) | Methods, systems and devices for cardiac valve repair | |
US7112219B2 (en) | Devices and methods for heart valve treatment | |
EP3238663B1 (en) | Devices and systems for reshaping a heart valve annulus | |
CN111885982A (en) | Flexible canopy valve repair system and method of use | |
CN111212614A (en) | Axisymmetric adjustable device for treating mitral regurgitation | |
US20150025553A1 (en) | Right ventricular papillary approximation | |
US11253360B2 (en) | Low profile tissue anchor for minimally invasive heart valve repair | |
WO2020123763A1 (en) | Wire annuloplasty ring |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: EVALVE, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POWELL, FEROLYN;THORNTON, TROY I.;GOLDFARH, ERIC A.;AND OTHERS;REEL/FRAME:017812/0033;SIGNING DATES FROM 20060420 TO 20060503 |
|
AS | Assignment |
Owner name: ABBOTT VASCULAR INC., CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:EVALVE, INC.;REEL/FRAME:023245/0637 Effective date: 20090909 Owner name: ABBOTT VASCULAR INC.,CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:EVALVE, INC.;REEL/FRAME:023245/0637 Effective date: 20090909 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |